id	sid	tid	token	lemma	pos
dti-2573	1	1	dti	dti	PROPN
dti-2573	1	2	drug	drug	PROPN
dti-2573	1	3	target	target	NOUN
dti-2573	1	4	insights	insight	NOUN
dti-2573	1	5	2023	2023	NUM
dti-2573	1	6	;	;	PUNCT
dti-2573	1	7	17	17	NUM
dti-2573	1	8	:	:	PUNCT
dti-2573	1	9	54	54	NUM
dti-2573	1	10	-	-	SYM
dti-2573	1	11	57	57	NUM
dti-2573	1	12	issn	issn	PROPN
dti-2573	1	13	1177	1177	NUM
dti-2573	1	14	-	-	SYM
dti-2573	1	15	3928	3928	NUM
dti-2573	1	16	|	|	ADV
dti-2573	1	17	doi	doi	NOUN
dti-2573	1	18	:	:	PUNCT
dti-2573	1	19	10.33393	10.33393	NUM
dti-2573	1	20	/	/	SYM
dti-2573	1	21	dti.2023.2573	dti.2023.2573	PRON
dti-2573	1	22	original	original	ADJ
dti-2573	1	23	research	research	NOUN
dti-2573	1	24	article	article	NOUN
dti-2573	1	25	drug	drug	NOUN
dti-2573	1	26	target	target	NOUN
dti-2573	1	27	insights	insight	NOUN
dti-2573	1	28	issn	issn	VERB
dti-2573	1	29	1177	1177	NUM
dti-2573	1	30	-	-	SYM
dti-2573	1	31	3928	3928	NUM
dti-2573	1	32	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2573	1	33	©	©	PROPN
dti-2573	1	34	2023	2023	NUM
dti-2573	1	35	the	the	DET
dti-2573	1	36	authors	author	NOUN
dti-2573	1	37	.	.	PUNCT
dti-2573	2	1	this	this	DET
dti-2573	2	2	article	article	NOUN
dti-2573	2	3	is	be	AUX
dti-2573	2	4	published	publish	VERB
dti-2573	2	5	by	by	ADP
dti-2573	2	6	aboutscience	aboutscience	NOUN
dti-2573	2	7	and	and	CCONJ
dti-2573	2	8	licensed	license	VERB
dti-2573	2	9	under	under	ADP
dti-2573	2	10	creative	creative	ADJ
dti-2573	2	11	commons	common	NOUN
dti-2573	2	12	attribution	attribution	NOUN
dti-2573	2	13	-	-	PUNCT
dti-2573	2	14	noncommercial	noncommercial	ADJ
dti-2573	2	15	4.0	4.0	NUM
dti-2573	2	16	international	international	NOUN
dti-2573	2	17	(	(	PUNCT
dti-2573	2	18	cc	cc	NOUN
dti-2573	2	19	by	by	ADP
dti-2573	2	20	-	-	PUNCT
dti-2573	2	21	nc	nc	PROPN
dti-2573	2	22	4.0	4.0	NUM
dti-2573	2	23	)	)	PUNCT
dti-2573	2	24	.	.	PUNCT
dti-2573	3	1	commercial	commercial	ADJ
dti-2573	3	2	use	use	NOUN
dti-2573	3	3	is	be	AUX
dti-2573	3	4	not	not	PART
dti-2573	3	5	permitted	permit	VERB
dti-2573	3	6	and	and	CCONJ
dti-2573	3	7	is	be	AUX
dti-2573	3	8	subject	subject	ADJ
dti-2573	3	9	to	to	ADP
dti-2573	3	10	publisher	publisher	NOUN
dti-2573	3	11	’s	’s	PART
dti-2573	3	12	permissions	permission	NOUN
dti-2573	3	13	.	.	PUNCT
dti-2573	4	1	full	full	ADJ
dti-2573	4	2	information	information	NOUN
dti-2573	4	3	is	be	AUX
dti-2573	4	4	available	available	ADJ
dti-2573	4	5	at	at	ADP
dti-2573	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2573	4	7	are	be	AUX
dti-2573	4	8	calcium	calcium	NOUN
dti-2573	4	9	channel	channel	NOUN
dti-2573	4	10	blockers	blocker	NOUN
dti-2573	4	11	related	relate	VERB
dti-2573	4	12	to	to	ADP
dti-2573	4	13	lung	lung	NOUN
dti-2573	4	14	cancer	cancer	NOUN
dti-2573	4	15	?	?	PUNCT
dti-2573	5	1	ratchanon	ratchanon	NOUN
dti-2573	5	2	rattanathanoo	rattanathanoo	PROPN
dti-2573	5	3	,	,	PUNCT
dti-2573	5	4	jarin	jarin	PROPN
dti-2573	5	5	chindaprasirt	chindaprasirt	PROPN
dti-2573	5	6	,	,	PUNCT
dti-2573	5	7	watchara	watchara	PROPN
dti-2573	5	8	boonsawat	boonsawat	PROPN
dti-2573	5	9	,	,	PUNCT
dti-2573	5	10	panita	panita	PROPN
dti-2573	5	11	limpawattana	limpawattana	PROPN
dti-2573	5	12	,	,	PUNCT
dti-2573	5	13	sittichai	sittichai	PROPN
dti-2573	5	14	khamsai	khamsai	PROPN
dti-2573	5	15	,	,	PUNCT
dti-2573	5	16	kittisak	kittisak	PROPN
dti-2573	5	17	sawanyawisuth	sawanyawisuth	PROPN
dti-2573	5	18	department	department	PROPN
dti-2573	5	19	of	of	ADP
dti-2573	5	20	medicine	medicine	NOUN
dti-2573	5	21	,	,	PUNCT
dti-2573	5	22	faculty	faculty	NOUN
dti-2573	5	23	of	of	ADP
dti-2573	5	24	medicine	medicine	NOUN
dti-2573	5	25	,	,	PUNCT
dti-2573	5	26	khon	khon	PROPN
dti-2573	5	27	kaen	kaen	PROPN
dti-2573	5	28	university	university	PROPN
dti-2573	5	29	,	,	PUNCT
dti-2573	5	30	khon	khon	PROPN
dti-2573	5	31	kaen	kaen	PROPN
dti-2573	5	32	thailand	thailand	PROPN
dti-2573	6	1	abstract	abstract	PROPN
dti-2573	6	2	background	background	NOUN
dti-2573	6	3	:	:	PUNCT
dti-2573	6	4	calcium	calcium	NOUN
dti-2573	6	5	channel	channel	NOUN
dti-2573	6	6	blocker	blocker	NOUN
dti-2573	6	7	(	(	PUNCT
dti-2573	6	8	ccb	ccb	PROPN
dti-2573	6	9	)	)	PUNCT
dti-2573	6	10	is	be	AUX
dti-2573	6	11	a	a	DET
dti-2573	6	12	common	common	ADJ
dti-2573	6	13	antihypertensive	antihypertensive	ADJ
dti-2573	6	14	agent	agent	NOUN
dti-2573	6	15	for	for	ADP
dti-2573	6	16	the	the	DET
dti-2573	6	17	treatment	treatment	NOUN
dti-2573	6	18	of	of	ADP
dti-2573	6	19	hypertension	hypertension	NOUN
dti-2573	6	20	.	.	PUNCT
dti-2573	7	1	there	there	PRON
dti-2573	7	2	are	be	VERB
dti-2573	7	3	inconsistent	inconsistent	ADJ
dti-2573	7	4	data	datum	NOUN
dti-2573	7	5	of	of	ADP
dti-2573	7	6	an	an	DET
dti-2573	7	7	association	association	NOUN
dti-2573	7	8	of	of	ADP
dti-2573	7	9	ccb	ccb	PROPN
dti-2573	7	10	and	and	CCONJ
dti-2573	7	11	lung	lung	NOUN
dti-2573	7	12	cancer	cancer	NOUN
dti-2573	7	13	in	in	ADP
dti-2573	7	14	the	the	DET
dti-2573	7	15	literature	literature	NOUN
dti-2573	7	16	.	.	PUNCT
dti-2573	8	1	this	this	DET
dti-2573	8	2	study	study	NOUN
dti-2573	8	3	aimed	aim	VERB
dti-2573	8	4	to	to	PART
dti-2573	8	5	evaluate	evaluate	VERB
dti-2573	8	6	this	this	DET
dti-2573	8	7	association	association	NOUN
dti-2573	8	8	by	by	ADP
dti-2573	8	9	a	a	DET
dti-2573	8	10	case	case	NOUN
dti-2573	8	11	-	-	PUNCT
dti-2573	8	12	control	control	NOUN
dti-2573	8	13	design	design	NOUN
dti-2573	8	14	.	.	PUNCT
dti-2573	9	1	methods	method	NOUN
dti-2573	9	2	:	:	PUNCT
dti-2573	9	3	the	the	DET
dti-2573	9	4	inclusion	inclusion	NOUN
dti-2573	9	5	criteria	criterion	NOUN
dti-2573	9	6	were	be	AUX
dti-2573	9	7	adult	adult	NOUN
dti-2573	9	8	patients	patient	NOUN
dti-2573	9	9	18	18	NUM
dti-2573	9	10	years	year	NOUN
dti-2573	9	11	or	or	CCONJ
dti-2573	9	12	over	over	ADV
dti-2573	9	13	,	,	PUNCT
dti-2573	9	14	diagnosed	diagnose	VERB
dti-2573	9	15	with	with	ADP
dti-2573	9	16	hypertension	hypertension	NOUN
dti-2573	9	17	,	,	PUNCT
dti-2573	9	18	lung	lung	NOUN
dti-2573	9	19	cancer	cancer	NOUN
dti-2573	9	20	or	or	CCONJ
dti-2573	9	21	pulmonary	pulmonary	ADJ
dti-2573	9	22	tuberculosis	tuberculosis	NOUN
dti-2573	9	23	,	,	PUNCT
dti-2573	9	24	and	and	CCONJ
dti-2573	9	25	presenting	present	VERB
dti-2573	9	26	with	with	ADP
dti-2573	9	27	one	one	NUM
dti-2573	9	28	of	of	ADP
dti-2573	9	29	the	the	DET
dti-2573	9	30	suggestive	suggestive	ADJ
dti-2573	9	31	symptoms	symptom	NOUN
dti-2573	9	32	of	of	ADP
dti-2573	9	33	lung	lung	NOUN
dti-2573	9	34	cancer	cancer	NOUN
dti-2573	9	35	.	.	PUNCT
dti-2573	10	1	those	those	PRON
dti-2573	10	2	who	who	PRON
dti-2573	10	3	were	be	AUX
dti-2573	10	4	pregnant	pregnant	ADJ
dti-2573	10	5	or	or	CCONJ
dti-2573	10	6	had	have	VERB
dti-2573	10	7	a	a	DET
dti-2573	10	8	diagnosis	diagnosis	NOUN
dti-2573	10	9	of	of	ADP
dti-2573	10	10	lung	lung	NOUN
dti-2573	10	11	cancer	cancer	NOUN
dti-2573	10	12	or	or	CCONJ
dti-2573	10	13	pulmonary	pulmonary	ADJ
dti-2573	10	14	tuberculosis	tuberculosis	NOUN
dti-2573	10	15	prior	prior	ADV
dti-2573	10	16	to	to	ADP
dti-2573	10	17	the	the	DET
dti-2573	10	18	diagnosis	diagnosis	NOUN
dti-2573	10	19	of	of	ADP
dti-2573	10	20	hypertension	hypertension	NOUN
dti-2573	10	21	were	be	AUX
dti-2573	10	22	excluded	exclude	VERB
dti-2573	10	23	.	.	PUNCT
dti-2573	11	1	diagnosis	diagnosis	NOUN
dti-2573	11	2	of	of	ADP
dti-2573	11	3	lung	lung	NOUN
dti-2573	11	4	cancer	cancer	NOUN
dti-2573	11	5	was	be	AUX
dti-2573	11	6	made	make	VERB
dti-2573	11	7	pathologically	pathologically	ADV
dti-2573	11	8	,	,	PUNCT
dti-2573	11	9	while	while	SCONJ
dti-2573	11	10	tuberculosis	tuberculosis	NOUN
dti-2573	11	11	was	be	AUX
dti-2573	11	12	made	make	VERB
dti-2573	11	13	by	by	ADP
dti-2573	11	14	positive	positive	ADJ
dti-2573	11	15	acid	acid	NOUN
dti-2573	11	16	-	-	PUNCT
dti-2573	11	17	fast	fast	ADJ
dti-2573	11	18	bacilli	bacilli	NOUN
dti-2573	11	19	on	on	ADP
dti-2573	11	20	sputum	sputum	PROPN
dti-2573	11	21	examination	examination	NOUN
dti-2573	11	22	,	,	PUNCT
dti-2573	11	23	sputum	sputum	PROPN
dti-2573	11	24	culture	culture	NOUN
dti-2573	11	25	positive	positive	ADJ
dti-2573	11	26	for	for	ADP
dti-2573	11	27	mycobacterium	mycobacterium	NOUN
dti-2573	11	28	tuberculosis	tuberculosis	NOUN
dti-2573	11	29	,	,	PUNCT
dti-2573	11	30	or	or	CCONJ
dti-2573	11	31	polymerase	polymerase	NOUN
dti-2573	11	32	chain	chain	NOUN
dti-2573	11	33	reaction	reaction	NOUN
dti-2573	11	34	positive	positive	ADJ
dti-2573	11	35	for	for	ADP
dti-2573	11	36	m.	m.	NOUN
dti-2573	11	37	tuberculosis	tuberculosis	NOUN
dti-2573	11	38	with	with	ADP
dti-2573	11	39	a	a	DET
dti-2573	11	40	chest	chest	NOUN
dti-2573	11	41	x	x	NOUN
dti-2573	11	42	-	-	NOUN
dti-2573	11	43	ray	ray	NOUN
dti-2573	11	44	compatible	compatible	ADJ
dti-2573	11	45	with	with	ADP
dti-2573	11	46	tuberculosis	tuberculosis	NOUN
dti-2573	11	47	.	.	PUNCT
dti-2573	12	1	cases	case	NOUN
dti-2573	12	2	were	be	AUX
dti-2573	12	3	those	those	PRON
dti-2573	12	4	diagnosed	diagnose	VERB
dti-2573	12	5	with	with	ADP
dti-2573	12	6	lung	lung	NOUN
dti-2573	12	7	cancer	cancer	NOUN
dti-2573	12	8	,	,	PUNCT
dti-2573	12	9	while	while	SCONJ
dti-2573	12	10	controls	control	NOUN
dti-2573	12	11	were	be	AUX
dti-2573	12	12	those	those	PRON
dti-2573	12	13	diagnosed	diagnose	VERB
dti-2573	12	14	with	with	ADP
dti-2573	12	15	tuberculosis	tuberculosis	NOUN
dti-2573	12	16	.	.	PUNCT
dti-2573	13	1	factors	factor	NOUN
dti-2573	13	2	associated	associate	VERB
dti-2573	13	3	with	with	ADP
dti-2573	13	4	lung	lung	NOUN
dti-2573	13	5	cancer	cancer	NOUN
dti-2573	13	6	were	be	AUX
dti-2573	13	7	calculated	calculate	VERB
dti-2573	13	8	by	by	ADP
dti-2573	13	9	logistic	logistic	ADJ
dti-2573	13	10	regression	regression	NOUN
dti-2573	13	11	analysis	analysis	NOUN
dti-2573	13	12	.	.	PUNCT
dti-2573	14	1	results	result	NOUN
dti-2573	14	2	:	:	PUNCT
dti-2573	14	3	there	there	PRON
dti-2573	14	4	were	be	VERB
dti-2573	14	5	178	178	NUM
dti-2573	14	6	patients	patient	NOUN
dti-2573	14	7	who	who	PRON
dti-2573	14	8	met	meet	VERB
dti-2573	14	9	the	the	DET
dti-2573	14	10	study	study	NOUN
dti-2573	14	11	criteria	criterion	NOUN
dti-2573	14	12	.	.	PUNCT
dti-2573	15	1	of	of	ADP
dti-2573	15	2	those	those	PRON
dti-2573	15	3	,	,	PUNCT
dti-2573	15	4	69	69	NUM
dti-2573	15	5	patients	patient	NOUN
dti-2573	15	6	(	(	PUNCT
dti-2573	15	7	38.8	38.8	NUM
dti-2573	15	8	%	%	NOUN
dti-2573	15	9	)	)	PUNCT
dti-2573	15	10	were	be	AUX
dti-2573	15	11	in	in	ADP
dti-2573	15	12	the	the	DET
dti-2573	15	13	case	case	NOUN
dti-2573	15	14	group	group	NOUN
dti-2573	15	15	.	.	PUNCT
dti-2573	16	1	the	the	DET
dti-2573	16	2	lung	lung	PROPN
dti-2573	16	3	cancer	cancer	NOUN
dti-2573	16	4	group	group	NOUN
dti-2573	16	5	had	have	VERB
dti-2573	16	6	egfr	egfr	ADJ
dti-2573	16	7	gene	gene	NOUN
dti-2573	16	8	mutation	mutation	NOUN
dti-2573	16	9	in	in	ADP
dti-2573	16	10	21	21	NUM
dti-2573	16	11	patients	patient	NOUN
dti-2573	16	12	(	(	PUNCT
dti-2573	16	13	52.5	52.5	NUM
dti-2573	16	14	%	%	NOUN
dti-2573	16	15	)	)	PUNCT
dti-2573	16	16	and	and	CCONJ
dti-2573	16	17	adenocarcinoma	adenocarcinoma	NOUN
dti-2573	16	18	was	be	AUX
dti-2573	16	19	the	the	DET
dti-2573	16	20	most	most	ADV
dti-2573	16	21	common	common	ADJ
dti-2573	16	22	cell	cell	NOUN
dti-2573	16	23	type	type	NOUN
dti-2573	16	24	of	of	ADP
dti-2573	16	25	lung	lung	NOUN
dti-2573	16	26	cancer	cancer	NOUN
dti-2573	16	27	(	(	PUNCT
dti-2573	16	28	55	55	NUM
dti-2573	16	29	patients	patient	NOUN
dti-2573	16	30	;	;	PUNCT
dti-2573	16	31	79.7	79.7	NUM
dti-2573	16	32	%	%	NOUN
dti-2573	16	33	)	)	PUNCT
dti-2573	16	34	.	.	PUNCT
dti-2573	17	1	there	there	PRON
dti-2573	17	2	were	be	VERB
dti-2573	17	3	two	two	NUM
dti-2573	17	4	factors	factor	NOUN
dti-2573	17	5	independently	independently	ADV
dti-2573	17	6	associated	associate	VERB
dti-2573	17	7	with	with	ADP
dti-2573	17	8	lung	lung	NOUN
dti-2573	17	9	cancer	cancer	NOUN
dti-2573	17	10	including	include	VERB
dti-2573	17	11	dyslipidemia	dyslipidemia	NOUN
dti-2573	17	12	and	and	CCONJ
dti-2573	17	13	family	family	NOUN
dti-2573	17	14	history	history	NOUN
dti-2573	17	15	of	of	ADP
dti-2573	17	16	lung	lung	NOUN
dti-2573	17	17	cancer	cancer	NOUN
dti-2573	17	18	.	.	PUNCT
dti-2573	18	1	conclusions	conclusion	NOUN
dti-2573	18	2	:	:	PUNCT
dti-2573	19	1	ccb	ccb	PROPN
dti-2573	19	2	was	be	AUX
dti-2573	19	3	not	not	PART
dti-2573	19	4	associated	associate	VERB
dti-2573	19	5	with	with	ADP
dti-2573	19	6	lung	lung	NOUN
dti-2573	19	7	cancer	cancer	NOUN
dti-2573	19	8	in	in	ADP
dti-2573	19	9	patients	patient	NOUN
dti-2573	19	10	with	with	ADP
dti-2573	19	11	hypertension	hypertension	NOUN
dti-2573	19	12	but	but	CCONJ
dti-2573	19	13	dyslipidemia	dyslipidemia	NOUN
dti-2573	19	14	and	and	CCONJ
dti-2573	19	15	family	family	NOUN
dti-2573	19	16	history	history	NOUN
dti-2573	19	17	of	of	ADP
dti-2573	19	18	lung	lung	NOUN
dti-2573	19	19	cancer	cancer	NOUN
dti-2573	19	20	were	be	AUX
dti-2573	19	21	independently	independently	ADV
dti-2573	19	22	associated	associate	VERB
dti-2573	19	23	with	with	ADP
dti-2573	19	24	lung	lung	NOUN
dti-2573	19	25	cancer	cancer	NOUN
dti-2573	19	26	in	in	ADP
dti-2573	19	27	this	this	DET
dti-2573	19	28	setting	setting	NOUN
dti-2573	19	29	.	.	PUNCT
dti-2573	20	1	keywords	keyword	NOUN
dti-2573	20	2	:	:	PUNCT
dti-2573	20	3	dyslipidemia	dyslipidemia	NOUN
dti-2573	20	4	,	,	PUNCT
dti-2573	20	5	family	family	NOUN
dti-2573	20	6	history	history	NOUN
dti-2573	20	7	,	,	PUNCT
dti-2573	20	8	risk	risk	NOUN
dti-2573	20	9	factors	factor	NOUN
dti-2573	20	10	received	receive	VERB
dti-2573	20	11	:	:	PUNCT
dti-2573	20	12	february	february	PROPN
dti-2573	20	13	7	7	NUM
dti-2573	20	14	,	,	PUNCT
dti-2573	20	15	2023	2023	NUM
dti-2573	20	16	accepted	accept	VERB
dti-2573	20	17	:	:	PUNCT
dti-2573	20	18	may	may	AUX
dti-2573	20	19	1	1	NUM
dti-2573	20	20	,	,	PUNCT
dti-2573	20	21	2023	2023	NUM
dti-2573	20	22	published	publish	VERB
dti-2573	20	23	online	online	ADV
dti-2573	20	24	:	:	PUNCT
dti-2573	20	25	may	may	AUX
dti-2573	20	26	19	19	NUM
dti-2573	20	27	,	,	PUNCT
dti-2573	20	28	2023	2023	NUM
dti-2573	20	29	corresponding	correspond	VERB
dti-2573	20	30	author	author	NOUN
dti-2573	20	31	:	:	PUNCT
dti-2573	20	32	sittichai	sittichai	PROPN
dti-2573	20	33	khamsai	khamsai	PROPN
dti-2573	20	34	department	department	PROPN
dti-2573	20	35	of	of	ADP
dti-2573	20	36	medicine	medicine	NOUN
dti-2573	20	37	,	,	PUNCT
dti-2573	20	38	khon	khon	PROPN
dti-2573	20	39	kaen	kaen	PROPN
dti-2573	20	40	university	university	PROPN
dti-2573	20	41	khon	khon	PROPN
dti-2573	20	42	kaen	kaen	PROPN
dti-2573	20	43	40002	40002	NUM
dti-2573	21	1	thailand	thailand	PROPN
dti-2573	21	2	sittikh@kku.ac.th	sittikh@kku.ac.th	PROPN
dti-2573	21	3	kittisak	kittisak	PROPN
dti-2573	21	4	sawanyawisuth	sawanyawisuth	PROPN
dti-2573	21	5	123	123	NUM
dti-2573	21	6	mitraparp	mitraparp	ADJ
dti-2573	21	7	road	road	NOUN
dti-2573	21	8	,	,	PUNCT
dti-2573	21	9	department	department	NOUN
dti-2573	21	10	of	of	ADP
dti-2573	21	11	medicine	medicine	NOUN
dti-2573	21	12	faculty	faculty	NOUN
dti-2573	21	13	of	of	ADP
dti-2573	21	14	medicine	medicine	NOUN
dti-2573	21	15	,	,	PUNCT
dti-2573	21	16	khon	khon	PROPN
dti-2573	21	17	kaen	kaen	PROPN
dti-2573	21	18	university	university	PROPN
dti-2573	21	19	khon	khon	PROPN
dti-2573	21	20	kaen	kaen	PROPN
dti-2573	21	21	,	,	PUNCT
dti-2573	21	22	40002	40002	NUM
dti-2573	21	23	thailand	thailand	PROPN
dti-2573	21	24	kittisak@kku.ac.th	kittisak@kku.ac.th	PROPN
dti-2573	21	25	in	in	ADP
dti-2573	21	26	reduction	reduction	NOUN
dti-2573	21	27	of	of	ADP
dti-2573	21	28	stroke	stroke	NOUN
dti-2573	21	29	by	by	ADP
dti-2573	21	30	up	up	ADP
dti-2573	21	31	to	to	PART
dti-2573	21	32	40	40	NUM
dti-2573	21	33	%	%	NOUN
dti-2573	21	34	,	,	PUNCT
dti-2573	21	35	and	and	CCONJ
dti-2573	21	36	reduction	reduction	NOUN
dti-2573	21	37	in	in	ADP
dti-2573	21	38	heart	heart	NOUN
dti-2573	21	39	failure	failure	NOUN
dti-2573	21	40	by	by	ADP
dti-2573	21	41	up	up	ADP
dti-2573	21	42	to	to	PART
dti-2573	21	43	50	50	NUM
dti-2573	21	44	%	%	NOUN
dti-2573	21	45	(	(	PUNCT
dti-2573	21	46	3	3	NUM
dti-2573	21	47	)	)	PUNCT
dti-2573	21	48	.	.	PUNCT
dti-2573	22	1	additionally	additionally	ADV
dti-2573	22	2	,	,	PUNCT
dti-2573	22	3	treatment	treatment	NOUN
dti-2573	22	4	of	of	ADP
dti-2573	22	5	conditions	condition	NOUN
dti-2573	22	6	or	or	CCONJ
dti-2573	22	7	comorbid	comorbid	NOUN
dti-2573	22	8	diseases	disease	NOUN
dti-2573	22	9	of	of	ADP
dti-2573	22	10	hypertension	hypertension	NOUN
dti-2573	22	11	is	be	AUX
dti-2573	22	12	also	also	ADV
dti-2573	22	13	crucial	crucial	ADJ
dti-2573	22	14	(	(	PUNCT
dti-2573	22	15	4	4	NUM
dti-2573	22	16	-	-	SYM
dti-2573	22	17	8)	8)	NUM
dti-2573	22	18	.	.	PUNCT
dti-2573	23	1	antihypertensive	antihypertensive	ADJ
dti-2573	23	2	agents	agent	NOUN
dti-2573	23	3	are	be	AUX
dti-2573	23	4	effective	effective	ADJ
dti-2573	23	5	in	in	ADP
dti-2573	23	6	blood	blood	NOUN
dti-2573	23	7	pressure	pressure	NOUN
dti-2573	23	8	lowering	lower	VERB
dti-2573	23	9	including	include	VERB
dti-2573	23	10	calcium	calcium	NOUN
dti-2573	23	11	channel	channel	NOUN
dti-2573	23	12	blockers	blocker	NOUN
dti-2573	23	13	(	(	PUNCT
dti-2573	23	14	ccbs	ccbs	PROPN
dti-2573	23	15	)	)	PUNCT
dti-2573	23	16	.	.	PUNCT
dti-2573	24	1	even	even	ADV
dti-2573	24	2	though	though	SCONJ
dti-2573	24	3	ccb	ccb	PROPN
dti-2573	24	4	is	be	AUX
dti-2573	24	5	recommended	recommend	VERB
dti-2573	24	6	as	as	ADP
dti-2573	24	7	the	the	DET
dti-2573	24	8	first	first	ADJ
dti-2573	24	9	-	-	PUNCT
dti-2573	24	10	line	line	NOUN
dti-2573	24	11	treatment	treatment	NOUN
dti-2573	24	12	for	for	ADP
dti-2573	24	13	hypertension	hypertension	NOUN
dti-2573	24	14	(	(	PUNCT
dti-2573	24	15	9	9	NUM
dti-2573	24	16	)	)	PUNCT
dti-2573	24	17	,	,	PUNCT
dti-2573	24	18	it	it	PRON
dti-2573	24	19	has	have	AUX
dti-2573	24	20	been	be	AUX
dti-2573	24	21	reported	report	VERB
dti-2573	24	22	to	to	PART
dti-2573	24	23	be	be	AUX
dti-2573	24	24	increasing	increase	VERB
dti-2573	24	25	the	the	DET
dti-2573	24	26	risk	risk	NOUN
dti-2573	24	27	of	of	ADP
dti-2573	24	28	cancer	cancer	NOUN
dti-2573	24	29	(	(	PUNCT
dti-2573	24	30	10	10	NUM
dti-2573	24	31	)	)	PUNCT
dti-2573	24	32	.	.	PUNCT
dti-2573	25	1	several	several	ADJ
dti-2573	25	2	studies	study	NOUN
dti-2573	25	3	including	include	VERB
dti-2573	25	4	a	a	DET
dti-2573	25	5	meta	meta	ADJ
dti-2573	25	6	-	-	PUNCT
dti-2573	25	7	analysis	analysis	NOUN
dti-2573	25	8	showed	show	VERB
dti-2573	25	9	that	that	SCONJ
dti-2573	25	10	ccb	ccb	PROPN
dti-2573	25	11	was	be	AUX
dti-2573	25	12	associated	associate	VERB
dti-2573	25	13	with	with	ADP
dti-2573	25	14	lung	lung	NOUN
dti-2573	25	15	cancer	cancer	NOUN
dti-2573	25	16	with	with	ADP
dti-2573	25	17	adjusted	adjust	VERB
dti-2573	25	18	odds	odd	NOUN
dti-2573	25	19	ratio	ratio	NOUN
dti-2573	25	20	of	of	ADP
dti-2573	25	21	1.13	1.13	NUM
dti-2573	25	22	(	(	PUNCT
dti-2573	25	23	95	95	NUM
dti-2573	25	24	%	%	NOUN
dti-2573	25	25	confidence	confidence	NOUN
dti-2573	25	26	interval	interval	NOUN
dti-2573	25	27	1.06	1.06	NUM
dti-2573	25	28	,	,	PUNCT
dti-2573	25	29	1.21	1.21	NUM
dti-2573	25	30	)	)	PUNCT
dti-2573	25	31	(	(	PUNCT
dti-2573	25	32	11	11	NUM
dti-2573	25	33	-	-	SYM
dti-2573	25	34	13	13	NUM
dti-2573	25	35	)	)	PUNCT
dti-2573	25	36	,	,	PUNCT
dti-2573	25	37	while	while	SCONJ
dti-2573	25	38	other	other	ADJ
dti-2573	25	39	studies	study	NOUN
dti-2573	25	40	did	do	AUX
dti-2573	25	41	not	not	PART
dti-2573	25	42	find	find	VERB
dti-2573	25	43	this	this	DET
dti-2573	25	44	association	association	NOUN
dti-2573	25	45	(	(	PUNCT
dti-2573	25	46	14,15	14,15	NUM
dti-2573	25	47	)	)	PUNCT
dti-2573	25	48	.	.	PUNCT
dti-2573	26	1	as	as	SCONJ
dti-2573	26	2	there	there	PRON
dti-2573	26	3	are	be	VERB
dti-2573	26	4	inconsistent	inconsistent	ADJ
dti-2573	26	5	and	and	CCONJ
dti-2573	26	6	inconclusive	inconclusive	ADJ
dti-2573	26	7	data	datum	NOUN
dti-2573	26	8	on	on	ADP
dti-2573	26	9	this	this	DET
dti-2573	26	10	issue	issue	NOUN
dti-2573	26	11	,	,	PUNCT
dti-2573	26	12	this	this	DET
dti-2573	26	13	study	study	NOUN
dti-2573	26	14	aimed	aim	VERB
dti-2573	26	15	to	to	PART
dti-2573	26	16	evaluate	evaluate	VERB
dti-2573	26	17	the	the	DET
dti-2573	26	18	additional	additional	ADJ
dti-2573	26	19	association	association	NOUN
dti-2573	26	20	of	of	ADP
dti-2573	26	21	ccb	ccb	PROPN
dti-2573	26	22	and	and	CCONJ
dti-2573	26	23	lung	lung	NOUN
dti-2573	26	24	cancer	cancer	NOUN
dti-2573	26	25	.	.	PUNCT
dti-2573	27	1	methods	method	NOUN
dti-2573	27	2	this	this	PRON
dti-2573	27	3	was	be	AUX
dti-2573	27	4	a	a	DET
dti-2573	27	5	case	case	NOUN
dti-2573	27	6	-	-	PUNCT
dti-2573	27	7	control	control	NOUN
dti-2573	27	8	study	study	NOUN
dti-2573	27	9	conducted	conduct	VERB
dti-2573	27	10	at	at	ADP
dti-2573	27	11	srinagarind	srinagarind	ADJ
dti-2573	27	12	hospital	hospital	NOUN
dti-2573	27	13	,	,	PUNCT
dti-2573	27	14	khon	khon	PROPN
dti-2573	27	15	kaen	kaen	PROPN
dti-2573	27	16	university	university	PROPN
dti-2573	27	17	,	,	PUNCT
dti-2573	27	18	thailand	thailand	PROPN
dti-2573	27	19	.	.	PUNCT
dti-2573	28	1	the	the	DET
dti-2573	28	2	inclusion	inclusion	NOUN
dti-2573	28	3	criteria	criterion	NOUN
dti-2573	28	4	were	be	AUX
dti-2573	28	5	adult	adult	NOUN
dti-2573	28	6	patients	patient	NOUN
dti-2573	28	7	18	18	NUM
dti-2573	28	8	years	year	NOUN
dti-2573	28	9	or	or	CCONJ
dti-2573	28	10	over	over	ADV
dti-2573	28	11	,	,	PUNCT
dti-2573	28	12	diagnosed	diagnose	VERB
dti-2573	28	13	with	with	ADP
dti-2573	28	14	lung	lung	NOUN
dti-2573	28	15	cancer	cancer	NOUN
dti-2573	28	16	or	or	CCONJ
dti-2573	28	17	pulmonary	pulmonary	ADJ
dti-2573	28	18	tuberculosis	tuberculosis	NOUN
dti-2573	28	19	,	,	PUNCT
dti-2573	28	20	and	and	CCONJ
dti-2573	28	21	presenting	present	VERB
dti-2573	28	22	with	with	ADP
dti-2573	28	23	one	one	NUM
dti-2573	28	24	of	of	ADP
dti-2573	28	25	the	the	DET
dti-2573	28	26	following	follow	VERB
dti-2573	28	27	symptoms	symptom	NOUN
dti-2573	28	28	:	:	PUNCT
dti-2573	28	29	hemoptysis	hemoptysis	NOUN
dti-2573	28	30	,	,	PUNCT
dti-2573	28	31	chronic	chronic	ADJ
dti-2573	28	32	cough	cough	NOUN
dti-2573	28	33	,	,	PUNCT
dti-2573	28	34	constitutional	constitutional	ADJ
dti-2573	28	35	symptoms	symptom	NOUN
dti-2573	28	36	,	,	PUNCT
dti-2573	28	37	lung	lung	NOUN
dti-2573	28	38	mass	mass	NOUN
dti-2573	28	39	,	,	PUNCT
dti-2573	28	40	and	and	CCONJ
dti-2573	28	41	a	a	DET
dti-2573	28	42	checkup	checkup	NOUN
dti-2573	28	43	.	.	PUNCT
dti-2573	29	1	those	those	PRON
dti-2573	29	2	who	who	PRON
dti-2573	29	3	were	be	AUX
dti-2573	29	4	pregnant	pregnant	ADJ
dti-2573	29	5	or	or	CCONJ
dti-2573	29	6	with	with	ADP
dti-2573	29	7	diagnosis	diagnosis	NOUN
dti-2573	29	8	of	of	ADP
dti-2573	29	9	lung	lung	NOUN
dti-2573	29	10	cancer	cancer	NOUN
dti-2573	29	11	introduction	introduction	NOUN
dti-2573	29	12	hypertension	hypertension	NOUN
dti-2573	29	13	is	be	AUX
dti-2573	29	14	a	a	DET
dti-2573	29	15	common	common	ADJ
dti-2573	29	16	disease	disease	NOUN
dti-2573	29	17	,	,	PUNCT
dti-2573	29	18	with	with	ADP
dti-2573	29	19	an	an	DET
dti-2573	29	20	estimated	estimate	VERB
dti-2573	29	21	1.39	1.39	NUM
dti-2573	29	22	billion	billion	NUM
dti-2573	29	23	adults	adult	NOUN
dti-2573	29	24	diagnosed	diagnose	VERB
dti-2573	29	25	with	with	ADP
dti-2573	29	26	hypertension	hypertension	NOUN
dti-2573	29	27	(	(	PUNCT
dti-2573	29	28	1	1	NUM
dti-2573	29	29	)	)	PUNCT
dti-2573	29	30	.	.	PUNCT
dti-2573	30	1	generally	generally	ADV
dti-2573	30	2	,	,	PUNCT
dti-2573	30	3	the	the	DET
dti-2573	30	4	prevalence	prevalence	NOUN
dti-2573	30	5	of	of	ADP
dti-2573	30	6	hypertension	hypertension	NOUN
dti-2573	30	7	was	be	AUX
dti-2573	30	8	31.1	31.1	NUM
dti-2573	30	9	%	%	NOUN
dti-2573	30	10	worldwide	worldwide	ADV
dti-2573	30	11	in	in	ADP
dti-2573	30	12	2010	2010	NUM
dti-2573	30	13	.	.	PUNCT
dti-2573	31	1	the	the	DET
dti-2573	31	2	main	main	ADJ
dti-2573	31	3	goal	goal	NOUN
dti-2573	31	4	of	of	ADP
dti-2573	31	5	hypertension	hypertension	NOUN
dti-2573	31	6	treatment	treatment	NOUN
dti-2573	31	7	is	be	AUX
dti-2573	31	8	to	to	PART
dti-2573	31	9	achieve	achieve	VERB
dti-2573	31	10	blood	blood	NOUN
dti-2573	31	11	pressure	pressure	NOUN
dti-2573	31	12	control	control	NOUN
dti-2573	31	13	.	.	PUNCT
dti-2573	32	1	a	a	DET
dti-2573	32	2	previous	previous	ADJ
dti-2573	32	3	report	report	NOUN
dti-2573	32	4	found	find	VERB
dti-2573	32	5	that	that	SCONJ
dti-2573	32	6	only	only	ADV
dti-2573	32	7	23	23	NUM
dti-2573	32	8	%	%	NOUN
dti-2573	32	9	of	of	ADP
dti-2573	32	10	women	woman	NOUN
dti-2573	32	11	and	and	CCONJ
dti-2573	32	12	18	18	NUM
dti-2573	32	13	%	%	NOUN
dti-2573	32	14	of	of	ADP
dti-2573	32	15	men	man	NOUN
dti-2573	32	16	with	with	ADP
dti-2573	32	17	hypertension	hypertension	NOUN
dti-2573	32	18	had	have	VERB
dti-2573	32	19	a	a	DET
dti-2573	32	20	good	good	ADJ
dti-2573	32	21	blood	blood	NOUN
dti-2573	32	22	pressure	pressure	NOUN
dti-2573	32	23	control	control	NOUN
dti-2573	32	24	globally	globally	ADV
dti-2573	32	25	(	(	PUNCT
dti-2573	32	26	2	2	NUM
dti-2573	32	27	)	)	PUNCT
dti-2573	32	28	.	.	PUNCT
dti-2573	33	1	blood	blood	NOUN
dti-2573	33	2	pressure	pressure	NOUN
dti-2573	33	3	lowering	lower	VERB
dti-2573	33	4	may	may	AUX
dti-2573	33	5	result	result	VERB
dti-2573	33	6	https://doi.org/10.33393/dti.2023.2573	https://doi.org/10.33393/dti.2023.2573	VERB
dti-2573	33	7	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NUM
dti-2573	33	8	rattanathanoo	rattanathanoo	VERB
dti-2573	33	9	et	et	PROPN
dti-2573	33	10	al	al	PROPN
dti-2573	33	11	drug	drug	PROPN
dti-2573	33	12	target	target	NOUN
dti-2573	33	13	insights	insight	NOUN
dti-2573	33	14	2023	2023	NUM
dti-2573	33	15	;	;	PUNCT
dti-2573	33	16	17	17	NUM
dti-2573	33	17	:	:	SYM
dti-2573	33	18	55	55	NUM
dti-2573	33	19	©	©	PROPN
dti-2573	33	20	2023	2023	NUM
dti-2573	33	21	the	the	DET
dti-2573	33	22	authors	author	NOUN
dti-2573	33	23	.	.	PUNCT
dti-2573	34	1	published	publish	VERB
dti-2573	34	2	by	by	ADP
dti-2573	34	3	aboutscience	aboutscience	NOUN
dti-2573	34	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2573	34	5	or	or	CCONJ
dti-2573	34	6	pulmonary	pulmonary	ADJ
dti-2573	34	7	tuberculosis	tuberculosis	NOUN
dti-2573	34	8	prior	prior	ADV
dti-2573	34	9	to	to	ADP
dti-2573	34	10	the	the	DET
dti-2573	34	11	diagnosis	diagnosis	NOUN
dti-2573	34	12	of	of	ADP
dti-2573	34	13	hypertension	hypertension	NOUN
dti-2573	34	14	were	be	AUX
dti-2573	34	15	excluded	exclude	VERB
dti-2573	34	16	.	.	PUNCT
dti-2573	35	1	diagnosis	diagnosis	NOUN
dti-2573	35	2	of	of	ADP
dti-2573	35	3	lung	lung	NOUN
dti-2573	35	4	cancer	cancer	NOUN
dti-2573	35	5	was	be	AUX
dti-2573	35	6	made	make	VERB
dti-2573	35	7	pathologically	pathologically	ADV
dti-2573	35	8	,	,	PUNCT
dti-2573	35	9	while	while	SCONJ
dti-2573	35	10	tuberculosis	tuberculosis	NOUN
dti-2573	35	11	was	be	AUX
dti-2573	35	12	made	make	VERB
dti-2573	35	13	by	by	ADP
dti-2573	35	14	positive	positive	ADJ
dti-2573	35	15	acidfast	acidfast	ADJ
dti-2573	35	16	bacilli	bacilli	NOUN
dti-2573	35	17	on	on	ADP
dti-2573	35	18	sputum	sputum	PROPN
dti-2573	35	19	examination	examination	NOUN
dti-2573	35	20	,	,	PUNCT
dti-2573	35	21	sputum	sputum	PROPN
dti-2573	35	22	culture	culture	NOUN
dti-2573	35	23	positive	positive	ADJ
dti-2573	35	24	for	for	ADP
dti-2573	35	25	mycobacterium	mycobacterium	NOUN
dti-2573	35	26	tuberculosis	tuberculosis	NOUN
dti-2573	35	27	,	,	PUNCT
dti-2573	35	28	or	or	CCONJ
dti-2573	35	29	polymerase	polymerase	NOUN
dti-2573	35	30	chain	chain	NOUN
dti-2573	35	31	reaction	reaction	NOUN
dti-2573	35	32	(	(	PUNCT
dti-2573	35	33	pcr	pcr	ADJ
dti-2573	35	34	)	)	PUNCT
dti-2573	35	35	positive	positive	ADJ
dti-2573	35	36	for	for	ADP
dti-2573	35	37	m.	m.	NOUN
dti-2573	35	38	tuberculosis	tuberculosis	NOUN
dti-2573	35	39	with	with	ADP
dti-2573	35	40	a	a	DET
dti-2573	35	41	chest	chest	NOUN
dti-2573	35	42	x	x	NOUN
dti-2573	35	43	-	-	NOUN
dti-2573	35	44	ray	ray	NOUN
dti-2573	35	45	compatible	compatible	ADJ
dti-2573	35	46	with	with	ADP
dti-2573	35	47	tuberculosis	tuberculosis	NOUN
dti-2573	35	48	.	.	PUNCT
dti-2573	36	1	cases	case	NOUN
dti-2573	36	2	were	be	AUX
dti-2573	36	3	those	those	PRON
dti-2573	36	4	diagnosed	diagnose	VERB
dti-2573	36	5	with	with	ADP
dti-2573	36	6	lung	lung	NOUN
dti-2573	36	7	cancer	cancer	NOUN
dti-2573	36	8	,	,	PUNCT
dti-2573	36	9	while	while	SCONJ
dti-2573	36	10	controls	control	NOUN
dti-2573	36	11	were	be	AUX
dti-2573	36	12	those	those	PRON
dti-2573	36	13	diagnosed	diagnose	VERB
dti-2573	36	14	with	with	ADP
dti-2573	36	15	tuberculosis	tuberculosis	NOUN
dti-2573	36	16	.	.	PUNCT
dti-2573	37	1	the	the	DET
dti-2573	37	2	study	study	NOUN
dti-2573	37	3	period	period	NOUN
dti-2573	37	4	was	be	AUX
dti-2573	37	5	between	between	ADP
dti-2573	37	6	2007	2007	NUM
dti-2573	37	7	and	and	CCONJ
dti-2573	37	8	2019	2019	NUM
dti-2573	37	9	.	.	PUNCT
dti-2573	38	1	eligible	eligible	ADJ
dti-2573	38	2	patients	patient	NOUN
dti-2573	38	3	were	be	AUX
dti-2573	38	4	recorded	record	VERB
dti-2573	38	5	for	for	ADP
dti-2573	38	6	baseline	baseline	NOUN
dti-2573	38	7	characteristics	characteristic	NOUN
dti-2573	38	8	,	,	PUNCT
dti-2573	38	9	medications	medication	NOUN
dti-2573	38	10	,	,	PUNCT
dti-2573	38	11	and	and	CCONJ
dti-2573	38	12	risk	risk	NOUN
dti-2573	38	13	factors	factor	NOUN
dti-2573	38	14	for	for	ADP
dti-2573	38	15	lung	lung	NOUN
dti-2573	38	16	cancer	cancer	NOUN
dti-2573	38	17	.	.	PUNCT
dti-2573	39	1	baseline	baseline	PROPN
dti-2573	39	2	characteristics	characteristic	NOUN
dti-2573	39	3	included	include	VERB
dti-2573	39	4	age	age	NOUN
dti-2573	39	5	,	,	PUNCT
dti-2573	39	6	sex	sex	NOUN
dti-2573	39	7	,	,	PUNCT
dti-2573	39	8	body	body	NOUN
dti-2573	39	9	mass	mass	PROPN
dti-2573	39	10	index	index	NOUN
dti-2573	39	11	,	,	PUNCT
dti-2573	39	12	comorbid	comorbid	NOUN
dti-2573	39	13	diseases	disease	NOUN
dti-2573	39	14	,	,	PUNCT
dti-2573	39	15	alcohol	alcohol	NOUN
dti-2573	39	16	consumption	consumption	NOUN
dti-2573	39	17	,	,	PUNCT
dti-2573	39	18	and	and	CCONJ
dti-2573	39	19	smoking	smoking	NOUN
dti-2573	39	20	history	history	NOUN
dti-2573	39	21	.	.	PUNCT
dti-2573	40	1	risk	risk	NOUN
dti-2573	40	2	factors	factor	NOUN
dti-2573	40	3	of	of	ADP
dti-2573	40	4	lung	lung	NOUN
dti-2573	40	5	cancer	cancer	NOUN
dti-2573	40	6	were	be	AUX
dti-2573	40	7	also	also	ADV
dti-2573	40	8	recorded	record	VERB
dti-2573	40	9	:	:	PUNCT
dti-2573	40	10	family	family	NOUN
dti-2573	40	11	history	history	NOUN
dti-2573	40	12	of	of	ADP
dti-2573	40	13	lung	lung	NOUN
dti-2573	40	14	cancer	cancer	NOUN
dti-2573	40	15	,	,	PUNCT
dti-2573	40	16	occupational	occupational	ADJ
dti-2573	40	17	exposure	exposure	NOUN
dti-2573	40	18	,	,	PUNCT
dti-2573	40	19	or	or	CCONJ
dti-2573	40	20	chest	chest	NOUN
dti-2573	40	21	wall	wall	NOUN
dti-2573	40	22	radiation	radiation	NOUN
dti-2573	40	23	.	.	PUNCT
dti-2573	41	1	antihypertensive	antihypertensive	ADJ
dti-2573	41	2	medications	medication	NOUN
dti-2573	41	3	particularly	particularly	ADV
dti-2573	41	4	ccb	ccb	PROPN
dti-2573	41	5	were	be	AUX
dti-2573	41	6	retrieved	retrieve	VERB
dti-2573	41	7	as	as	ADV
dti-2573	41	8	well	well	ADV
dti-2573	41	9	as	as	ADP
dti-2573	41	10	duration	duration	NOUN
dti-2573	41	11	of	of	ADP
dti-2573	41	12	ccb	ccb	PROPN
dti-2573	41	13	use	use	NOUN
dti-2573	41	14	.	.	PUNCT
dti-2573	42	1	the	the	DET
dti-2573	42	2	primary	primary	ADJ
dti-2573	42	3	outcome	outcome	NOUN
dti-2573	42	4	of	of	ADP
dti-2573	42	5	this	this	DET
dti-2573	42	6	study	study	NOUN
dti-2573	42	7	was	be	AUX
dti-2573	42	8	to	to	PART
dti-2573	42	9	evaluate	evaluate	VERB
dti-2573	42	10	the	the	DET
dti-2573	42	11	association	association	NOUN
dti-2573	42	12	of	of	ADP
dti-2573	42	13	lung	lung	NOUN
dti-2573	42	14	cancer	cancer	NOUN
dti-2573	42	15	and	and	CCONJ
dti-2573	42	16	ccb	ccb	PROPN
dti-2573	42	17	.	.	PUNCT
dti-2573	43	1	sample	sample	NOUN
dti-2573	43	2	size	size	NOUN
dti-2573	43	3	calculation	calculation	NOUN
dti-2573	43	4	based	base	VERB
dti-2573	43	5	on	on	ADP
dti-2573	43	6	a	a	DET
dti-2573	43	7	probability	probability	NOUN
dti-2573	43	8	of	of	ADP
dti-2573	43	9	event	event	NOUN
dti-2573	43	10	in	in	ADP
dti-2573	43	11	the	the	DET
dti-2573	43	12	case	case	NOUN
dti-2573	43	13	and	and	CCONJ
dti-2573	43	14	control	control	NOUN
dti-2573	43	15	group	group	NOUN
dti-2573	43	16	of	of	ADP
dti-2573	43	17	0.6	0.6	NUM
dti-2573	43	18	and	and	CCONJ
dti-2573	43	19	0.3	0.3	NUM
dti-2573	43	20	,	,	PUNCT
dti-2573	43	21	the	the	DET
dti-2573	43	22	required	require	VERB
dti-2573	43	23	sample	sample	NOUN
dti-2573	43	24	size	size	NOUN
dti-2573	43	25	for	for	ADP
dti-2573	43	26	case	case	NOUN
dti-2573	43	27	group	group	NOUN
dti-2573	43	28	was	be	AUX
dti-2573	43	29	49	49	NUM
dti-2573	43	30	patients	patient	NOUN
dti-2573	43	31	with	with	ADP
dti-2573	43	32	a	a	DET
dti-2573	43	33	confidence	confidence	NOUN
dti-2573	43	34	of	of	ADP
dti-2573	43	35	95	95	NUM
dti-2573	43	36	%	%	NOUN
dti-2573	43	37	and	and	CCONJ
dti-2573	43	38	power	power	NOUN
dti-2573	43	39	of	of	ADP
dti-2573	43	40	80	80	NUM
dti-2573	43	41	%	%	NOUN
dti-2573	43	42	.	.	PUNCT
dti-2573	44	1	the	the	DET
dti-2573	44	2	control	control	NOUN
dti-2573	44	3	group	group	NOUN
dti-2573	44	4	was	be	AUX
dti-2573	44	5	enrolled	enrol	VERB
dti-2573	44	6	for	for	ADP
dti-2573	44	7	a	a	DET
dti-2573	44	8	ratio	ratio	NOUN
dti-2573	44	9	of	of	ADP
dti-2573	44	10	case	case	NOUN
dti-2573	44	11	:	:	PUNCT
dti-2573	44	12	control	control	NOUN
dti-2573	44	13	of	of	ADP
dti-2573	44	14	1:1	1:1	NUM
dti-2573	44	15	-	-	SYM
dti-2573	44	16	2	2	NUM
dti-2573	44	17	.	.	PUNCT
dti-2573	45	1	statistical	statistical	ADJ
dti-2573	45	2	analyses	analysis	NOUN
dti-2573	45	3	patients	patient	NOUN
dti-2573	45	4	were	be	AUX
dti-2573	45	5	categorized	categorize	VERB
dti-2573	45	6	into	into	ADP
dti-2573	45	7	two	two	NUM
dti-2573	45	8	groups	group	NOUN
dti-2573	45	9	:	:	PUNCT
dti-2573	45	10	lung	lung	NOUN
dti-2573	45	11	cancer	cancer	NOUN
dti-2573	45	12	(	(	PUNCT
dti-2573	45	13	cases	case	NOUN
dti-2573	45	14	)	)	PUNCT
dti-2573	45	15	and	and	CCONJ
dti-2573	45	16	tuberculosis	tuberculosis	NOUN
dti-2573	45	17	(	(	PUNCT
dti-2573	45	18	controls	control	NOUN
dti-2573	45	19	)	)	PUNCT
dti-2573	45	20	.	.	PUNCT
dti-2573	46	1	descriptive	descriptive	ADJ
dti-2573	46	2	statistics	statistic	NOUN
dti-2573	46	3	were	be	AUX
dti-2573	46	4	used	use	VERB
dti-2573	46	5	to	to	PART
dti-2573	46	6	compare	compare	VERB
dti-2573	46	7	differences	difference	NOUN
dti-2573	46	8	between	between	ADP
dti-2573	46	9	both	both	DET
dti-2573	46	10	groups	group	NOUN
dti-2573	46	11	:	:	PUNCT
dti-2573	46	12	independent	independent	ADJ
dti-2573	46	13	t	t	PROPN
dti-2573	46	14	-	-	PUNCT
dti-2573	46	15	test	test	NOUN
dti-2573	46	16	or	or	CCONJ
dti-2573	46	17	wilcoxon	wilcoxon	ADJ
dti-2573	46	18	rank	rank	PROPN
dti-2573	46	19	sum	sum	NOUN
dti-2573	46	20	test	test	NOUN
dti-2573	46	21	for	for	ADP
dti-2573	46	22	numerical	numerical	ADJ
dti-2573	46	23	variables	variable	NOUN
dti-2573	46	24	and	and	CCONJ
dti-2573	46	25	chi	chi	ADJ
dti-2573	46	26	-	-	PUNCT
dti-2573	46	27	square	square	NOUN
dti-2573	46	28	or	or	CCONJ
dti-2573	46	29	fisher	fisher	NOUN
dti-2573	46	30	’s	’s	PART
dti-2573	46	31	exact	exact	ADJ
dti-2573	46	32	test	test	NOUN
dti-2573	46	33	for	for	ADP
dti-2573	46	34	categorical	categorical	ADJ
dti-2573	46	35	variables	variable	NOUN
dti-2573	46	36	.	.	PUNCT
dti-2573	47	1	factors	factor	NOUN
dti-2573	47	2	associated	associate	VERB
dti-2573	47	3	with	with	ADP
dti-2573	47	4	lung	lung	NOUN
dti-2573	47	5	cancer	cancer	NOUN
dti-2573	47	6	were	be	AUX
dti-2573	47	7	calculated	calculate	VERB
dti-2573	47	8	by	by	ADP
dti-2573	47	9	logistic	logistic	ADJ
dti-2573	47	10	regression	regression	NOUN
dti-2573	47	11	analysis	analysis	NOUN
dti-2573	47	12	.	.	PUNCT
dti-2573	48	1	multicollinearity	multicollinearity	NOUN
dti-2573	48	2	was	be	AUX
dti-2573	48	3	checked	check	VERB
dti-2573	48	4	in	in	ADP
dti-2573	48	5	the	the	DET
dti-2573	48	6	logistic	logistic	ADJ
dti-2573	48	7	regression	regression	NOUN
dti-2573	48	8	analysis	analysis	NOUN
dti-2573	48	9	.	.	PUNCT
dti-2573	49	1	the	the	DET
dti-2573	49	2	final	final	ADJ
dti-2573	49	3	model	model	NOUN
dti-2573	49	4	was	be	AUX
dti-2573	49	5	executed	execute	VERB
dti-2573	49	6	for	for	ADP
dti-2573	49	7	goodness	goodness	NOUN
dti-2573	49	8	of	of	ADP
dti-2573	49	9	fit	fit	ADJ
dti-2573	49	10	by	by	ADP
dti-2573	49	11	hosmer	hosmer	NOUN
dti-2573	49	12	-	-	PUNCT
dti-2573	49	13	lemeshow	lemeshow	NOUN
dti-2573	49	14	test	test	NOUN
dti-2573	49	15	.	.	PUNCT
dti-2573	50	1	statistical	statistical	ADJ
dti-2573	50	2	analyses	analysis	NOUN
dti-2573	50	3	were	be	AUX
dti-2573	50	4	calculated	calculate	VERB
dti-2573	50	5	by	by	ADP
dti-2573	50	6	stata	stata	NOUN
dti-2573	50	7	software	software	NOUN
dti-2573	50	8	version	version	NOUN
dti-2573	50	9	10.1	10.1	NUM
dti-2573	50	10	(	(	PUNCT
dti-2573	50	11	college	college	NOUN
dti-2573	50	12	station	station	NOUN
dti-2573	50	13	,	,	PUNCT
dti-2573	50	14	texas	texas	PROPN
dti-2573	50	15	,	,	PUNCT
dti-2573	50	16	usa	usa	PROPN
dti-2573	50	17	)	)	PUNCT
dti-2573	50	18	.	.	PUNCT
dti-2573	51	1	results	result	NOUN
dti-2573	51	2	there	there	PRON
dti-2573	51	3	were	be	VERB
dti-2573	51	4	178	178	NUM
dti-2573	51	5	patients	patient	NOUN
dti-2573	51	6	who	who	PRON
dti-2573	51	7	met	meet	VERB
dti-2573	51	8	the	the	DET
dti-2573	51	9	study	study	NOUN
dti-2573	51	10	criteria	criterion	NOUN
dti-2573	51	11	.	.	PUNCT
dti-2573	52	1	of	of	ADP
dti-2573	52	2	those	those	PRON
dti-2573	52	3	,	,	PUNCT
dti-2573	52	4	69	69	NUM
dti-2573	52	5	patients	patient	NOUN
dti-2573	52	6	(	(	PUNCT
dti-2573	52	7	38.8	38.8	NUM
dti-2573	52	8	%	%	NOUN
dti-2573	52	9	)	)	PUNCT
dti-2573	52	10	were	be	AUX
dti-2573	52	11	in	in	ADP
dti-2573	52	12	the	the	DET
dti-2573	52	13	case	case	NOUN
dti-2573	52	14	group	group	NOUN
dti-2573	52	15	or	or	CCONJ
dti-2573	52	16	lung	lung	NOUN
dti-2573	52	17	cancer	cancer	NOUN
dti-2573	52	18	group	group	NOUN
dti-2573	52	19	.	.	PUNCT
dti-2573	53	1	the	the	DET
dti-2573	53	2	lung	lung	PROPN
dti-2573	53	3	cancer	cancer	NOUN
dti-2573	53	4	group	group	NOUN
dti-2573	53	5	had	have	AUX
dti-2573	53	6	tested	test	VERB
dti-2573	53	7	for	for	ADP
dti-2573	53	8	gene	gene	NOUN
dti-2573	53	9	mutation	mutation	NOUN
dti-2573	53	10	in	in	ADP
dti-2573	53	11	40	40	NUM
dti-2573	53	12	patients	patient	NOUN
dti-2573	53	13	(	(	PUNCT
dti-2573	53	14	56.0	56.0	NUM
dti-2573	53	15	%	%	NOUN
dti-2573	53	16	)	)	PUNCT
dti-2573	53	17	.	.	PUNCT
dti-2573	54	1	egfr	egfr	PROPN
dti-2573	54	2	was	be	AUX
dti-2573	54	3	the	the	DET
dti-2573	54	4	most	most	ADV
dti-2573	54	5	common	common	ADJ
dti-2573	54	6	gene	gene	NOUN
dti-2573	54	7	mutation	mutation	NOUN
dti-2573	54	8	(	(	PUNCT
dti-2573	54	9	21	21	NUM
dti-2573	54	10	patients	patient	NOUN
dti-2573	54	11	;	;	PUNCT
dti-2573	54	12	52.5	52.5	NUM
dti-2573	54	13	%	%	NOUN
dti-2573	54	14	)	)	PUNCT
dti-2573	54	15	,	,	PUNCT
dti-2573	54	16	followed	follow	VERB
dti-2573	54	17	by	by	ADP
dti-2573	54	18	no	no	DET
dti-2573	54	19	mutation	mutation	NOUN
dti-2573	54	20	(	(	PUNCT
dti-2573	54	21	15	15	NUM
dti-2573	54	22	patients	patient	NOUN
dti-2573	54	23	;	;	PUNCT
dti-2573	54	24	37.5	37.5	NUM
dti-2573	54	25	%	%	NOUN
dti-2573	54	26	)	)	PUNCT
dti-2573	54	27	,	,	PUNCT
dti-2573	54	28	and	and	CCONJ
dti-2573	54	29	alk	alk	VERB
dti-2573	54	30	mutation	mutation	NOUN
dti-2573	54	31	(	(	PUNCT
dti-2573	54	32	4	4	NUM
dti-2573	54	33	patients	patient	NOUN
dti-2573	54	34	;	;	PUNCT
dti-2573	54	35	10	10	NUM
dti-2573	54	36	%	%	NOUN
dti-2573	54	37	)	)	PUNCT
dti-2573	54	38	.	.	PUNCT
dti-2573	55	1	adenocarcinoma	adenocarcinoma	PROPN
dti-2573	55	2	was	be	AUX
dti-2573	55	3	the	the	DET
dti-2573	55	4	most	most	ADV
dti-2573	55	5	common	common	ADJ
dti-2573	55	6	cell	cell	NOUN
dti-2573	55	7	type	type	NOUN
dti-2573	55	8	of	of	ADP
dti-2573	55	9	lung	lung	NOUN
dti-2573	55	10	cancer	cancer	NOUN
dti-2573	55	11	(	(	PUNCT
dti-2573	55	12	55	55	NUM
dti-2573	55	13	patients	patient	NOUN
dti-2573	55	14	;	;	PUNCT
dti-2573	55	15	79.7	79.7	NUM
dti-2573	55	16	%	%	NOUN
dti-2573	55	17	)	)	PUNCT
dti-2573	55	18	,	,	PUNCT
dti-2573	55	19	followed	follow	VERB
dti-2573	55	20	by	by	ADP
dti-2573	55	21	squamous	squamous	ADJ
dti-2573	55	22	cell	cell	NOUN
dti-2573	55	23	carcinoma	carcinoma	NOUN
dti-2573	55	24	(	(	PUNCT
dti-2573	55	25	8	8	NUM
dti-2573	55	26	patients	patient	NOUN
dti-2573	55	27	;	;	PUNCT
dti-2573	55	28	11.6	11.6	NUM
dti-2573	55	29	%	%	NOUN
dti-2573	55	30	)	)	PUNCT
dti-2573	55	31	.	.	PUNCT
dti-2573	56	1	table	table	NOUN
dti-2573	56	2	i	i	PRON
dti-2573	56	3	shows	show	VERB
dti-2573	56	4	baseline	baseline	ADJ
dti-2573	56	5	characteristics	characteristic	NOUN
dti-2573	56	6	and	and	CCONJ
dti-2573	56	7	ccb	ccb	PROPN
dti-2573	56	8	treatment	treatment	NOUN
dti-2573	56	9	of	of	ADP
dti-2573	56	10	the	the	DET
dti-2573	56	11	case	case	NOUN
dti-2573	56	12	and	and	CCONJ
dti-2573	56	13	control	control	NOUN
dti-2573	56	14	groups	group	NOUN
dti-2573	56	15	.	.	PUNCT
dti-2573	57	1	there	there	PRON
dti-2573	57	2	were	be	VERB
dti-2573	57	3	three	three	NUM
dti-2573	57	4	significant	significant	ADJ
dti-2573	57	5	factors	factor	NOUN
dti-2573	57	6	between	between	ADP
dti-2573	57	7	both	both	DET
dti-2573	57	8	groups	group	NOUN
dti-2573	57	9	,	,	PUNCT
dti-2573	57	10	namely	namely	ADV
dti-2573	57	11	dyslipidemia	dyslipidemia	NOUN
dti-2573	57	12	,	,	PUNCT
dti-2573	57	13	obstructive	obstructive	ADJ
dti-2573	57	14	sleep	sleep	NOUN
dti-2573	57	15	apnea	apnea	NOUN
dti-2573	57	16	,	,	PUNCT
dti-2573	57	17	and	and	CCONJ
dti-2573	57	18	family	family	NOUN
dti-2573	57	19	history	history	NOUN
dti-2573	57	20	of	of	ADP
dti-2573	57	21	lung	lung	NOUN
dti-2573	57	22	cancer	cancer	NOUN
dti-2573	57	23	.	.	PUNCT
dti-2573	58	1	the	the	DET
dti-2573	58	2	case	case	NOUN
dti-2573	58	3	group	group	NOUN
dti-2573	58	4	had	have	VERB
dti-2573	58	5	significantly	significantly	ADV
dti-2573	58	6	higher	high	ADJ
dti-2573	58	7	proportions	proportion	NOUN
dti-2573	58	8	of	of	ADP
dti-2573	58	9	these	these	DET
dti-2573	58	10	three	three	NUM
dti-2573	58	11	factors	factor	NOUN
dti-2573	58	12	than	than	ADP
dti-2573	58	13	the	the	DET
dti-2573	58	14	control	control	NOUN
dti-2573	58	15	group	group	NOUN
dti-2573	58	16	such	such	ADJ
dti-2573	58	17	as	as	ADP
dti-2573	58	18	family	family	NOUN
dti-2573	58	19	history	history	NOUN
dti-2573	58	20	of	of	ADP
dti-2573	58	21	lung	lung	NOUN
dti-2573	58	22	cancer	cancer	NOUN
dti-2573	58	23	(	(	PUNCT
dti-2573	58	24	15.9	15.9	NUM
dti-2573	58	25	%	%	NOUN
dti-2573	58	26	vs.	vs.	ADP
dti-2573	58	27	0.9	0.9	NUM
dti-2573	58	28	%	%	NOUN
dti-2573	58	29	;	;	PUNCT
dti-2573	58	30	p	p	X
dti-2573	58	31	<	<	X
dti-2573	58	32	0.001	0.001	NUM
dti-2573	58	33	)	)	PUNCT
dti-2573	58	34	.	.	PUNCT
dti-2573	59	1	table	table	NOUN
dti-2573	59	2	i	i	PRON
dti-2573	59	3	baseline	baseline	VERB
dti-2573	59	4	characteristics	characteristic	NOUN
dti-2573	59	5	and	and	CCONJ
dti-2573	59	6	ccb	ccb	PROPN
dti-2573	59	7	treatment	treatment	NOUN
dti-2573	59	8	of	of	ADP
dti-2573	59	9	patients	patient	NOUN
dti-2573	59	10	with	with	ADP
dti-2573	59	11	hypertension	hypertension	NOUN
dti-2573	59	12	categorized	categorize	VERB
dti-2573	59	13	by	by	ADP
dti-2573	59	14	lung	lung	NOUN
dti-2573	59	15	cancer	cancer	NOUN
dti-2573	59	16	(	(	PUNCT
dti-2573	59	17	case	case	NOUN
dti-2573	59	18	group	group	NOUN
dti-2573	59	19	)	)	PUNCT
dti-2573	59	20	and	and	CCONJ
dti-2573	59	21	tuberculosis	tuberculosis	NOUN
dti-2573	59	22	(	(	PUNCT
dti-2573	59	23	control	control	NOUN
dti-2573	59	24	group	group	NOUN
dti-2573	59	25	)	)	PUNCT
dti-2573	59	26	factors	factor	NOUN
dti-2573	59	27	cases	case	NOUN
dti-2573	59	28	(	(	PUNCT
dti-2573	59	29	n	n	NOUN
dti-2573	59	30	=	=	SYM
dti-2573	59	31	69	69	NUM
dti-2573	59	32	)	)	PUNCT
dti-2573	59	33	controls	control	NOUN
dti-2573	59	34	(	(	PUNCT
dti-2573	59	35	n	n	NOUN
dti-2573	59	36	=	=	SYM
dti-2573	59	37	109	109	NUM
dti-2573	59	38	)	)	PUNCT
dti-2573	59	39	p	p	NOUN
dti-2573	59	40	value	value	NOUN
dti-2573	59	41	age	age	NOUN
dti-2573	59	42	,	,	PUNCT
dti-2573	59	43	years	year	NOUN
dti-2573	59	44	*	*	SYM
dti-2573	59	45	67	67	NUM
dti-2573	59	46	(	(	PUNCT
dti-2573	59	47	61,71	61,71	NUM
dti-2573	59	48	)	)	PUNCT
dti-2573	59	49	66	66	NUM
dti-2573	59	50	(	(	PUNCT
dti-2573	59	51	59,71	59,71	NUM
dti-2573	59	52	)	)	PUNCT
dti-2573	59	53	0.603	0.603	NUM
dti-2573	59	54	male	male	NOUN
dti-2573	59	55	44	44	NUM
dti-2573	59	56	(	(	PUNCT
dti-2573	59	57	63.8	63.8	NUM
dti-2573	59	58	)	)	PUNCT
dti-2573	59	59	77	77	NUM
dti-2573	59	60	(	(	PUNCT
dti-2573	59	61	70.6	70.6	NUM
dti-2573	59	62	)	)	PUNCT
dti-2573	59	63	0.338	0.338	NUM
dti-2573	59	64	female	female	NOUN
dti-2573	59	65	25	25	NUM
dti-2573	59	66	(	(	PUNCT
dti-2573	59	67	36.2	36.2	NUM
dti-2573	59	68	)	)	PUNCT
dti-2573	59	69	32	32	NUM
dti-2573	59	70	(	(	PUNCT
dti-2573	59	71	29.4	29.4	NUM
dti-2573	59	72	)	)	PUNCT
dti-2573	59	73	bmi	bmi	VERB
dti-2573	59	74	0.676	0.676	NUM
dti-2573	59	75	 	 	SPACE
dti-2573	59	76	<	<	X
dti-2573	59	77	19	19	NUM
dti-2573	59	78	13	13	NUM
dti-2573	59	79	(	(	PUNCT
dti-2573	59	80	18.8	18.8	NUM
dti-2573	59	81	)	)	PUNCT
dti-2573	59	82	17	17	NUM
dti-2573	59	83	(	(	PUNCT
dti-2573	59	84	15.9	15.9	NUM
dti-2573	59	85	)	)	PUNCT
dti-2573	59	86	 	 	SPACE
dti-2573	59	87	19	19	NUM
dti-2573	59	88	-	-	SYM
dti-2573	59	89	24.5	24.5	NUM
dti-2573	59	90	16	16	NUM
dti-2573	59	91	(	(	PUNCT
dti-2573	59	92	23.2	23.2	NUM
dti-2573	59	93	)	)	PUNCT
dti-2573	59	94	25	25	NUM
dti-2573	59	95	(	(	PUNCT
dti-2573	59	96	23.4	23.4	NUM
dti-2573	59	97	)	)	PUNCT
dti-2573	59	98	 	 	SPACE
dti-2573	59	99	24.5	24.5	NUM
dti-2573	59	100	-	-	SYM
dti-2573	59	101	30	30	NUM
dti-2573	59	102	5	5	NUM
dti-2573	59	103	(	(	PUNCT
dti-2573	59	104	7.2	7.2	NUM
dti-2573	59	105	)	)	PUNCT
dti-2573	59	106	4	4	NUM
dti-2573	59	107	(	(	PUNCT
dti-2573	59	108	3.7	3.7	NUM
dti-2573	59	109	)	)	PUNCT
dti-2573	59	110	 	 	SPACE
dti-2573	59	111	>	>	SYM
dti-2573	59	112	30	30	NUM
dti-2573	59	113	35	35	NUM
dti-2573	59	114	(	(	PUNCT
dti-2573	59	115	50.7	50.7	NUM
dti-2573	59	116	)	)	PUNCT
dti-2573	59	117	61	61	NUM
dti-2573	59	118	(	(	PUNCT
dti-2573	59	119	57.0	57.0	NUM
dti-2573	59	120	)	)	PUNCT
dti-2573	59	121	smoking	smoking	NOUN
dti-2573	59	122	40	40	NUM
dti-2573	59	123	(	(	PUNCT
dti-2573	59	124	58	58	NUM
dti-2573	59	125	)	)	PUNCT
dti-2573	59	126	64	64	NUM
dti-2573	59	127	(	(	PUNCT
dti-2573	59	128	58.7	58.7	NUM
dti-2573	59	129	)	)	PUNCT
dti-2573	59	130	0.922	0.922	NUM
dti-2573	59	131	alcohol	alcohol	NOUN
dti-2573	59	132	drinking	drinking	NOUN
dti-2573	59	133	28	28	NUM
dti-2573	59	134	(	(	PUNCT
dti-2573	59	135	40.6	40.6	NUM
dti-2573	59	136	)	)	PUNCT
dti-2573	59	137	53	53	NUM
dti-2573	59	138	(	(	PUNCT
dti-2573	59	139	48.6	48.6	NUM
dti-2573	59	140	)	)	PUNCT
dti-2573	59	141	0.294	0.294	NUM
dti-2573	59	142	comorbidities	comorbiditie	NOUN
dti-2573	59	143	 	 	SPACE
dti-2573	59	144	cvd	cvd	PROPN
dti-2573	59	145	10	10	NUM
dti-2573	59	146	(	(	PUNCT
dti-2573	59	147	14.5	14.5	NUM
dti-2573	59	148	)	)	PUNCT
dti-2573	59	149	17(15.6	17(15.6	NUM
dti-2573	59	150	)	)	PUNCT
dti-2573	59	151	0.841	0.841	NUM
dti-2573	59	152	 	 	SPACE
dti-2573	59	153	dyslipidemia	dyslipidemia	VERB
dti-2573	59	154	29	29	NUM
dti-2573	59	155	(	(	PUNCT
dti-2573	59	156	42	42	NUM
dti-2573	59	157	)	)	PUNCT
dti-2573	59	158	27	27	NUM
dti-2573	59	159	(	(	PUNCT
dti-2573	59	160	24.8	24.8	NUM
dti-2573	59	161	)	)	PUNCT
dti-2573	59	162	0.016	0.016	NUM
dti-2573	59	163	 	 	SPACE
dti-2573	59	164	dm	dm	PROPN
dti-2573	59	165	27	27	NUM
dti-2573	59	166	(	(	PUNCT
dti-2573	59	167	39.1	39.1	NUM
dti-2573	59	168	)	)	PUNCT
dti-2573	59	169	48	48	NUM
dti-2573	59	170	(	(	PUNCT
dti-2573	59	171	44	44	NUM
dti-2573	59	172	)	)	PUNCT
dti-2573	59	173	0.518	0.518	NUM
dti-2573	59	174	 	 	SPACE
dti-2573	59	175	osa	osa	X
dti-2573	59	176	5	5	NUM
dti-2573	59	177	(	(	PUNCT
dti-2573	59	178	7.2	7.2	NUM
dti-2573	59	179	)	)	PUNCT
dti-2573	59	180	1	1	NUM
dti-2573	59	181	(	(	PUNCT
dti-2573	59	182	0.9	0.9	NUM
dti-2573	59	183	)	)	PUNCT
dti-2573	59	184	0.033	0.033	NUM
dti-2573	59	185	 	 	SPACE
dti-2573	59	186	ckd	ckd	PROPN
dti-2573	59	187	10	10	NUM
dti-2573	59	188	(	(	PUNCT
dti-2573	59	189	14.5	14.5	NUM
dti-2573	59	190	)	)	PUNCT
dti-2573	59	191	23	23	NUM
dti-2573	59	192	(	(	PUNCT
dti-2573	59	193	21.1	21.1	NUM
dti-2573	59	194	)	)	PUNCT
dti-2573	59	195	0.269	0.269	NUM
dti-2573	59	196	 	 	SPACE
dti-2573	59	197	ischemic	ischemic	ADJ
dti-2573	59	198	stroke	stroke	NOUN
dti-2573	59	199	6	6	NUM
dti-2573	59	200	(	(	PUNCT
dti-2573	59	201	8.7	8.7	NUM
dti-2573	59	202	)	)	SYM
dti-2573	59	203	2	2	NUM
dti-2573	59	204	(	(	PUNCT
dti-2573	59	205	1.8	1.8	NUM
dti-2573	59	206	)	)	PUNCT
dti-2573	59	207	0.057	0.057	NUM
dti-2573	59	208	 	 	SPACE
dti-2573	59	209	autoimmune	autoimmune	ADJ
dti-2573	59	210	2	2	NUM
dti-2573	59	211	(	(	PUNCT
dti-2573	59	212	2.9	2.9	NUM
dti-2573	59	213	)	)	SYM
dti-2573	59	214	4	4	NUM
dti-2573	59	215	(	(	PUNCT
dti-2573	59	216	3.7	3.7	NUM
dti-2573	59	217	)	)	PUNCT
dti-2573	59	218	>	>	PUNCT
dti-2573	59	219	0.999	0.999	NUM
dti-2573	59	220	 	 	SPACE
dti-2573	59	221	hbv	hbv	NOUN
dti-2573	59	222	infection	infection	NOUN
dti-2573	59	223	2	2	NUM
dti-2573	59	224	(	(	PUNCT
dti-2573	59	225	2.9	2.9	NUM
dti-2573	59	226	)	)	PUNCT
dti-2573	59	227	3	3	NUM
dti-2573	59	228	(	(	PUNCT
dti-2573	59	229	2.8	2.8	NUM
dti-2573	59	230	)	)	PUNCT
dti-2573	59	231	>	>	ADP
dti-2573	59	232	0.999	0.999	NUM
dti-2573	59	233	 	 	SPACE
dti-2573	59	234	hcv	hcv	NOUN
dti-2573	59	235	infection	infection	NOUN
dti-2573	59	236	0	0	NUM
dti-2573	59	237	5	5	NUM
dti-2573	59	238	(	(	PUNCT
dti-2573	59	239	4.6	4.6	NUM
dti-2573	59	240	)	)	PUNCT
dti-2573	59	241	0.158	0.158	NUM
dti-2573	59	242	 	 	SPACE
dti-2573	59	243	hyperthyroidism	hyperthyroidism	NOUN
dti-2573	59	244	1	1	NUM
dti-2573	59	245	(	(	PUNCT
dti-2573	59	246	1.4	1.4	NUM
dti-2573	59	247	)	)	PUNCT
dti-2573	59	248	0	0	NUM
dti-2573	59	249	0.388	0.388	NUM
dti-2573	59	250	family	family	NOUN
dti-2573	59	251	history	history	NOUN
dti-2573	59	252	of	of	ADP
dti-2573	59	253	lung	lung	NOUN
dti-2573	59	254	cancer	cancer	NOUN
dti-2573	59	255	11	11	NUM
dti-2573	59	256	(	(	PUNCT
dti-2573	59	257	15.9	15.9	NUM
dti-2573	59	258	)	)	PUNCT
dti-2573	59	259	1	1	NUM
dti-2573	59	260	(	(	PUNCT
dti-2573	59	261	0.9	0.9	NUM
dti-2573	59	262	)	)	PUNCT
dti-2573	59	263	<	<	X
dti-2573	59	264	0.001	0.001	NUM
dti-2573	59	265	occupational	occupational	ADJ
dti-2573	59	266	exposure	exposure	NOUN
dti-2573	59	267	1	1	NUM
dti-2573	59	268	(	(	PUNCT
dti-2573	59	269	1.4	1.4	NUM
dti-2573	59	270	)	)	PUNCT
dti-2573	59	271	2	2	NUM
dti-2573	59	272	(	(	PUNCT
dti-2573	59	273	1.8	1.8	NUM
dti-2573	59	274	)	)	PUNCT
dti-2573	59	275	>	>	ADP
dti-2573	59	276	0.999	0.999	NUM
dti-2573	59	277	chest	ch	ADJ
dti-2573	59	278	wall	wall	NOUN
dti-2573	59	279	radiation	radiation	NOUN
dti-2573	59	280	0	0	NUM
dti-2573	59	281	0	0	NUM
dti-2573	60	1	na	na	NOUN
dti-2573	60	2	ccb	ccb	PROPN
dti-2573	60	3	used	use	VERB
dti-2573	60	4	45	45	NUM
dti-2573	60	5	(	(	PUNCT
dti-2573	60	6	65.2	65.2	NUM
dti-2573	60	7	)	)	PUNCT
dti-2573	60	8	62	62	NUM
dti-2573	60	9	(	(	PUNCT
dti-2573	60	10	56.9	56.9	NUM
dti-2573	60	11	)	)	PUNCT
dti-2573	60	12	0.268	0.268	NUM
dti-2573	60	13	ccb	ccb	PROPN
dti-2573	60	14	duration	duration	NOUN
dti-2573	60	15	,	,	PUNCT
dti-2573	60	16	years	year	NOUN
dti-2573	60	17	*	*	SYM
dti-2573	60	18	5	5	NUM
dti-2573	60	19	(	(	PUNCT
dti-2573	60	20	3	3	NUM
dti-2573	60	21	-	-	SYM
dti-2573	60	22	10	10	NUM
dti-2573	60	23	)	)	PUNCT
dti-2573	60	24	6	6	NUM
dti-2573	60	25	(	(	PUNCT
dti-2573	60	26	2.8	2.8	NUM
dti-2573	60	27	-	-	SYM
dti-2573	60	28	8.2	8.2	NUM
dti-2573	60	29	)	)	PUNCT
dti-2573	60	30	0.642	0.642	NUM
dti-2573	60	31	data	datum	NOUN
dti-2573	60	32	presented	present	VERB
dti-2573	60	33	as	as	ADP
dti-2573	60	34	number	number	NOUN
dti-2573	60	35	(	(	PUNCT
dti-2573	60	36	percentage	percentage	NOUN
dti-2573	60	37	)	)	PUNCT
dti-2573	60	38	except	except	SCONJ
dti-2573	60	39	*	*	PUNCT
dti-2573	60	40	indicated	indicate	VERB
dti-2573	60	41	as	as	ADP
dti-2573	60	42	median	median	NOUN
dti-2573	60	43	(	(	PUNCT
dti-2573	60	44	1st-3rd	1st-3rd	NUM
dti-2573	60	45	quartile	quartile	ADJ
dti-2573	60	46	range	range	NOUN
dti-2573	60	47	)	)	PUNCT
dti-2573	60	48	.	.	PUNCT
dti-2573	61	1	bmi	bmi	PROPN
dti-2573	61	2	=	=	SYM
dti-2573	61	3	body	body	PROPN
dti-2573	61	4	mass	mass	PROPN
dti-2573	61	5	index	index	NOUN
dti-2573	61	6	;	;	PUNCT
dti-2573	61	7	ccb	ccb	PROPN
dti-2573	61	8	=	=	SYM
dti-2573	61	9	calcium	calcium	NOUN
dti-2573	61	10	channel	channel	NOUN
dti-2573	61	11	blocker	blocker	NOUN
dti-2573	61	12	;	;	PUNCT
dti-2573	61	13	ckd	ckd	PROPN
dti-2573	61	14	=	=	SYM
dti-2573	61	15	chronic	chronic	ADJ
dti-2573	61	16	kidney	kidney	NOUN
dti-2573	61	17	disease	disease	NOUN
dti-2573	61	18	;	;	PUNCT
dti-2573	61	19	cvd	cvd	PROPN
dti-2573	61	20	=	=	PROPN
dti-2573	61	21	cardiovascular	cardiovascular	ADJ
dti-2573	61	22	disease	disease	NOUN
dti-2573	61	23	;	;	PUNCT
dti-2573	61	24	dm	dm	PROPN
dti-2573	61	25	=	=	SYM
dti-2573	61	26	diabetic	diabetic	ADJ
dti-2573	61	27	mellitus	mellitus	NOUN
dti-2573	61	28	;	;	PUNCT
dti-2573	61	29	hbv	hbv	NOUN
dti-2573	61	30	=	=	SYM
dti-2573	61	31	hepatitis	hepatitis	PROPN
dti-2573	61	32	b	b	PROPN
dti-2573	61	33	virus	virus	NOUN
dti-2573	61	34	;	;	PUNCT
dti-2573	61	35	hcv	hcv	X
dti-2573	61	36	=	=	SYM
dti-2573	61	37	hepatitis	hepatitis	PROPN
dti-2573	61	38	c	c	PROPN
dti-2573	61	39	virus	virus	NOUN
dti-2573	61	40	;	;	PUNCT
dti-2573	61	41	na	na	ADP
dti-2573	61	42	=	=	PUNCT
dti-2573	61	43	not	not	PART
dti-2573	61	44	available	available	ADJ
dti-2573	61	45	;	;	PUNCT
dti-2573	61	46	osa	osa	X
dti-2573	61	47	=	=	PUNCT
dti-2573	61	48	obstructive	obstructive	ADJ
dti-2573	61	49	sleep	sleep	NOUN
dti-2573	61	50	apnea	apnea	NOUN
dti-2573	61	51	.	.	PUNCT
dti-2573	62	1	there	there	PRON
dti-2573	62	2	were	be	VERB
dti-2573	62	3	five	five	NUM
dti-2573	62	4	factors	factor	NOUN
dti-2573	62	5	in	in	ADP
dti-2573	62	6	the	the	DET
dti-2573	62	7	final	final	ADJ
dti-2573	62	8	model	model	NOUN
dti-2573	62	9	for	for	ADP
dti-2573	62	10	prediction	prediction	NOUN
dti-2573	62	11	of	of	ADP
dti-2573	62	12	lung	lung	NOUN
dti-2573	62	13	cancer	cancer	NOUN
dti-2573	62	14	(	(	PUNCT
dti-2573	62	15	tab	tab	PROPN
dti-2573	62	16	.	.	PUNCT
dti-2573	62	17	ii	ii	PROPN
dti-2573	62	18	)	)	PUNCT
dti-2573	62	19	.	.	PUNCT
dti-2573	63	1	two	two	NUM
dti-2573	63	2	factors	factor	NOUN
dti-2573	63	3	were	be	AUX
dti-2573	63	4	independently	independently	ADV
dti-2573	63	5	associated	associate	VERB
dti-2573	63	6	with	with	ADP
dti-2573	63	7	lung	lung	NOUN
dti-2573	63	8	cancer	cancer	NOUN
dti-2573	63	9	including	include	VERB
dti-2573	63	10	dyslipidemia	dyslipidemia	NOUN
dti-2573	63	11	and	and	CCONJ
dti-2573	63	12	family	family	NOUN
dti-2573	63	13	history	history	NOUN
dti-2573	63	14	of	of	ADP
dti-2573	63	15	lung	lung	NOUN
dti-2573	63	16	cancer	cancer	NOUN
dti-2573	63	17	.	.	PUNCT
dti-2573	64	1	these	these	DET
dti-2573	64	2	factors	factor	NOUN
dti-2573	64	3	had	have	VERB
dti-2573	64	4	an	an	DET
dti-2573	64	5	adjusted	adjust	VERB
dti-2573	64	6	odds	odd	NOUN
dti-2573	64	7	ratio	ratio	NOUN
dti-2573	64	8	(	(	PUNCT
dti-2573	64	9	95	95	NUM
dti-2573	64	10	%	%	NOUN
dti-2573	64	11	confidence	confidence	NOUN
dti-2573	64	12	interval	interval	NOUN
dti-2573	64	13	)	)	PUNCT
dti-2573	64	14	of	of	ADP
dti-2573	64	15	2.12	2.12	NUM
dti-2573	64	16	(	(	PUNCT
dti-2573	64	17	1.07	1.07	NUM
dti-2573	64	18	,	,	PUNCT
dti-2573	64	19	4.23	4.23	NUM
dti-2573	64	20	)	)	PUNCT
dti-2573	64	21	and	and	CCONJ
dti-2573	64	22	22.43	22.43	NUM
dti-2573	64	23	(	(	PUNCT
dti-2573	64	24	2.76	2.76	NUM
dti-2573	64	25	,	,	PUNCT
dti-2573	64	26	182.36	182.36	NUM
dti-2573	64	27	)	)	PUNCT
dti-2573	64	28	,	,	PUNCT
dti-2573	64	29	respectively	respectively	ADV
dti-2573	64	30	.	.	PUNCT
dti-2573	65	1	the	the	DET
dti-2573	65	2	hosmer	hosmer	NOUN
dti-2573	65	3	-	-	PUNCT
dti-2573	65	4	lemeshow	lemeshow	NOUN
dti-2573	65	5	chi	chi	NOUN
dti-2573	65	6	-	-	PUNCT
dti-2573	65	7	square	square	PROPN
dti-2573	65	8	was	be	AUX
dti-2573	65	9	4.88	4.88	NUM
dti-2573	65	10	(	(	PUNCT
dti-2573	65	11	p	p	X
dti-2573	65	12	=	=	NOUN
dti-2573	65	13	0.559	0.559	NUM
dti-2573	65	14	)	)	PUNCT
dti-2573	65	15	.	.	PUNCT
dti-2573	66	1	ccb	ccb	PROPN
dti-2573	66	2	use	use	NOUN
dti-2573	66	3	had	have	VERB
dti-2573	66	4	an	an	DET
dti-2573	66	5	adjusted	adjust	VERB
dti-2573	66	6	odds	odd	NOUN
dti-2573	66	7	ratio	ratio	NOUN
dti-2573	66	8	of	of	ADP
dti-2573	66	9	1.50	1.50	NUM
dti-2573	66	10	(	(	PUNCT
dti-2573	66	11	95	95	NUM
dti-2573	66	12	%	%	NOUN
dti-2573	66	13	confidence	confidence	NOUN
dti-2573	66	14	interval	interval	NOUN
dti-2573	66	15	of	of	ADP
dti-2573	66	16	0.53	0.53	NUM
dti-2573	66	17	,	,	PUNCT
dti-2573	66	18	2.01	2.01	NUM
dti-2573	66	19	)	)	PUNCT
dti-2573	66	20	.	.	PUNCT
dti-2573	67	1	discussion	discussion	NOUN
dti-2573	67	2	this	this	DET
dti-2573	67	3	study	study	NOUN
dti-2573	67	4	found	find	VERB
dti-2573	67	5	that	that	SCONJ
dti-2573	67	6	ccb	ccb	PROPN
dti-2573	67	7	was	be	AUX
dti-2573	67	8	not	not	PART
dti-2573	67	9	associated	associate	VERB
dti-2573	67	10	with	with	ADP
dti-2573	67	11	lung	lung	NOUN
dti-2573	67	12	cancer	cancer	NOUN
dti-2573	67	13	but	but	CCONJ
dti-2573	67	14	dyslipidemia	dyslipidemia	NOUN
dti-2573	67	15	and	and	CCONJ
dti-2573	67	16	family	family	NOUN
dti-2573	67	17	history	history	NOUN
dti-2573	67	18	of	of	ADP
dti-2573	67	19	lung	lung	NOUN
dti-2573	67	20	cancer	cancer	NOUN
dti-2573	67	21	did	do	VERB
dti-2573	67	22	.	.	PUNCT
dti-2573	68	1	ccb	ccb	PROPN
dti-2573	68	2	and	and	CCONJ
dti-2573	68	3	lung	lung	PROPN
dti-2573	68	4	cancer56	cancer56	NOUN
dti-2573	69	1	©	©	ADP
dti-2573	69	2	2023	2023	NUM
dti-2573	69	3	the	the	DET
dti-2573	69	4	authors	author	NOUN
dti-2573	69	5	.	.	PUNCT
dti-2573	70	1	drug	drug	NOUN
dti-2573	70	2	target	target	NOUN
dti-2573	70	3	insights	insight	NOUN
dti-2573	70	4	issn	issn	VERB
dti-2573	70	5	1177	1177	NUM
dti-2573	70	6	-	-	SYM
dti-2573	70	7	3928	3928	NUM
dti-2573	70	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2573	70	9	ccb	ccb	PROPN
dti-2573	70	10	-	-	PUNCT
dti-2573	70	11	related	relate	VERB
dti-2573	70	12	cancer	cancer	NOUN
dti-2573	70	13	is	be	AUX
dti-2573	70	14	still	still	ADV
dti-2573	70	15	inconclusive	inconclusive	ADJ
dti-2573	70	16	and	and	CCONJ
dti-2573	70	17	needs	need	VERB
dti-2573	70	18	further	further	ADJ
dti-2573	70	19	studies	study	NOUN
dti-2573	70	20	to	to	PART
dti-2573	70	21	evaluate	evaluate	VERB
dti-2573	70	22	this	this	DET
dti-2573	70	23	issue	issue	NOUN
dti-2573	70	24	(	(	PUNCT
dti-2573	70	25	16	16	NUM
dti-2573	70	26	)	)	PUNCT
dti-2573	70	27	.	.	PUNCT
dti-2573	71	1	the	the	DET
dti-2573	71	2	possible	possible	ADJ
dti-2573	71	3	mechanisms	mechanism	NOUN
dti-2573	71	4	of	of	ADP
dti-2573	71	5	ccb	ccb	PROPN
dti-2573	71	6	-	-	PUNCT
dti-2573	71	7	related	relate	VERB
dti-2573	71	8	cancer	cancer	NOUN
dti-2573	71	9	include	include	VERB
dti-2573	71	10	cell	cell	NOUN
dti-2573	71	11	growth	growth	NOUN
dti-2573	71	12	,	,	PUNCT
dti-2573	71	13	cell	cell	NOUN
dti-2573	71	14	proliferation	proliferation	NOUN
dti-2573	71	15	,	,	PUNCT
dti-2573	71	16	and	and	CCONJ
dti-2573	71	17	cell	cell	NOUN
dti-2573	71	18	apoptosis	apoptosis	NOUN
dti-2573	71	19	(	(	PUNCT
dti-2573	71	20	17,18	17,18	NUM
dti-2573	71	21	)	)	PUNCT
dti-2573	71	22	.	.	PUNCT
dti-2573	72	1	however	however	ADV
dti-2573	72	2	,	,	PUNCT
dti-2573	72	3	some	some	DET
dti-2573	72	4	studies	study	NOUN
dti-2573	72	5	found	find	VERB
dti-2573	72	6	that	that	SCONJ
dti-2573	72	7	ccb	ccb	PROPN
dti-2573	72	8	may	may	AUX
dti-2573	72	9	reduce	reduce	VERB
dti-2573	72	10	risks	risk	NOUN
dti-2573	72	11	of	of	ADP
dti-2573	72	12	lung	lung	NOUN
dti-2573	72	13	cancer	cancer	NOUN
dti-2573	72	14	as	as	SCONJ
dti-2573	72	15	ccb	ccb	PROPN
dti-2573	72	16	may	may	AUX
dti-2573	72	17	suppress	suppress	VERB
dti-2573	72	18	lung	lung	NOUN
dti-2573	72	19	tumorigenesis	tumorigenesis	NOUN
dti-2573	72	20	and	and	CCONJ
dti-2573	72	21	suppression	suppression	NOUN
dti-2573	72	22	of	of	ADP
dti-2573	72	23	cacna2d2	cacna2d2	PRON
dti-2573	72	24	,	,	PUNCT
dti-2573	72	25	a	a	DET
dti-2573	72	26	link	link	NOUN
dti-2573	72	27	to	to	ADP
dti-2573	72	28	non	non	ADJ
dti-2573	72	29	–	–	ADJ
dti-2573	72	30	small	small	ADJ
dti-2573	72	31	cell	cell	NOUN
dti-2573	72	32	lung	lung	NOUN
dti-2573	72	33	cancer	cancer	NOUN
dti-2573	72	34	(	(	PUNCT
dti-2573	72	35	19,20	19,20	NOUN
dti-2573	72	36	)	)	PUNCT
dti-2573	72	37	.	.	PUNCT
dti-2573	73	1	previous	previous	ADJ
dti-2573	73	2	studies	study	NOUN
dti-2573	73	3	and	and	CCONJ
dti-2573	73	4	meta	meta	NOUN
dti-2573	73	5	-	-	PUNCT
dti-2573	73	6	analyses	analysis	NOUN
dti-2573	73	7	that	that	PRON
dti-2573	73	8	reported	report	VERB
dti-2573	73	9	on	on	ADP
dti-2573	73	10	the	the	DET
dti-2573	73	11	risk	risk	NOUN
dti-2573	73	12	of	of	ADP
dti-2573	73	13	ccb	ccb	PROPN
dti-2573	73	14	on	on	ADP
dti-2573	73	15	lung	lung	NOUN
dti-2573	73	16	cancer	cancer	NOUN
dti-2573	73	17	were	be	AUX
dti-2573	73	18	mainly	mainly	ADV
dti-2573	73	19	from	from	ADP
dti-2573	73	20	database	database	NOUN
dti-2573	73	21	study	study	NOUN
dti-2573	73	22	with	with	ADP
dti-2573	73	23	asymptomatic	asymptomatic	ADJ
dti-2573	73	24	controls	control	NOUN
dti-2573	73	25	,	,	PUNCT
dti-2573	73	26	while	while	SCONJ
dti-2573	73	27	this	this	DET
dti-2573	73	28	study	study	NOUN
dti-2573	73	29	evaluated	evaluate	VERB
dti-2573	73	30	this	this	DET
dti-2573	73	31	association	association	NOUN
dti-2573	73	32	with	with	ADP
dti-2573	73	33	a	a	DET
dti-2573	73	34	case	case	NOUN
dti-2573	73	35	-	-	PUNCT
dti-2573	73	36	control	control	NOUN
dti-2573	73	37	study	study	NOUN
dti-2573	73	38	using	use	VERB
dti-2573	73	39	controls	control	NOUN
dti-2573	73	40	who	who	PRON
dti-2573	73	41	presented	present	VERB
dti-2573	73	42	with	with	ADP
dti-2573	73	43	similar	similar	ADJ
dti-2573	73	44	symptoms	symptom	NOUN
dti-2573	73	45	of	of	ADP
dti-2573	73	46	lung	lung	NOUN
dti-2573	73	47	cancer	cancer	NOUN
dti-2573	73	48	.	.	PUNCT
dti-2573	74	1	rotshild	rotshild	PROPN
dti-2573	74	2	et	et	PROPN
dti-2573	74	3	al	al	PROPN
dti-2573	74	4	published	publish	VERB
dti-2573	74	5	one	one	NUM
dti-2573	74	6	meta	meta	ADJ
dti-2573	74	7	-	-	PUNCT
dti-2573	74	8	analysis	analysis	NOUN
dti-2573	74	9	and	and	CCONJ
dti-2573	74	10	one	one	NUM
dti-2573	74	11	nested	nested	ADJ
dti-2573	74	12	case	case	NOUN
dti-2573	74	13	-	-	PUNCT
dti-2573	74	14	control	control	NOUN
dti-2573	74	15	study	study	NOUN
dti-2573	74	16	.	.	PUNCT
dti-2573	75	1	both	both	DET
dti-2573	75	2	studies	study	NOUN
dti-2573	75	3	reported	report	VERB
dti-2573	75	4	that	that	SCONJ
dti-2573	75	5	ccb	ccb	PROPN
dti-2573	75	6	was	be	AUX
dti-2573	75	7	associated	associate	VERB
dti-2573	75	8	with	with	ADP
dti-2573	75	9	lung	lung	NOUN
dti-2573	75	10	cancer	cancer	NOUN
dti-2573	75	11	with	with	ADP
dti-2573	75	12	an	an	DET
dti-2573	75	13	adjusted	adjust	VERB
dti-2573	75	14	odds	odd	NOUN
dti-2573	75	15	ratio	ratio	NOUN
dti-2573	75	16	of	of	ADP
dti-2573	75	17	1.13	1.13	NUM
dti-2573	75	18	(	(	PUNCT
dti-2573	75	19	95	95	NUM
dti-2573	75	20	%	%	NOUN
dti-2573	75	21	confidence	confidence	NOUN
dti-2573	75	22	interval	interval	NOUN
dti-2573	75	23	1.06	1.06	NUM
dti-2573	75	24	,	,	PUNCT
dti-2573	75	25	1.21	1.21	NUM
dti-2573	75	26	)	)	PUNCT
dti-2573	75	27	and	and	CCONJ
dti-2573	75	28	a	a	DET
dti-2573	75	29	risk	risk	NOUN
dti-2573	75	30	ratio	ratio	NOUN
dti-2573	75	31	of	of	ADP
dti-2573	75	32	1.15	1.15	NUM
dti-2573	75	33	(	(	PUNCT
dti-2573	75	34	95	95	NUM
dti-2573	75	35	%	%	NOUN
dti-2573	75	36	confidence	confidence	NOUN
dti-2573	75	37	interval	interval	NOUN
dti-2573	75	38	1.01	1.01	NUM
dti-2573	75	39	-	-	SYM
dti-2573	75	40	1.30	1.30	NUM
dti-2573	75	41	)	)	PUNCT
dti-2573	75	42	(	(	PUNCT
dti-2573	75	43	12,13	12,13	NUM
dti-2573	75	44	)	)	PUNCT
dti-2573	75	45	.	.	PUNCT
dti-2573	76	1	however	however	ADV
dti-2573	76	2	,	,	PUNCT
dti-2573	76	3	there	there	PRON
dti-2573	76	4	are	be	VERB
dti-2573	76	5	some	some	DET
dti-2573	76	6	limitations	limitation	NOUN
dti-2573	76	7	in	in	ADP
dti-2573	76	8	both	both	DET
dti-2573	76	9	studies	study	NOUN
dti-2573	76	10	.	.	PUNCT
dti-2573	77	1	the	the	DET
dti-2573	77	2	case	case	NOUN
dti-2573	77	3	-	-	PUNCT
dti-2573	77	4	control	control	NOUN
dti-2573	77	5	study	study	NOUN
dti-2573	77	6	did	do	AUX
dti-2573	77	7	not	not	PART
dti-2573	77	8	state	state	VERB
dti-2573	77	9	how	how	SCONJ
dti-2573	77	10	lung	lung	NOUN
dti-2573	77	11	cancer	cancer	NOUN
dti-2573	77	12	diagnosis	diagnosis	NOUN
dti-2573	77	13	was	be	AUX
dti-2573	77	14	made	make	VERB
dti-2573	77	15	and	and	CCONJ
dti-2573	77	16	significant	significant	ADJ
dti-2573	77	17	factors	factor	NOUN
dti-2573	77	18	in	in	ADP
dti-2573	77	19	this	this	DET
dti-2573	77	20	study	study	NOUN
dti-2573	77	21	,	,	PUNCT
dti-2573	77	22	namely	namely	ADV
dti-2573	77	23	dyslipidemia	dyslipidemia	NOUN
dti-2573	77	24	and	and	CCONJ
dti-2573	77	25	family	family	NOUN
dti-2573	77	26	history	history	NOUN
dti-2573	77	27	of	of	ADP
dti-2573	77	28	lung	lung	NOUN
dti-2573	77	29	cancer	cancer	NOUN
dti-2573	77	30	,	,	PUNCT
dti-2573	77	31	were	be	AUX
dti-2573	77	32	not	not	PART
dti-2573	77	33	studied	study	VERB
dti-2573	77	34	(	(	PUNCT
dti-2573	77	35	12	12	NUM
dti-2573	77	36	)	)	PUNCT
dti-2573	77	37	.	.	PUNCT
dti-2573	78	1	the	the	DET
dti-2573	78	2	results	result	NOUN
dti-2573	78	3	of	of	ADP
dti-2573	78	4	this	this	DET
dti-2573	78	5	study	study	NOUN
dti-2573	78	6	were	be	AUX
dti-2573	78	7	compatible	compatible	ADJ
dti-2573	78	8	with	with	ADP
dti-2573	78	9	the	the	DET
dti-2573	78	10	large	large	ADJ
dti-2573	78	11	population	population	NOUN
dti-2573	78	12	cohort	cohort	NOUN
dti-2573	78	13	study	study	NOUN
dti-2573	78	14	in	in	ADP
dti-2573	78	15	hong	hong	PROPN
dti-2573	78	16	kong	kong	PROPN
dti-2573	78	17	(	(	PUNCT
dti-2573	78	18	21	21	NUM
dti-2573	78	19	)	)	PUNCT
dti-2573	78	20	.	.	PUNCT
dti-2573	79	1	among	among	ADP
dti-2573	79	2	84,116	84,116	NUM
dti-2573	79	3	patients	patient	NOUN
dti-2573	79	4	with	with	ADP
dti-2573	79	5	lung	lung	NOUN
dti-2573	79	6	cancer	cancer	NOUN
dti-2573	79	7	,	,	PUNCT
dti-2573	79	8	ccb	ccb	PROPN
dti-2573	79	9	did	do	AUX
dti-2573	79	10	not	not	PART
dti-2573	79	11	increase	increase	VERB
dti-2573	79	12	the	the	DET
dti-2573	79	13	risk	risk	NOUN
dti-2573	79	14	of	of	ADP
dti-2573	79	15	lung	lung	NOUN
dti-2573	79	16	cancer	cancer	NOUN
dti-2573	79	17	regardless	regardless	ADV
dti-2573	79	18	of	of	ADP
dti-2573	79	19	aspirin	aspirin	NOUN
dti-2573	79	20	therapy	therapy	NOUN
dti-2573	79	21	.	.	PUNCT
dti-2573	80	1	the	the	DET
dti-2573	80	2	hazard	hazard	NOUN
dti-2573	80	3	ratios	ratio	NOUN
dti-2573	80	4	for	for	ADP
dti-2573	80	5	both	both	DET
dti-2573	80	6	settings	setting	NOUN
dti-2573	80	7	were	be	AUX
dti-2573	80	8	0.89	0.89	NUM
dti-2573	80	9	(	(	PUNCT
dti-2573	80	10	95	95	NUM
dti-2573	80	11	%	%	NOUN
dti-2573	80	12	confidence	confidence	NOUN
dti-2573	80	13	interval	interval	NOUN
dti-2573	80	14	of	of	ADP
dti-2573	80	15	0.73	0.73	NUM
dti-2573	80	16	,	,	PUNCT
dti-2573	80	17	1.08	1.08	NUM
dti-2573	80	18	)	)	PUNCT
dti-2573	80	19	for	for	ADP
dti-2573	80	20	ccb	ccb	PROPN
dti-2573	80	21	and	and	CCONJ
dti-2573	80	22	0.82	0.82	NUM
dti-2573	80	23	(	(	PUNCT
dti-2573	80	24	95	95	NUM
dti-2573	80	25	%	%	NOUN
dti-2573	80	26	confidence	confidence	NOUN
dti-2573	80	27	interval	interval	NOUN
dti-2573	80	28	of	of	ADP
dti-2573	80	29	0.64	0.64	NUM
dti-2573	80	30	,	,	PUNCT
dti-2573	80	31	1.06	1.06	NUM
dti-2573	80	32	)	)	PUNCT
dti-2573	80	33	for	for	ADP
dti-2573	80	34	ccb	ccb	PROPN
dti-2573	80	35	plus	plus	CCONJ
dti-2573	80	36	aspirin	aspirin	NOUN
dti-2573	80	37	.	.	PUNCT
dti-2573	81	1	as	as	SCONJ
dti-2573	81	2	data	datum	NOUN
dti-2573	81	3	regarding	regard	VERB
dti-2573	81	4	ccb	ccb	PROPN
dti-2573	81	5	and	and	CCONJ
dti-2573	81	6	lung	lung	NOUN
dti-2573	81	7	cancer	cancer	NOUN
dti-2573	81	8	are	be	AUX
dti-2573	81	9	still	still	ADV
dti-2573	81	10	conflicting	conflict	VERB
dti-2573	81	11	,	,	PUNCT
dti-2573	81	12	further	further	ADJ
dti-2573	81	13	studies	study	NOUN
dti-2573	81	14	are	be	AUX
dti-2573	81	15	required	require	VERB
dti-2573	81	16	.	.	PUNCT
dti-2573	82	1	this	this	DET
dti-2573	82	2	study	study	NOUN
dti-2573	82	3	found	find	VERB
dti-2573	82	4	that	that	SCONJ
dti-2573	82	5	dyslipidemia	dyslipidemia	NOUN
dti-2573	82	6	was	be	AUX
dti-2573	82	7	associated	associate	VERB
dti-2573	82	8	with	with	ADP
dti-2573	82	9	lung	lung	NOUN
dti-2573	82	10	cancer	cancer	NOUN
dti-2573	82	11	,	,	PUNCT
dti-2573	82	12	which	which	PRON
dti-2573	82	13	was	be	AUX
dti-2573	82	14	supported	support	VERB
dti-2573	82	15	by	by	ADP
dti-2573	82	16	a	a	DET
dti-2573	82	17	previous	previous	ADJ
dti-2573	82	18	study	study	NOUN
dti-2573	82	19	from	from	ADP
dti-2573	82	20	china	china	PROPN
dti-2573	82	21	(	(	PUNCT
dti-2573	82	22	22	22	NUM
dti-2573	82	23	)	)	PUNCT
dti-2573	82	24	.	.	PUNCT
dti-2573	83	1	high	high	ADJ
dti-2573	83	2	-	-	PUNCT
dti-2573	83	3	density	density	NOUN
dti-2573	83	4	lipoprotein	lipoprotein	ADJ
dti-2573	83	5	cholesterol	cholesterol	NOUN
dti-2573	83	6	(	(	PUNCT
dti-2573	83	7	hdlc	hdlc	NOUN
dti-2573	83	8	)	)	PUNCT
dti-2573	83	9	reduced	reduce	VERB
dti-2573	83	10	the	the	DET
dti-2573	83	11	risk	risk	NOUN
dti-2573	83	12	of	of	ADP
dti-2573	83	13	non	non	ADJ
dti-2573	83	14	–	–	ADJ
dti-2573	83	15	small	small	ADJ
dti-2573	83	16	cell	cell	NOUN
dti-2573	83	17	lung	lung	NOUN
dti-2573	83	18	cancer	cancer	NOUN
dti-2573	83	19	by	by	ADP
dti-2573	83	20	77	77	NUM
dti-2573	83	21	%	%	NOUN
dti-2573	83	22	(	(	PUNCT
dti-2573	83	23	adjusted	adjust	VERB
dti-2573	83	24	odds	odd	NOUN
dti-2573	83	25	ratio	ratio	NOUN
dti-2573	83	26	of	of	ADP
dti-2573	83	27	0.233	0.233	NUM
dti-2573	83	28	;	;	PUNCT
dti-2573	83	29	95	95	NUM
dti-2573	83	30	%	%	NOUN
dti-2573	83	31	confidence	confidence	NOUN
dti-2573	83	32	interval	interval	NOUN
dti-2573	83	33	of	of	ADP
dti-2573	83	34	0.134	0.134	NUM
dti-2573	83	35	,	,	PUNCT
dti-2573	83	36	0.407	0.407	NUM
dti-2573	83	37	)	)	PUNCT
dti-2573	83	38	.	.	PUNCT
dti-2573	84	1	there	there	PRON
dti-2573	84	2	are	be	VERB
dti-2573	84	3	several	several	ADJ
dti-2573	84	4	biological	biological	ADJ
dti-2573	84	5	explanations	explanation	NOUN
dti-2573	84	6	for	for	ADP
dti-2573	84	7	the	the	DET
dti-2573	84	8	reduction	reduction	NOUN
dti-2573	84	9	of	of	ADP
dti-2573	84	10	cancer	cancer	NOUN
dti-2573	84	11	and	and	CCONJ
dti-2573	84	12	high	high	ADJ
dti-2573	84	13	hdl	hdl	PROPN
dti-2573	84	14	-	-	PUNCT
dti-2573	84	15	c	c	PROPN
dti-2573	84	16	,	,	PUNCT
dti-2573	84	17	such	such	ADJ
dti-2573	84	18	as	as	ADP
dti-2573	84	19	suppression	suppression	NOUN
dti-2573	84	20	of	of	ADP
dti-2573	84	21	signaling	signal	VERB
dti-2573	84	22	via	via	ADP
dti-2573	84	23	lipid	lipid	NOUN
dti-2573	84	24	raft	raft	NOUN
dti-2573	84	25	formation	formation	NOUN
dti-2573	84	26	and	and	CCONJ
dti-2573	84	27	reduction	reduction	NOUN
dti-2573	84	28	of	of	ADP
dti-2573	84	29	viability	viability	NOUN
dti-2573	84	30	and	and	CCONJ
dti-2573	84	31	proliferation	proliferation	NOUN
dti-2573	84	32	(	(	PUNCT
dti-2573	84	33	23,24	23,24	NOUN
dti-2573	84	34	)	)	PUNCT
dti-2573	84	35	.	.	PUNCT
dti-2573	85	1	regarding	regard	VERB
dti-2573	85	2	family	family	NOUN
dti-2573	85	3	history	history	NOUN
dti-2573	85	4	of	of	ADP
dti-2573	85	5	lung	lung	NOUN
dti-2573	85	6	cancer	cancer	NOUN
dti-2573	85	7	,	,	PUNCT
dti-2573	85	8	several	several	ADJ
dti-2573	85	9	studies	study	NOUN
dti-2573	85	10	support	support	VERB
dti-2573	85	11	this	this	DET
dti-2573	85	12	finding	finding	NOUN
dti-2573	85	13	conducted	conduct	VERB
dti-2573	85	14	in	in	ADP
dti-2573	85	15	twins	twin	NOUN
dti-2573	85	16	,	,	PUNCT
dti-2573	85	17	women	woman	NOUN
dti-2573	85	18	,	,	PUNCT
dti-2573	85	19	and	and	CCONJ
dti-2573	85	20	nonsmokers	nonsmoker	NOUN
dti-2573	85	21	(	(	PUNCT
dti-2573	85	22	25	25	NUM
dti-2573	85	23	-	-	SYM
dti-2573	85	24	27	27	NUM
dti-2573	85	25	)	)	PUNCT
dti-2573	85	26	.	.	PUNCT
dti-2573	86	1	this	this	DET
dti-2573	86	2	association	association	NOUN
dti-2573	86	3	may	may	AUX
dti-2573	86	4	be	be	AUX
dti-2573	86	5	explained	explain	VERB
dti-2573	86	6	by	by	ADP
dti-2573	86	7	second	second	ADJ
dti-2573	86	8	-	-	PUNCT
dti-2573	86	9	hand	hand	NOUN
dti-2573	86	10	smokers	smoker	NOUN
dti-2573	86	11	or	or	CCONJ
dti-2573	86	12	genetic	genetic	ADJ
dti-2573	86	13	factors	factor	NOUN
dti-2573	86	14	such	such	ADJ
dti-2573	86	15	as	as	ADP
dti-2573	86	16	her2	her2	PROPN
dti-2573	86	17	gene	gene	NOUN
dti-2573	86	18	or	or	CCONJ
dti-2573	86	19	egfr	egfr	ADJ
dti-2573	86	20	variant	variant	NOUN
dti-2573	86	21	(	(	PUNCT
dti-2573	86	22	28	28	NUM
dti-2573	86	23	-	-	SYM
dti-2573	86	24	32	32	NUM
dti-2573	86	25	)	)	PUNCT
dti-2573	86	26	.	.	PUNCT
dti-2573	87	1	study	study	NOUN
dti-2573	87	2	limitations	limitation	NOUN
dti-2573	87	3	there	there	PRON
dti-2573	87	4	are	be	VERB
dti-2573	87	5	some	some	DET
dti-2573	87	6	limitations	limitation	NOUN
dti-2573	87	7	in	in	ADP
dti-2573	87	8	this	this	DET
dti-2573	87	9	study	study	NOUN
dti-2573	87	10	.	.	PUNCT
dti-2573	88	1	first	first	ADV
dti-2573	88	2	,	,	PUNCT
dti-2573	88	3	this	this	PRON
dti-2573	88	4	was	be	AUX
dti-2573	88	5	a	a	DET
dti-2573	88	6	study	study	NOUN
dti-2573	88	7	conducted	conduct	VERB
dti-2573	88	8	in	in	ADP
dti-2573	88	9	a	a	DET
dti-2573	88	10	single	single	ADJ
dti-2573	88	11	,	,	PUNCT
dti-2573	88	12	referral	referral	ADJ
dti-2573	88	13	university	university	NOUN
dti-2573	88	14	hospital	hospital	NOUN
dti-2573	88	15	resulting	result	VERB
dti-2573	88	16	in	in	ADP
dti-2573	88	17	a	a	DET
dti-2573	88	18	small	small	ADJ
dti-2573	88	19	sample	sample	NOUN
dti-2573	88	20	size	size	NOUN
dti-2573	88	21	.	.	PUNCT
dti-2573	89	1	second	second	ADJ
dti-2573	89	2	,	,	PUNCT
dti-2573	89	3	some	some	DET
dti-2573	89	4	factors	factor	NOUN
dti-2573	89	5	were	be	AUX
dti-2573	89	6	not	not	PART
dti-2573	89	7	completely	completely	ADV
dti-2573	89	8	evaluated	evaluate	VERB
dti-2573	89	9	such	such	ADJ
dti-2573	89	10	as	as	ADP
dti-2573	89	11	genetic	genetic	ADJ
dti-2573	89	12	factors	factor	NOUN
dti-2573	89	13	,	,	PUNCT
dti-2573	89	14	sleep	sleep	VERB
dti-2573	89	15	apnea	apnea	NOUN
dti-2573	89	16	,	,	PUNCT
dti-2573	89	17	or	or	CCONJ
dti-2573	89	18	aspirin	aspirin	NOUN
dti-2573	89	19	therapy	therapy	NOUN
dti-2573	89	20	(	(	PUNCT
dti-2573	89	21	21,33	21,33	NUM
dti-2573	89	22	-	-	SYM
dti-2573	89	23	38	38	NUM
dti-2573	89	24	)	)	PUNCT
dti-2573	89	25	.	.	PUNCT
dti-2573	90	1	similar	similar	ADJ
dti-2573	90	2	to	to	ADP
dti-2573	90	3	previous	previous	ADJ
dti-2573	90	4	published	publish	VERB
dti-2573	90	5	articles	article	NOUN
dti-2573	90	6	,	,	PUNCT
dti-2573	90	7	smoking	smoke	VERB
dti-2573	90	8	history	history	NOUN
dti-2573	90	9	may	may	AUX
dti-2573	90	10	be	be	AUX
dti-2573	90	11	underestimated	underestimate	VERB
dti-2573	90	12	as	as	SCONJ
dti-2573	90	13	smoking	smoking	NOUN
dti-2573	90	14	status	status	NOUN
dti-2573	90	15	may	may	AUX
dti-2573	90	16	not	not	PART
dti-2573	90	17	be	be	AUX
dti-2573	90	18	recorded	record	VERB
dti-2573	90	19	in	in	ADP
dti-2573	90	20	the	the	DET
dti-2573	90	21	medical	medical	ADJ
dti-2573	90	22	records	record	NOUN
dti-2573	90	23	(	(	PUNCT
dti-2573	90	24	12,13,21	12,13,21	NUM
dti-2573	90	25	)	)	PUNCT
dti-2573	90	26	.	.	PUNCT
dti-2573	91	1	additionally	additionally	ADV
dti-2573	91	2	,	,	PUNCT
dti-2573	91	3	selection	selection	NOUN
dti-2573	91	4	bias	bias	NOUN
dti-2573	91	5	may	may	AUX
dti-2573	91	6	have	have	AUX
dti-2573	91	7	existed	exist	VERB
dti-2573	91	8	as	as	SCONJ
dti-2573	91	9	this	this	DET
dti-2573	91	10	study	study	NOUN
dti-2573	91	11	enrolled	enrol	VERB
dti-2573	91	12	only	only	ADV
dti-2573	91	13	those	those	PRON
dti-2573	91	14	with	with	ADP
dti-2573	91	15	pathological	pathological	ADJ
dti-2573	91	16	diagnosis	diagnosis	NOUN
dti-2573	91	17	of	of	ADP
dti-2573	91	18	lung	lung	NOUN
dti-2573	91	19	cancer	cancer	NOUN
dti-2573	91	20	.	.	PUNCT
dti-2573	92	1	this	this	PRON
dti-2573	92	2	may	may	AUX
dti-2573	92	3	also	also	ADV
dti-2573	92	4	result	result	VERB
dti-2573	92	5	in	in	ADP
dti-2573	92	6	small	small	ADJ
dti-2573	92	7	sample	sample	NOUN
dti-2573	92	8	size	size	NOUN
dti-2573	92	9	.	.	PUNCT
dti-2573	93	1	finally	finally	ADV
dti-2573	93	2	,	,	PUNCT
dti-2573	93	3	some	some	DET
dti-2573	93	4	factors	factor	NOUN
dti-2573	93	5	such	such	ADJ
dti-2573	93	6	as	as	ADP
dti-2573	93	7	alcohol	alcohol	NOUN
dti-2573	93	8	consumption	consumption	NOUN
dti-2573	93	9	may	may	AUX
dti-2573	93	10	not	not	PART
dti-2573	93	11	be	be	AUX
dti-2573	93	12	studied	study	VERB
dti-2573	93	13	or	or	CCONJ
dti-2573	93	14	may	may	AUX
dti-2573	93	15	be	be	AUX
dti-2573	93	16	missing	miss	VERB
dti-2573	93	17	due	due	ADJ
dti-2573	93	18	to	to	ADP
dti-2573	93	19	retrospective	retrospective	ADJ
dti-2573	93	20	design	design	NOUN
dti-2573	93	21	.	.	PUNCT
dti-2573	94	1	conclusions	conclusion	NOUN
dti-2573	94	2	ccb	ccb	PROPN
dti-2573	94	3	was	be	AUX
dti-2573	94	4	not	not	PART
dti-2573	94	5	associated	associate	VERB
dti-2573	94	6	with	with	ADP
dti-2573	94	7	lung	lung	NOUN
dti-2573	94	8	cancer	cancer	NOUN
dti-2573	94	9	in	in	ADP
dti-2573	94	10	patients	patient	NOUN
dti-2573	94	11	with	with	ADP
dti-2573	94	12	hypertension	hypertension	NOUN
dti-2573	94	13	but	but	CCONJ
dti-2573	94	14	dyslipidemia	dyslipidemia	NOUN
dti-2573	94	15	and	and	CCONJ
dti-2573	94	16	family	family	NOUN
dti-2573	94	17	history	history	NOUN
dti-2573	94	18	of	of	ADP
dti-2573	94	19	lung	lung	NOUN
dti-2573	94	20	cancer	cancer	NOUN
dti-2573	94	21	were	be	AUX
dti-2573	94	22	independently	independently	ADV
dti-2573	94	23	associated	associate	VERB
dti-2573	94	24	with	with	ADP
dti-2573	94	25	lung	lung	NOUN
dti-2573	94	26	cancer	cancer	NOUN
dti-2573	94	27	in	in	ADP
dti-2573	94	28	this	this	DET
dti-2573	94	29	setting	setting	NOUN
dti-2573	94	30	.	.	PUNCT
dti-2573	95	1	disclosures	disclosure	NOUN
dti-2573	95	2	conflict	conflict	NOUN
dti-2573	95	3	of	of	ADP
dti-2573	95	4	interest	interest	NOUN
dti-2573	95	5	:	:	PUNCT
dti-2573	95	6	the	the	DET
dti-2573	95	7	authors	author	NOUN
dti-2573	95	8	declare	declare	VERB
dti-2573	95	9	that	that	SCONJ
dti-2573	95	10	they	they	PRON
dti-2573	95	11	have	have	VERB
dti-2573	95	12	no	no	DET
dti-2573	95	13	conflicts	conflict	NOUN
dti-2573	95	14	of	of	ADP
dti-2573	95	15	interest	interest	NOUN
dti-2573	95	16	.	.	PUNCT
dti-2573	96	1	financial	financial	ADJ
dti-2573	96	2	support	support	NOUN
dti-2573	96	3	:	:	PUNCT
dti-2573	96	4	this	this	DET
dti-2573	96	5	study	study	NOUN
dti-2573	96	6	was	be	AUX
dti-2573	96	7	funded	fund	VERB
dti-2573	96	8	by	by	ADP
dti-2573	96	9	a	a	DET
dti-2573	96	10	grant	grant	NOUN
dti-2573	96	11	from	from	ADP
dti-2573	96	12	khon	khon	PROPN
dti-2573	96	13	kaen	kaen	PROPN
dti-2573	96	14	university	university	PROPN
dti-2573	96	15	,	,	PUNCT
dti-2573	96	16	faculty	faculty	NOUN
dti-2573	96	17	of	of	ADP
dti-2573	96	18	medicine	medicine	NOUN
dti-2573	96	19	,	,	PUNCT
dti-2573	96	20	thailand	thailand	PROPN
dti-2573	96	21	(	(	PUNCT
dti-2573	96	22	grant	grant	PROPN
dti-2573	96	23	number	number	NOUN
dti-2573	96	24	:	:	PUNCT
dti-2573	96	25	mn66003	mn66003	PROPN
dti-2573	96	26	)	)	PUNCT
dti-2573	96	27	.	.	PUNCT
dti-2573	97	1	references	reference	NOUN
dti-2573	97	2	1	1	NUM
dti-2573	97	3	.	.	PUNCT
dti-2573	97	4	mills	mills	PROPN
dti-2573	97	5	kt	kt	PROPN
dti-2573	97	6	,	,	PUNCT
dti-2573	97	7	stefanescu	stefanescu	PROPN
dti-2573	97	8	a	a	PRON
dti-2573	97	9	,	,	PUNCT
dti-2573	97	10	he	he	PRON
dti-2573	97	11	j.	j.	PROPN
dti-2573	97	12	the	the	DET
dti-2573	97	13	global	global	ADJ
dti-2573	97	14	epidemiology	epidemiology	NOUN
dti-2573	97	15	of	of	ADP
dti-2573	97	16	hypertension	hypertension	NOUN
dti-2573	97	17	.	.	PUNCT
dti-2573	98	1	nat	nat	PROPN
dti-2573	98	2	rev	rev	VERB
dti-2573	98	3	nephrol	nephrol	NOUN
dti-2573	98	4	.	.	PUNCT
dti-2573	99	1	2020;16(4):223	2020;16(4):223	NUM
dti-2573	99	2	-	-	PUNCT
dti-2573	99	3	237	237	NUM
dti-2573	99	4	.	.	PUNCT
dti-2573	100	1	crossref	crossref	PROPN
dti-2573	100	2	pubmed	pubmed	PROPN
dti-2573	100	3	2	2	PROPN
dti-2573	100	4	.	.	PUNCT
dti-2573	101	1	zhou	zhou	PROPN
dti-2573	101	2	b	b	PROPN
dti-2573	101	3	,	,	PUNCT
dti-2573	101	4	carrillo	carrillo	PROPN
dti-2573	101	5	-	-	PUNCT
dti-2573	101	6	larco	larco	PROPN
dti-2573	101	7	rm	rm	PROPN
dti-2573	101	8	,	,	PUNCT
dti-2573	101	9	danaei	danaei	NOUN
dti-2573	101	10	g	g	PROPN
dti-2573	101	11	,	,	PUNCT
dti-2573	101	12	et	et	PROPN
dti-2573	101	13	al	al	PROPN
dti-2573	101	14	;	;	PUNCT
dti-2573	101	15	ncd	ncd	X
dti-2573	101	16	risk	risk	NOUN
dti-2573	101	17	factor	factor	NOUN
dti-2573	101	18	collaboration	collaboration	NOUN
dti-2573	101	19	(	(	PUNCT
dti-2573	101	20	ncd	ncd	NOUN
dti-2573	101	21	-	-	PUNCT
dti-2573	101	22	risc	risc	PROPN
dti-2573	101	23	)	)	PUNCT
dti-2573	101	24	.	.	PUNCT
dti-2573	102	1	worldwide	worldwide	ADJ
dti-2573	102	2	trends	trend	NOUN
dti-2573	102	3	in	in	ADP
dti-2573	102	4	hypertension	hypertension	NOUN
dti-2573	102	5	prevalence	prevalence	NOUN
dti-2573	102	6	and	and	CCONJ
dti-2573	102	7	progress	progress	NOUN
dti-2573	102	8	in	in	ADP
dti-2573	102	9	treatment	treatment	NOUN
dti-2573	102	10	and	and	CCONJ
dti-2573	102	11	control	control	NOUN
dti-2573	102	12	from	from	ADP
dti-2573	102	13	1990	1990	NUM
dti-2573	102	14	to	to	ADP
dti-2573	102	15	2019	2019	NUM
dti-2573	102	16	:	:	PUNCT
dti-2573	102	17	a	a	DET
dti-2573	102	18	pooled	pooled	ADJ
dti-2573	102	19	analysis	analysis	NOUN
dti-2573	102	20	of	of	ADP
dti-2573	102	21	1201	1201	NUM
dti-2573	102	22	population	population	NOUN
dti-2573	102	23	-	-	PUNCT
dti-2573	102	24	representative	representative	NOUN
dti-2573	102	25	studies	study	NOUN
dti-2573	102	26	with	with	ADP
dti-2573	102	27	104	104	NUM
dti-2573	102	28	million	million	NUM
dti-2573	102	29	participants	participant	NOUN
dti-2573	102	30	.	.	PUNCT
dti-2573	103	1	lancet	lancet	VERB
dti-2573	103	2	.	.	PUNCT
dti-2573	104	1	2021;398(10304	2021;398(10304	NUM
dti-2573	104	2	):	):	PUNCT
dti-2573	104	3	957	957	NUM
dti-2573	104	4	-	-	SYM
dti-2573	104	5	980	980	NUM
dti-2573	104	6	.	.	PUNCT
dti-2573	105	1	crossref	crossref	PROPN
dti-2573	105	2	pubmed	pubmed	PROPN
dti-2573	105	3	3	3	PROPN
dti-2573	105	4	.	.	PUNCT
dti-2573	105	5	chobanian	chobanian	PROPN
dti-2573	105	6	av	av	PROPN
dti-2573	105	7	,	,	PUNCT
dti-2573	105	8	bakris	bakris	PROPN
dti-2573	105	9	gl	gl	PROPN
dti-2573	105	10	,	,	PUNCT
dti-2573	105	11	black	black	ADJ
dti-2573	105	12	hr	hr	NOUN
dti-2573	105	13	,	,	PUNCT
dti-2573	105	14	et	et	PROPN
dti-2573	105	15	al	al	PROPN
dti-2573	105	16	;	;	PUNCT
dti-2573	105	17	national	national	ADJ
dti-2573	105	18	high	high	ADJ
dti-2573	105	19	blood	blood	NOUN
dti-2573	105	20	pressure	pressure	NOUN
dti-2573	105	21	education	education	NOUN
dti-2573	105	22	program	program	NOUN
dti-2573	105	23	coordinating	coordinate	VERB
dti-2573	105	24	committee	committee	NOUN
dti-2573	105	25	.	.	PUNCT
dti-2573	106	1	the	the	DET
dti-2573	106	2	seventh	seventh	ADJ
dti-2573	106	3	report	report	NOUN
dti-2573	106	4	of	of	ADP
dti-2573	106	5	the	the	DET
dti-2573	106	6	joint	joint	ADJ
dti-2573	106	7	national	national	PROPN
dti-2573	106	8	committee	committee	PROPN
dti-2573	106	9	on	on	ADP
dti-2573	106	10	prevention	prevention	NOUN
dti-2573	106	11	,	,	PUNCT
dti-2573	106	12	detection	detection	NOUN
dti-2573	106	13	,	,	PUNCT
dti-2573	106	14	evaluation	evaluation	NOUN
dti-2573	106	15	,	,	PUNCT
dti-2573	106	16	and	and	CCONJ
dti-2573	106	17	treatment	treatment	NOUN
dti-2573	106	18	of	of	ADP
dti-2573	106	19	high	high	ADJ
dti-2573	106	20	blood	blood	NOUN
dti-2573	106	21	pressure	pressure	NOUN
dti-2573	106	22	:	:	PUNCT
dti-2573	106	23	the	the	DET
dti-2573	106	24	jnc	jnc	NOUN
dti-2573	106	25	7	7	NUM
dti-2573	106	26	report	report	NOUN
dti-2573	106	27	.	.	PUNCT
dti-2573	107	1	jama	jama	PROPN
dti-2573	107	2	.	.	PUNCT
dti-2573	108	1	2003;289(19):25602572	2003;289(19):25602572	X
dti-2573	108	2	.	.	PUNCT
dti-2573	108	3	crossref	crossref	PROPN
dti-2573	108	4	pubmed	pubmed	PROPN
dti-2573	108	5	4	4	PROPN
dti-2573	108	6	.	.	PUNCT
dti-2573	108	7	khamsai	khamsai	PROPN
dti-2573	108	8	s	s	PROPN
dti-2573	108	9	,	,	PUNCT
dti-2573	108	10	mahawarakorn	mahawarakorn	ADJ
dti-2573	108	11	p	p	NOUN
dti-2573	108	12	,	,	PUNCT
dti-2573	108	13	limpawattana	limpawattana	NOUN
dti-2573	108	14	p	p	NOUN
dti-2573	108	15	,	,	PUNCT
dti-2573	108	16	et	et	PROPN
dti-2573	108	17	al	al	PROPN
dti-2573	108	18	.	.	PUNCT
dti-2573	109	1	prevalence	prevalence	NOUN
dti-2573	109	2	and	and	CCONJ
dti-2573	109	3	factors	factor	NOUN
dti-2573	109	4	correlated	correlate	VERB
dti-2573	109	5	with	with	ADP
dti-2573	109	6	hypertension	hypertension	NOUN
dti-2573	109	7	secondary	secondary	ADJ
dti-2573	109	8	from	from	ADP
dti-2573	109	9	obstructive	obstructive	ADJ
dti-2573	109	10	sleep	sleep	NOUN
dti-2573	109	11	apnea	apnea	NOUN
dti-2573	109	12	.	.	PUNCT
dti-2573	110	1	multidiscip	multidiscip	NOUN
dti-2573	110	2	respir	respir	VERB
dti-2573	110	3	med	med	ADJ
dti-2573	110	4	.	.	PUNCT
dti-2573	111	1	2021;16(1	2021;16(1	NUM
dti-2573	111	2	):	):	PUNCT
dti-2573	111	3	777	777	NUM
dti-2573	111	4	.	.	PUNCT
dti-2573	112	1	crossref	crossref	PROPN
dti-2573	112	2	pubmed	pubmed	PROPN
dti-2573	112	3	5	5	NUM
dti-2573	112	4	.	.	PUNCT
dti-2573	113	1	jeerasuwannakul	jeerasuwannakul	PROPN
dti-2573	113	2	b	b	PROPN
dti-2573	113	3	,	,	PUNCT
dti-2573	113	4	sawunyavisuth	sawunyavisuth	ADJ
dti-2573	113	5	b	b	NOUN
dti-2573	113	6	,	,	PUNCT
dti-2573	113	7	khamsai	khamsai	PROPN
dti-2573	113	8	s	s	PROPN
dti-2573	113	9	,	,	PUNCT
dti-2573	113	10	sawanyawisuth	sawanyawisuth	PROPN
dti-2573	113	11	k.	k.	PROPN
dti-2573	113	12	prevalence	prevalence	NOUN
dti-2573	113	13	and	and	CCONJ
dti-2573	113	14	risk	risk	NOUN
dti-2573	113	15	factors	factor	NOUN
dti-2573	113	16	of	of	ADP
dti-2573	113	17	proteinuria	proteinuria	NOUN
dti-2573	113	18	in	in	ADP
dti-2573	113	19	patients	patient	NOUN
dti-2573	113	20	with	with	ADP
dti-2573	113	21	type	type	NOUN
dti-2573	113	22	2	2	NUM
dti-2573	113	23	diabetes	diabetes	NOUN
dti-2573	113	24	mellitus	mellitus	NOUN
dti-2573	113	25	.	.	PUNCT
dti-2573	114	1	asia	asia	PROPN
dti-2573	114	2	pac	pac	PROPN
dti-2573	114	3	j	j	PROPN
dti-2573	114	4	sci	sci	PROPN
dti-2573	114	5	technol	technol	NOUN
dti-2573	114	6	.	.	PUNCT
dti-2573	115	1	2021;26(04):apst-2604	2021;26(04):apst-2604	NUM
dti-2573	115	2	-	-	SYM
dti-2573	115	3	02	02	NUM
dti-2573	115	4	:	:	PUNCT
dti-2573	115	5	1	1	NUM
dti-2573	115	6	-	-	SYM
dti-2573	115	7	5	5	NUM
dti-2573	115	8	.	.	PUNCT
dti-2573	116	1	crossref	crossref	PROPN
dti-2573	116	2	6	6	NUM
dti-2573	116	3	.	.	PUNCT
dti-2573	117	1	manasirisuk	manasirisuk	PROPN
dti-2573	117	2	p	p	NOUN
dti-2573	117	3	,	,	PUNCT
dti-2573	117	4	chainirun	chainirun	NOUN
dti-2573	117	5	n	n	CCONJ
dti-2573	117	6	,	,	PUNCT
dti-2573	117	7	tiamkao	tiamkao	NOUN
dti-2573	117	8	s	s	PROPN
dti-2573	117	9	,	,	PUNCT
dti-2573	117	10	et	et	PROPN
dti-2573	117	11	al	al	PROPN
dti-2573	117	12	.	.	PROPN
dti-2573	117	13	efficacy	efficacy	NOUN
dti-2573	117	14	of	of	ADP
dti-2573	117	15	generic	generic	ADJ
dti-2573	117	16	atorvastatin	atorvastatin	NOUN
dti-2573	117	17	in	in	ADP
dti-2573	117	18	a	a	DET
dti-2573	117	19	real	real	ADJ
dti-2573	117	20	-	-	PUNCT
dti-2573	117	21	world	world	NOUN
dti-2573	117	22	setting	setting	NOUN
dti-2573	117	23	.	.	PUNCT
dti-2573	118	1	clin	clin	PROPN
dti-2573	118	2	pharmacol	pharmacol	PROPN
dti-2573	118	3	.	.	PUNCT
dti-2573	119	1	2021;13:45	2021;13:45	NUM
dti-2573	119	2	-	-	SYM
dti-2573	119	3	51	51	NUM
dti-2573	119	4	.	.	PUNCT
dti-2573	120	1	crossref	crossref	PROPN
dti-2573	120	2	pubmed	pubmed	PROPN
dti-2573	120	3	7	7	PROPN
dti-2573	120	4	.	.	PUNCT
dti-2573	120	5	soontornrungsun	soontornrungsun	PROPN
dti-2573	120	6	b	b	PROPN
dti-2573	120	7	,	,	PUNCT
dti-2573	120	8	khamsai	khamsai	PROPN
dti-2573	120	9	s	s	PROPN
dti-2573	120	10	,	,	PUNCT
dti-2573	120	11	sawunyavisuth	sawunyavisuth	ADJ
dti-2573	120	12	b	b	NOUN
dti-2573	120	13	,	,	PUNCT
dti-2573	120	14	et	et	PROPN
dti-2573	120	15	al	al	PROPN
dti-2573	120	16	.	.	PROPN
dti-2573	120	17	obstructive	obstructive	ADJ
dti-2573	120	18	sleep	sleep	NOUN
dti-2573	120	19	apnea	apnea	NOUN
dti-2573	120	20	in	in	ADP
dti-2573	120	21	patients	patient	NOUN
dti-2573	120	22	with	with	ADP
dti-2573	120	23	diabetes	diabetes	NOUN
dti-2573	120	24	less	less	ADJ
dti-2573	120	25	than	than	ADP
dti-2573	120	26	40	40	NUM
dti-2573	120	27	years	year	NOUN
dti-2573	120	28	of	of	ADP
dti-2573	120	29	table	table	NOUN
dti-2573	120	30	ii	ii	NOUN
dti-2573	120	31	factors	factor	NOUN
dti-2573	120	32	associated	associate	VERB
dti-2573	120	33	with	with	ADP
dti-2573	120	34	lung	lung	NOUN
dti-2573	120	35	cancer	cancer	NOUN
dti-2573	120	36	in	in	ADP
dti-2573	120	37	patients	patient	NOUN
dti-2573	120	38	with	with	ADP
dti-2573	120	39	hypertension	hypertension	NOUN
dti-2573	120	40	by	by	ADP
dti-2573	120	41	logistic	logistic	ADJ
dti-2573	120	42	regression	regression	NOUN
dti-2573	120	43	analysis	analysis	NOUN
dti-2573	120	44	factors	factor	NOUN
dti-2573	120	45	unadjusted	unadjuste	VERB
dti-2573	120	46	or	or	CCONJ
dti-2573	120	47	95	95	NUM
dti-2573	120	48	%	%	NOUN
dti-2573	120	49	ci	ci	NOUN
dti-2573	120	50	adjusted	adjust	VERB
dti-2573	120	51	or	or	CCONJ
dti-2573	120	52	95	95	NUM
dti-2573	120	53	%	%	NOUN
dti-2573	120	54	ci	ci	NOUN
dti-2573	120	55	smoking	smoke	VERB
dti-2573	120	56	0.97	0.97	NUM
dti-2573	120	57	0.53	0.53	NUM
dti-2573	120	58	,	,	PUNCT
dti-2573	120	59	1.79	1.79	NUM
dti-2573	120	60	1.03	1.03	NUM
dti-2573	120	61	0.53	0.53	NUM
dti-2573	120	62	,	,	PUNCT
dti-2573	120	63	2.01	2.01	NUM
dti-2573	120	64	dyslipidemia	dyslipidemia	NOUN
dti-2573	120	65	2.20	2.20	NUM
dti-2573	120	66	1.15	1.15	NUM
dti-2573	120	67	,	,	PUNCT
dti-2573	120	68	4.20	4.20	NUM
dti-2573	120	69	2.12	2.12	NUM
dti-2573	120	70	1.07	1.07	NUM
dti-2573	120	71	,	,	PUNCT
dti-2573	120	72	4.23	4.23	NUM
dti-2573	120	73	obstructive	obstructive	ADJ
dti-2573	120	74	sleep	sleep	NOUN
dti-2573	120	75	apnea	apnea	NOUN
dti-2573	120	76	8.44	8.44	NUM
dti-2573	120	77	0.96	0.96	NUM
dti-2573	120	78	,	,	PUNCT
dti-2573	120	79	73.84	73.84	NUM
dti-2573	120	80	7.50	7.50	NUM
dti-2573	120	81	0.79	0.79	NUM
dti-2573	120	82	,	,	PUNCT
dti-2573	120	83	71.17	71.17	NUM
dti-2573	120	84	family	family	NOUN
dti-2573	120	85	history	history	NOUN
dti-2573	120	86	of	of	ADP
dti-2573	120	87	lung	lung	NOUN
dti-2573	120	88	cancer	cancer	NOUN
dti-2573	120	89	20.48	20.48	NUM
dti-2573	120	90	2.58	2.58	NUM
dti-2573	120	91	,	,	PUNCT
dti-2573	120	92	162.61	162.61	NUM
dti-2573	120	93	22.43	22.43	NUM
dti-2573	120	94	2.76	2.76	NUM
dti-2573	120	95	,	,	PUNCT
dti-2573	120	96	182.36	182.36	NUM
dti-2573	120	97	calcium	calcium	NOUN
dti-2573	120	98	channel	channel	NOUN
dti-2573	120	99	blocker	blocker	NOUN
dti-2573	120	100	used	use	VERB
dti-2573	120	101	1.42	1.42	NUM
dti-2573	120	102	0.76	0.76	NUM
dti-2573	120	103	,	,	PUNCT
dti-2573	120	104	2.67	2.67	NUM
dti-2573	120	105	1.50	1.50	NUM
dti-2573	120	106	0.53	0.53	NUM
dti-2573	120	107	,	,	PUNCT
dti-2573	120	108	2.01	2.01	NUM
dti-2573	120	109	ci	ci	NOUN
dti-2573	120	110	=	=	NOUN
dti-2573	120	111	confidence	confidence	NOUN
dti-2573	120	112	interval	interval	NOUN
dti-2573	120	113	;	;	PUNCT
dti-2573	120	114	or	or	CCONJ
dti-2573	120	115	=	=	NOUN
dti-2573	120	116	odds	odd	NOUN
dti-2573	120	117	ratio	ratio	NOUN
dti-2573	120	118	.	.	PUNCT
dti-2573	121	1	https://doi.org/10.1038/s41581-019-0244-2	https://doi.org/10.1038/s41581-019-0244-2	NUM
dti-2573	121	2	https://www.ncbi.nlm.nih.gov/pubmed/32024986	https://www.ncbi.nlm.nih.gov/pubmed/32024986	PUNCT
dti-2573	122	1	https://doi.org/10.1016/s0140-6736(21)01330-1	https://doi.org/10.1016/s0140-6736(21)01330-1	PROPN
dti-2573	122	2	https://www.ncbi.nlm.nih.gov/pubmed/34450083	https://www.ncbi.nlm.nih.gov/pubmed/34450083	X
dti-2573	123	1	https://doi.org/10.1001/jama.289.19.2560	https://doi.org/10.1001/jama.289.19.2560	ADV
dti-2573	123	2	https://www.ncbi.nlm.nih.gov/pubmed/12748199	https://www.ncbi.nlm.nih.gov/pubmed/12748199	X
dti-2573	123	3	https://doi.org/10.4081/mrm.2021.777	https://doi.org/10.4081/mrm.2021.777	PROPN
dti-2573	123	4	https://www.ncbi.nlm.nih.gov/pubmed/34650797	https://www.ncbi.nlm.nih.gov/pubmed/34650797	PROPN
dti-2573	123	5	https://doi.org/10.14456/apst.2021.32	https://doi.org/10.14456/apst.2021.32	PROPN
dti-2573	123	6	https://doi.org/10.2147/cpaa.s285750	https://doi.org/10.2147/cpaa.s285750	PROPN
dti-2573	123	7	https://www.ncbi.nlm.nih.gov/pubmed/33707972	https://www.ncbi.nlm.nih.gov/pubmed/33707972	NUM
dti-2573	123	8	rattanathanoo	rattanathanoo	NOUN
dti-2573	123	9	et	et	PROPN
dti-2573	123	10	al	al	PROPN
dti-2573	123	11	drug	drug	PROPN
dti-2573	123	12	target	target	NOUN
dti-2573	123	13	insights	insight	NOUN
dti-2573	123	14	2023	2023	NUM
dti-2573	123	15	;	;	PUNCT
dti-2573	123	16	17	17	NUM
dti-2573	123	17	:	:	SYM
dti-2573	123	18	57	57	NUM
dti-2573	123	19	©	©	PROPN
dti-2573	123	20	2023	2023	NUM
dti-2573	123	21	the	the	DET
dti-2573	123	22	authors	author	NOUN
dti-2573	123	23	.	.	PUNCT
dti-2573	124	1	published	publish	VERB
dti-2573	124	2	by	by	ADP
dti-2573	124	3	aboutscience	aboutscience	NOUN
dti-2573	124	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2573	124	5	age	age	NOUN
dti-2573	124	6	.	.	PUNCT
dti-2573	125	1	diabetes	diabete	VERB
dti-2573	125	2	metab	metab	ADJ
dti-2573	125	3	syndr	syndr	NOUN
dti-2573	125	4	.	.	PUNCT
dti-2573	126	1	2020;14(6):1859	2020;14(6):1859	NUM
dti-2573	126	2	-	-	SYM
dti-2573	126	3	1863	1863	NUM
dti-2573	126	4	.	.	PUNCT
dti-2573	127	1	crossref	crossref	PROPN
dti-2573	127	2	pubmed	pubmed	PROPN
dti-2573	127	3	8	8	PROPN
dti-2573	127	4	.	.	PUNCT
dti-2573	128	1	khamsai	khamsai	PROPN
dti-2573	128	2	s	s	PROPN
dti-2573	128	3	,	,	PUNCT
dti-2573	128	4	chootrakool	chootrakool	VERB
dti-2573	128	5	a	a	PRON
dti-2573	128	6	,	,	PUNCT
dti-2573	128	7	limpawattana	limpawattana	NOUN
dti-2573	128	8	p	p	NOUN
dti-2573	128	9	,	,	PUNCT
dti-2573	128	10	et	et	PROPN
dti-2573	128	11	al	al	PROPN
dti-2573	128	12	.	.	PROPN
dti-2573	128	13	hypertensive	hypertensive	ADJ
dti-2573	128	14	crisis	crisis	NOUN
dti-2573	128	15	in	in	ADP
dti-2573	128	16	patients	patient	NOUN
dti-2573	128	17	with	with	ADP
dti-2573	128	18	obstructive	obstructive	ADJ
dti-2573	128	19	sleep	sleep	NOUN
dti-2573	128	20	apnea	apnea	NOUN
dti-2573	128	21	-	-	PUNCT
dti-2573	128	22	induced	induce	VERB
dti-2573	128	23	hypertension	hypertension	NOUN
dti-2573	128	24	.	.	PUNCT
dti-2573	129	1	bmc	bmc	PROPN
dti-2573	129	2	cardiovasc	cardiovasc	PROPN
dti-2573	129	3	disord	disord	PROPN
dti-2573	129	4	.	.	PUNCT
dti-2573	130	1	2021;21(1):310	2021;21(1):310	NUM
dti-2573	130	2	.	.	PUNCT
dti-2573	131	1	crossref	crossref	PROPN
dti-2573	131	2	pubmed	pubmed	PROPN
dti-2573	131	3	9	9	PROPN
dti-2573	131	4	.	.	PUNCT
dti-2573	132	1	james	james	PROPN
dti-2573	132	2	pa	pa	PROPN
dti-2573	132	3	,	,	PUNCT
dti-2573	132	4	oparil	oparil	NOUN
dti-2573	132	5	s	s	PART
dti-2573	132	6	,	,	PUNCT
dti-2573	132	7	carter	carter	PROPN
dti-2573	132	8	bl	bl	PROPN
dti-2573	132	9	,	,	PUNCT
dti-2573	132	10	et	et	PROPN
dti-2573	132	11	al	al	PROPN
dti-2573	132	12	.	.	PROPN
dti-2573	132	13	2014	2014	NUM
dti-2573	132	14	evidence	evidence	NOUN
dti-2573	132	15	-	-	PUNCT
dti-2573	132	16	based	base	VERB
dti-2573	132	17	guideline	guideline	NOUN
dti-2573	132	18	for	for	ADP
dti-2573	132	19	the	the	DET
dti-2573	132	20	management	management	NOUN
dti-2573	132	21	of	of	ADP
dti-2573	132	22	high	high	ADJ
dti-2573	132	23	blood	blood	NOUN
dti-2573	132	24	pressure	pressure	NOUN
dti-2573	132	25	in	in	ADP
dti-2573	132	26	adults	adult	NOUN
dti-2573	132	27	:	:	PUNCT
dti-2573	132	28	report	report	NOUN
dti-2573	132	29	from	from	ADP
dti-2573	132	30	the	the	DET
dti-2573	132	31	panel	panel	NOUN
dti-2573	132	32	members	member	NOUN
dti-2573	132	33	appointed	appoint	VERB
dti-2573	132	34	to	to	ADP
dti-2573	132	35	the	the	DET
dti-2573	132	36	eighth	eighth	ADJ
dti-2573	132	37	joint	joint	ADJ
dti-2573	132	38	national	national	PROPN
dti-2573	132	39	committee	committee	PROPN
dti-2573	132	40	(	(	PUNCT
dti-2573	132	41	jnc	jnc	PROPN
dti-2573	132	42	8)	8)	NUM
dti-2573	132	43	.	.	PUNCT
dti-2573	132	44	jama	jama	PROPN
dti-2573	132	45	.	.	PUNCT
dti-2573	133	1	2014;311(5):507	2014;311(5):507	NUM
dti-2573	133	2	-	-	SYM
dti-2573	133	3	520	520	NUM
dti-2573	133	4	.	.	PUNCT
dti-2573	134	1	crossref	crossref	PROPN
dti-2573	134	2	pubmed	pubmed	PROPN
dti-2573	134	3	10	10	PROPN
dti-2573	134	4	.	.	PUNCT
dti-2573	135	1	pahor	pahor	PROPN
dti-2573	135	2	m	m	PROPN
dti-2573	135	3	,	,	PUNCT
dti-2573	135	4	guralnik	guralnik	PROPN
dti-2573	135	5	jm	jm	PROPN
dti-2573	135	6	,	,	PUNCT
dti-2573	135	7	salive	salive	VERB
dti-2573	135	8	me	i	PRON
dti-2573	135	9	,	,	PUNCT
dti-2573	135	10	corti	corti	PROPN
dti-2573	135	11	mc	mc	PROPN
dti-2573	135	12	,	,	PUNCT
dti-2573	135	13	carbonin	carbonin	VERB
dti-2573	135	14	p	p	X
dti-2573	135	15	,	,	PUNCT
dti-2573	135	16	havlik	havlik	PROPN
dti-2573	135	17	rj	rj	PROPN
dti-2573	135	18	.	.	PROPN
dti-2573	136	1	do	do	AUX
dti-2573	136	2	calcium	calcium	NOUN
dti-2573	136	3	channel	channel	NOUN
dti-2573	136	4	blockers	blocker	NOUN
dti-2573	136	5	increase	increase	VERB
dti-2573	136	6	the	the	DET
dti-2573	136	7	risk	risk	NOUN
dti-2573	136	8	of	of	ADP
dti-2573	136	9	cancer	cancer	NOUN
dti-2573	136	10	?	?	PUNCT
dti-2573	137	1	am	be	AUX
dti-2573	137	2	j	j	PROPN
dti-2573	137	3	hypertens	hyperten	NOUN
dti-2573	137	4	.	.	PUNCT
dti-2573	138	1	1996;9(7):695	1996;9(7):695	X
dti-2573	138	2	-	-	SYM
dti-2573	138	3	699	699	NUM
dti-2573	138	4	.	.	PUNCT
dti-2573	139	1	crossref	crossref	PROPN
dti-2573	139	2	pubmed	pubmed	PROPN
dti-2573	139	3	11	11	NUM
dti-2573	139	4	.	.	PUNCT
dti-2573	140	1	azoulay	azoulay	VERB
dti-2573	140	2	l	l	NOUN
dti-2573	140	3	,	,	PUNCT
dti-2573	140	4	assimes	assime	NOUN
dti-2573	140	5	tl	tl	PROPN
dti-2573	140	6	,	,	PUNCT
dti-2573	140	7	yin	yin	PROPN
dti-2573	140	8	h	h	PROPN
dti-2573	140	9	,	,	PUNCT
dti-2573	140	10	bartels	bartels	PROPN
dti-2573	140	11	db	db	PROPN
dti-2573	140	12	,	,	PUNCT
dti-2573	140	13	schiffrin	schiffrin	PROPN
dti-2573	140	14	el	el	PROPN
dti-2573	140	15	,	,	PUNCT
dti-2573	140	16	suissa	suissa	PROPN
dti-2573	140	17	s.	s.	PROPN
dti-2573	140	18	long	long	ADJ
dti-2573	140	19	-	-	PUNCT
dti-2573	140	20	term	term	NOUN
dti-2573	140	21	use	use	NOUN
dti-2573	140	22	of	of	ADP
dti-2573	140	23	angiotensin	angiotensin	NOUN
dti-2573	140	24	receptor	receptor	NOUN
dti-2573	140	25	blockers	blocker	NOUN
dti-2573	140	26	and	and	CCONJ
dti-2573	140	27	the	the	DET
dti-2573	140	28	risk	risk	NOUN
dti-2573	140	29	of	of	ADP
dti-2573	140	30	cancer	cancer	NOUN
dti-2573	140	31	.	.	PUNCT
dti-2573	141	1	plos	plos	PROPN
dti-2573	141	2	one	one	NUM
dti-2573	141	3	.	.	PUNCT
dti-2573	142	1	2012;7(12):e50893	2012;7(12):e50893	NOUN
dti-2573	142	2	.	.	PUNCT
dti-2573	143	1	crossref	crossref	PROPN
dti-2573	143	2	pubmed	pubmed	PROPN
dti-2573	143	3	12	12	NUM
dti-2573	143	4	.	.	PUNCT
dti-2573	144	1	rotshild	rotshild	PROPN
dti-2573	144	2	v	v	NOUN
dti-2573	144	3	,	,	PUNCT
dti-2573	144	4	azoulay	azoulay	VERB
dti-2573	144	5	l	l	NOUN
dti-2573	144	6	,	,	PUNCT
dti-2573	144	7	feldhamer	feldhamer	PROPN
dti-2573	144	8	i	i	PRON
dti-2573	144	9	,	,	PUNCT
dti-2573	144	10	et	et	PROPN
dti-2573	144	11	al	al	PROPN
dti-2573	144	12	.	.	PROPN
dti-2573	144	13	calcium	calcium	NOUN
dti-2573	144	14	channel	channel	NOUN
dti-2573	144	15	blockers	blocker	NOUN
dti-2573	144	16	and	and	CCONJ
dti-2573	144	17	the	the	DET
dti-2573	144	18	risk	risk	NOUN
dti-2573	144	19	for	for	ADP
dti-2573	144	20	lung	lung	NOUN
dti-2573	144	21	cancer	cancer	NOUN
dti-2573	144	22	:	:	PUNCT
dti-2573	144	23	a	a	DET
dti-2573	144	24	population	population	NOUN
dti-2573	144	25	-	-	PUNCT
dti-2573	144	26	based	base	VERB
dti-2573	144	27	nested	nested	ADJ
dti-2573	144	28	case	case	NOUN
dti-2573	144	29	-	-	PUNCT
dti-2573	144	30	control	control	NOUN
dti-2573	144	31	study	study	NOUN
dti-2573	144	32	.	.	PUNCT
dti-2573	145	1	ann	ann	PROPN
dti-2573	145	2	pharmacother	pharmacother	PROPN
dti-2573	145	3	.	.	PUNCT
dti-2573	146	1	2019;53(5):445	2019;53(5):445	NUM
dti-2573	146	2	-	-	SYM
dti-2573	146	3	452	452	NUM
dti-2573	146	4	.	.	PUNCT
dti-2573	147	1	crossref	crossref	PROPN
dti-2573	147	2	pubmed	pubmed	PROPN
dti-2573	147	3	13	13	NUM
dti-2573	147	4	.	.	PUNCT
dti-2573	148	1	rotshild	rotshild	PROPN
dti-2573	148	2	v	v	NOUN
dti-2573	148	3	,	,	PUNCT
dti-2573	148	4	azoulay	azoulay	VERB
dti-2573	148	5	l	l	NOUN
dti-2573	148	6	,	,	PUNCT
dti-2573	148	7	zarifeh	zarifeh	PROPN
dti-2573	148	8	m	m	PROPN
dti-2573	148	9	,	,	PUNCT
dti-2573	148	10	et	et	PROPN
dti-2573	148	11	al	al	PROPN
dti-2573	148	12	.	.	PUNCT
dti-2573	149	1	the	the	DET
dti-2573	149	2	risk	risk	NOUN
dti-2573	149	3	for	for	ADP
dti-2573	149	4	lung	lung	NOUN
dti-2573	149	5	cancer	cancer	NOUN
dti-2573	149	6	incidence	incidence	NOUN
dti-2573	149	7	with	with	ADP
dti-2573	149	8	calcium	calcium	NOUN
dti-2573	149	9	channel	channel	NOUN
dti-2573	149	10	blockers	blocker	NOUN
dti-2573	149	11	:	:	PUNCT
dti-2573	149	12	a	a	DET
dti-2573	149	13	systematic	systematic	ADJ
dti-2573	149	14	review	review	NOUN
dti-2573	149	15	and	and	CCONJ
dti-2573	149	16	meta	meta	ADJ
dti-2573	149	17	-	-	PUNCT
dti-2573	149	18	analysis	analysis	NOUN
dti-2573	149	19	of	of	ADP
dti-2573	149	20	observational	observational	ADJ
dti-2573	149	21	studies	study	NOUN
dti-2573	149	22	.	.	PUNCT
dti-2573	150	1	drug	drug	PROPN
dti-2573	150	2	saf	saf	PROPN
dti-2573	150	3	.	.	PUNCT
dti-2573	151	1	2018;41(6):555564	2018;41(6):555564	NUM
dti-2573	151	2	.	.	PUNCT
dti-2573	152	1	crossref	crossref	PROPN
dti-2573	152	2	pubmed	pubmed	PROPN
dti-2573	152	3	14	14	NUM
dti-2573	152	4	.	.	PUNCT
dti-2573	153	1	hole	hole	NOUN
dti-2573	153	2	dj	dj	PROPN
dti-2573	153	3	,	,	PUNCT
dti-2573	153	4	gillis	gillis	PROPN
dti-2573	153	5	cr	cr	PROPN
dti-2573	153	6	,	,	PUNCT
dti-2573	153	7	mccallum	mccallum	PROPN
dti-2573	153	8	ir	ir	PROPN
dti-2573	153	9	,	,	PUNCT
dti-2573	153	10	et	et	PROPN
dti-2573	153	11	al	al	PROPN
dti-2573	153	12	.	.	PUNCT
dti-2573	154	1	cancer	cancer	NOUN
dti-2573	154	2	risk	risk	NOUN
dti-2573	154	3	of	of	ADP
dti-2573	154	4	hypertensive	hypertensive	ADJ
dti-2573	154	5	patients	patient	NOUN
dti-2573	154	6	taking	take	VERB
dti-2573	154	7	calcium	calcium	NOUN
dti-2573	154	8	antagonists	antagonist	NOUN
dti-2573	154	9	.	.	PUNCT
dti-2573	155	1	j	j	PROPN
dti-2573	155	2	hypertens	hypertens	PROPN
dti-2573	155	3	.	.	PUNCT
dti-2573	156	1	1998	1998	NUM
dti-2573	156	2	;	;	PUNCT
dti-2573	156	3	16(1):119	16(1):119	PROPN
dti-2573	156	4	-	-	SYM
dti-2573	156	5	124	124	NUM
dti-2573	156	6	.	.	PUNCT
dti-2573	157	1	crossref	crossref	PROPN
dti-2573	157	2	pubmed	pubmed	PROPN
dti-2573	157	3	15	15	PROPN
dti-2573	157	4	.	.	PUNCT
dti-2573	158	1	michels	michels	PROPN
dti-2573	158	2	kb	kb	PROPN
dti-2573	158	3	,	,	PUNCT
dti-2573	158	4	rosner	rosner	PROPN
dti-2573	158	5	ba	ba	PROPN
dti-2573	158	6	,	,	PUNCT
dti-2573	158	7	walker	walker	PROPN
dti-2573	158	8	am	am	PROPN
dti-2573	158	9	,	,	PUNCT
dti-2573	158	10	et	et	PROPN
dti-2573	158	11	al	al	PROPN
dti-2573	158	12	.	.	PROPN
dti-2573	158	13	calcium	calcium	NOUN
dti-2573	158	14	channel	channel	NOUN
dti-2573	158	15	blockers	blocker	NOUN
dti-2573	158	16	,	,	PUNCT
dti-2573	158	17	cancer	cancer	NOUN
dti-2573	158	18	incidence	incidence	NOUN
dti-2573	158	19	,	,	PUNCT
dti-2573	158	20	and	and	CCONJ
dti-2573	158	21	cancer	cancer	NOUN
dti-2573	158	22	mortality	mortality	NOUN
dti-2573	158	23	in	in	ADP
dti-2573	158	24	a	a	DET
dti-2573	158	25	cohort	cohort	NOUN
dti-2573	158	26	of	of	ADP
dti-2573	158	27	u.s	u.s	PROPN
dti-2573	158	28	.	.	PROPN
dti-2573	158	29	women	woman	NOUN
dti-2573	158	30	:	:	PUNCT
dti-2573	158	31	the	the	DET
dti-2573	158	32	nurses	nurse	NOUN
dti-2573	158	33	’	'	PUNCT
dti-2573	158	34	health	health	NOUN
dti-2573	158	35	study	study	NOUN
dti-2573	158	36	.	.	PUNCT
dti-2573	159	1	cancer	cancer	NOUN
dti-2573	159	2	.	.	PUNCT
dti-2573	160	1	1998;83(9):20032007	1998;83(9):20032007	X
dti-2573	160	2	.	.	PUNCT
dti-2573	161	1	crossref	crossref	PROPN
dti-2573	161	2	pubmed	pubmed	PROPN
dti-2573	161	3	16	16	NUM
dti-2573	161	4	.	.	PUNCT
dti-2573	162	1	yang	yang	PROPN
dti-2573	162	2	r	r	PROPN
dti-2573	162	3	,	,	PUNCT
dti-2573	162	4	zhang	zhang	PROPN
dti-2573	162	5	y	y	PROPN
dti-2573	162	6	,	,	PUNCT
dti-2573	162	7	liao	liao	PROPN
dti-2573	162	8	x	x	PROPN
dti-2573	162	9	,	,	PUNCT
dti-2573	162	10	yao	yao	PROPN
dti-2573	162	11	y	y	PROPN
dti-2573	162	12	,	,	PUNCT
dti-2573	162	13	huang	huang	PROPN
dti-2573	162	14	c	c	PROPN
dti-2573	162	15	,	,	PUNCT
dti-2573	162	16	liu	liu	PROPN
dti-2573	162	17	l.	l.	PROPN
dti-2573	162	18	the	the	DET
dti-2573	162	19	relationship	relationship	NOUN
dti-2573	162	20	between	between	ADP
dti-2573	162	21	anti	anti	ADJ
dti-2573	162	22	-	-	ADJ
dti-2573	162	23	hypertensive	hypertensive	ADJ
dti-2573	162	24	drugs	drug	NOUN
dti-2573	162	25	and	and	CCONJ
dti-2573	162	26	cancer	cancer	NOUN
dti-2573	162	27	:	:	PUNCT
dti-2573	162	28	anxiety	anxiety	NOUN
dti-2573	162	29	to	to	PART
dti-2573	162	30	be	be	AUX
dti-2573	162	31	resolved	resolve	VERB
dti-2573	162	32	in	in	ADP
dti-2573	162	33	urgent	urgent	ADJ
dti-2573	162	34	.	.	PUNCT
dti-2573	163	1	front	front	ADJ
dti-2573	163	2	pharmacol	pharmacol	PROPN
dti-2573	163	3	.	.	PUNCT
dti-2573	164	1	2020;11:610157	2020;11:610157	NUM
dti-2573	164	2	.	.	PUNCT
dti-2573	165	1	crossref	crossref	PROPN
dti-2573	165	2	pubmed	pubmed	PROPN
dti-2573	165	3	17	17	NUM
dti-2573	165	4	.	.	PUNCT
dti-2573	166	1	mason	mason	PROPN
dti-2573	166	2	rp	rp	PROPN
dti-2573	166	3	.	.	PROPN
dti-2573	166	4	calcium	calcium	NOUN
dti-2573	166	5	channel	channel	NOUN
dti-2573	166	6	blockers	blocker	NOUN
dti-2573	166	7	,	,	PUNCT
dti-2573	166	8	apoptosis	apoptosis	NOUN
dti-2573	166	9	and	and	CCONJ
dti-2573	166	10	cancer	cancer	NOUN
dti-2573	166	11	:	:	PUNCT
dti-2573	166	12	is	be	AUX
dti-2573	166	13	there	there	PRON
dti-2573	166	14	a	a	DET
dti-2573	166	15	biologic	biologic	NOUN
dti-2573	166	16	relationship	relationship	NOUN
dti-2573	166	17	?	?	PUNCT
dti-2573	167	1	j	j	PROPN
dti-2573	167	2	am	be	AUX
dti-2573	167	3	coll	coll	PROPN
dti-2573	167	4	cardiol	cardiol	NOUN
dti-2573	167	5	.	.	PUNCT
dti-2573	168	1	1999;34(7	1999;34(7	NUM
dti-2573	168	2	):	):	PUNCT
dti-2573	168	3	1857	1857	NUM
dti-2573	168	4	-	-	SYM
dti-2573	168	5	1866	1866	NUM
dti-2573	168	6	.	.	PUNCT
dti-2573	169	1	crossref	crossref	PROPN
dti-2573	169	2	pubmed	pubmed	PROPN
dti-2573	169	3	18	18	NUM
dti-2573	169	4	.	.	PUNCT
dti-2573	170	1	jick	jick	PROPN
dti-2573	170	2	h	h	PROPN
dti-2573	170	3	,	,	PUNCT
dti-2573	170	4	jick	jick	PROPN
dti-2573	170	5	s	s	PROPN
dti-2573	170	6	,	,	PUNCT
dti-2573	170	7	derby	derby	PROPN
dti-2573	170	8	le	le	PROPN
dti-2573	170	9	,	,	PUNCT
dti-2573	170	10	vasilakis	vasilaki	NOUN
dti-2573	170	11	c	c	NOUN
dti-2573	170	12	,	,	PUNCT
dti-2573	170	13	myers	myers	PROPN
dti-2573	170	14	mw	mw	PROPN
dti-2573	170	15	,	,	PUNCT
dti-2573	170	16	meier	meier	PROPN
dti-2573	170	17	cr	cr	PROPN
dti-2573	170	18	.	.	PUNCT
dti-2573	171	1	calciumchannel	calciumchannel	PROPN
dti-2573	171	2	blockers	blocker	NOUN
dti-2573	171	3	and	and	CCONJ
dti-2573	171	4	risk	risk	NOUN
dti-2573	171	5	of	of	ADP
dti-2573	171	6	cancer	cancer	NOUN
dti-2573	171	7	.	.	PUNCT
dti-2573	172	1	lancet	lancet	NOUN
dti-2573	172	2	.	.	PUNCT
dti-2573	173	1	1997;349(9051	1997;349(9051	NUM
dti-2573	173	2	):	):	PUNCT
dti-2573	173	3	525	525	NUM
dti-2573	173	4	-	-	SYM
dti-2573	173	5	528	528	NUM
dti-2573	173	6	.	.	PUNCT
dti-2573	174	1	crossref	crossref	PROPN
dti-2573	174	2	pubmed	pubmed	PROPN
dti-2573	174	3	19	19	NUM
dti-2573	174	4	.	.	PUNCT
dti-2573	175	1	boo	boo	VERB
dti-2573	175	2	h	h	PROPN
dti-2573	175	3	-	-	PUNCT
dti-2573	175	4	j	j	PROPN
dti-2573	175	5	,	,	PUNCT
dti-2573	175	6	min	min	PROPN
dti-2573	175	7	h	h	PROPN
dti-2573	175	8	-	-	PUNCT
dti-2573	175	9	y	y	PROPN
dti-2573	175	10	,	,	PUNCT
dti-2573	175	11	jang	jang	PROPN
dti-2573	175	12	h	h	PROPN
dti-2573	175	13	-	-	PUNCT
dti-2573	175	14	j	j	PROPN
dti-2573	175	15	,	,	PUNCT
dti-2573	175	16	et	et	PROPN
dti-2573	175	17	al	al	PROPN
dti-2573	175	18	.	.	PUNCT
dti-2573	176	1	the	the	DET
dti-2573	176	2	tobacco	tobacco	NOUN
dti-2573	176	3	-	-	PUNCT
dti-2573	176	4	specific	specific	ADJ
dti-2573	176	5	carcinogen	carcinogen	NOUN
dti-2573	176	6	-	-	PUNCT
dti-2573	176	7	operated	operate	VERB
dti-2573	176	8	calcium	calcium	NOUN
dti-2573	176	9	channel	channel	NOUN
dti-2573	176	10	promotes	promote	VERB
dti-2573	176	11	lung	lung	NOUN
dti-2573	176	12	tumorigenesis	tumorigenesis	NOUN
dti-2573	176	13	via	via	ADP
dti-2573	176	14	igf2	igf2	PROPN
dti-2573	176	15	exocytosis	exocytosis	NOUN
dti-2573	176	16	in	in	ADP
dti-2573	176	17	lung	lung	NOUN
dti-2573	176	18	epithelial	epithelial	ADJ
dti-2573	176	19	cells	cell	NOUN
dti-2573	176	20	.	.	PUNCT
dti-2573	177	1	nat	nat	PROPN
dti-2573	177	2	commun	commun	PROPN
dti-2573	177	3	.	.	PUNCT
dti-2573	178	1	2016;7(1):12961	2016;7(1):12961	X
dti-2573	178	2	.	.	PUNCT
dti-2573	178	3	crossref	crossref	PROPN
dti-2573	178	4	pubmed	pubmed	PROPN
dti-2573	178	5	20	20	PROPN
dti-2573	178	6	.	.	PUNCT
dti-2573	179	1	carboni	carboni	PROPN
dti-2573	179	2	gl	gl	PROPN
dti-2573	179	3	,	,	PUNCT
dti-2573	179	4	gao	gao	PROPN
dti-2573	179	5	b	b	PROPN
dti-2573	179	6	,	,	PUNCT
dti-2573	179	7	nishizaki	nishizaki	ADJ
dti-2573	179	8	m	m	PROPN
dti-2573	179	9	,	,	PUNCT
dti-2573	179	10	et	et	PROPN
dti-2573	179	11	al	al	PROPN
dti-2573	179	12	.	.	PUNCT
dti-2573	180	1	cacna2d2	cacna2d2	ADV
dti-2573	180	2	-	-	PUNCT
dti-2573	180	3	mediated	mediate	VERB
dti-2573	180	4	apoptosis	apoptosis	NOUN
dti-2573	180	5	in	in	ADP
dti-2573	180	6	nsclc	nsclc	NOUN
dti-2573	180	7	cells	cell	NOUN
dti-2573	180	8	is	be	AUX
dti-2573	180	9	associated	associate	VERB
dti-2573	180	10	with	with	ADP
dti-2573	180	11	alterations	alteration	NOUN
dti-2573	180	12	of	of	ADP
dti-2573	180	13	the	the	DET
dti-2573	180	14	intracellular	intracellular	ADJ
dti-2573	180	15	calcium	calcium	NOUN
dti-2573	180	16	signaling	signal	VERB
dti-2573	180	17	and	and	CCONJ
dti-2573	180	18	disruption	disruption	NOUN
dti-2573	180	19	of	of	ADP
dti-2573	180	20	mitochondria	mitochondria	ADJ
dti-2573	180	21	membrane	membrane	NOUN
dti-2573	180	22	integrity	integrity	NOUN
dti-2573	180	23	.	.	PUNCT
dti-2573	181	1	oncogene	oncogene	NOUN
dti-2573	181	2	.	.	PUNCT
dti-2573	182	1	2003;22(4):615	2003;22(4):615	NUM
dti-2573	182	2	-	-	PUNCT
dti-2573	182	3	626	626	NUM
dti-2573	182	4	.	.	PUNCT
dti-2573	183	1	crossref	crossref	PROPN
dti-2573	183	2	pubmed	pubmed	PROPN
dti-2573	183	3	21	21	NUM
dti-2573	183	4	.	.	PUNCT
dti-2573	184	1	li	li	PROPN
dti-2573	184	2	j	j	PROPN
dti-2573	184	3	,	,	PUNCT
dti-2573	184	4	lam	lam	PROPN
dti-2573	184	5	asm	asm	PROPN
dti-2573	184	6	,	,	PUNCT
dti-2573	184	7	yau	yau	PROPN
dti-2573	184	8	sty	sty	PROPN
dti-2573	184	9	,	,	PUNCT
dti-2573	184	10	yiu	yiu	PROPN
dti-2573	184	11	kkl	kkl	PROPN
dti-2573	184	12	,	,	PUNCT
dti-2573	184	13	tsoi	tsoi	PROPN
dti-2573	184	14	kkf	kkf	PROPN
dti-2573	184	15	.	.	PUNCT
dti-2573	185	1	antihypertensive	antihypertensive	ADJ
dti-2573	185	2	treatments	treatment	NOUN
dti-2573	185	3	and	and	CCONJ
dti-2573	185	4	risks	risk	NOUN
dti-2573	185	5	of	of	ADP
dti-2573	185	6	lung	lung	NOUN
dti-2573	185	7	cancer	cancer	NOUN
dti-2573	185	8	:	:	PUNCT
dti-2573	185	9	a	a	DET
dti-2573	185	10	large	large	ADJ
dti-2573	185	11	population	population	NOUN
dti-2573	185	12	-	-	PUNCT
dti-2573	185	13	based	base	VERB
dti-2573	185	14	cohort	cohort	NOUN
dti-2573	185	15	study	study	NOUN
dti-2573	185	16	in	in	ADP
dti-2573	185	17	hong	hong	PROPN
dti-2573	185	18	kong	kong	PROPN
dti-2573	185	19	.	.	PUNCT
dti-2573	186	1	bmc	bmc	ADJ
dti-2573	186	2	cancer	cancer	NOUN
dti-2573	186	3	.	.	PUNCT
dti-2573	187	1	2021;21(1):1202	2021;21(1):1202	PROPN
dti-2573	187	2	.	.	PUNCT
dti-2573	188	1	crossref	crossref	PROPN
dti-2573	188	2	pubmed	pubmed	PROPN
dti-2573	188	3	22	22	NUM
dti-2573	188	4	.	.	PUNCT
dti-2573	189	1	hao	hao	PROPN
dti-2573	189	2	b	b	PROPN
dti-2573	189	3	,	,	PUNCT
dti-2573	189	4	yu	yu	PROPN
dti-2573	189	5	m	m	PROPN
dti-2573	189	6	,	,	PUNCT
dti-2573	189	7	sang	sing	VERB
dti-2573	189	8	c	c	NOUN
dti-2573	189	9	,	,	PUNCT
dti-2573	189	10	bi	bi	PROPN
dti-2573	189	11	b	b	PROPN
dti-2573	189	12	,	,	PUNCT
dti-2573	189	13	chen	chen	PROPN
dti-2573	189	14	j.	j.	PROPN
dti-2573	189	15	dyslipidemia	dyslipidemia	PROPN
dti-2573	189	16	and	and	CCONJ
dti-2573	189	17	non	non	ADJ
dti-2573	189	18	-	-	ADJ
dti-2573	189	19	small	small	ADJ
dti-2573	189	20	cell	cell	NOUN
dti-2573	189	21	lung	lung	NOUN
dti-2573	189	22	cancer	cancer	NOUN
dti-2573	189	23	risk	risk	NOUN
dti-2573	189	24	in	in	ADP
dti-2573	189	25	chinese	chinese	ADJ
dti-2573	189	26	population	population	NOUN
dti-2573	189	27	:	:	PUNCT
dti-2573	189	28	a	a	DET
dti-2573	189	29	case	case	NOUN
dti-2573	189	30	-	-	PUNCT
dti-2573	189	31	control	control	NOUN
dti-2573	189	32	study	study	NOUN
dti-2573	189	33	.	.	PUNCT
dti-2573	190	1	lipids	lipids	ADP
dti-2573	190	2	health	health	NOUN
dti-2573	190	3	dis	dis	PROPN
dti-2573	190	4	.	.	PUNCT
dti-2573	191	1	2018;17(1):278	2018;17(1):278	PROPN
dti-2573	191	2	.	.	PUNCT
dti-2573	192	1	crossref	crossref	PROPN
dti-2573	192	2	pubmed	pubmed	PROPN
dti-2573	192	3	23	23	NUM
dti-2573	192	4	.	.	PUNCT
dti-2573	193	1	su	su	PROPN
dti-2573	193	2	f	f	PROPN
dti-2573	193	3	,	,	PUNCT
dti-2573	193	4	grijalva	grijalva	PROPN
dti-2573	193	5	v	v	PROPN
dti-2573	193	6	,	,	PUNCT
dti-2573	193	7	navab	navab	PROPN
dti-2573	193	8	k	k	PROPN
dti-2573	193	9	,	,	PUNCT
dti-2573	193	10	et	et	PROPN
dti-2573	193	11	al	al	PROPN
dti-2573	193	12	.	.	PROPN
dti-2573	194	1	hdl	hdl	PROPN
dti-2573	194	2	mimetics	mimetics	PROPN
dti-2573	194	3	inhibit	inhibit	VERB
dti-2573	194	4	tumor	tumor	NOUN
dti-2573	194	5	development	development	NOUN
dti-2573	194	6	in	in	ADP
dti-2573	194	7	both	both	CCONJ
dti-2573	194	8	induced	induced	ADJ
dti-2573	194	9	and	and	CCONJ
dti-2573	194	10	spontaneous	spontaneous	ADJ
dti-2573	194	11	mouse	mouse	NOUN
dti-2573	194	12	models	model	NOUN
dti-2573	194	13	of	of	ADP
dti-2573	194	14	colon	colon	NOUN
dti-2573	194	15	cancer	cancer	NOUN
dti-2573	194	16	.	.	PUNCT
dti-2573	195	1	mol	mol	ADP
dti-2573	195	2	cancer	cancer	NOUN
dti-2573	195	3	ther	ther	ADV
dti-2573	195	4	.	.	PUNCT
dti-2573	196	1	2012;11(6):1311	2012;11(6):1311	NUM
dti-2573	196	2	-	-	SYM
dti-2573	196	3	1319	1319	NUM
dti-2573	196	4	.	.	PUNCT
dti-2573	197	1	crossref	crossref	PROPN
dti-2573	197	2	pubmed	pubmed	PROPN
dti-2573	197	3	24	24	NUM
dti-2573	197	4	.	.	PUNCT
dti-2573	198	1	wolfe	wolfe	PROPN
dti-2573	198	2	ar	ar	PROPN
dti-2573	198	3	,	,	PUNCT
dti-2573	198	4	atkinson	atkinson	PROPN
dti-2573	198	5	rl	rl	PROPN
dti-2573	198	6	,	,	PUNCT
dti-2573	198	7	reddy	reddy	PROPN
dti-2573	198	8	jp	jp	PROPN
dti-2573	198	9	,	,	PUNCT
dti-2573	198	10	et	et	PROPN
dti-2573	198	11	al	al	PROPN
dti-2573	198	12	.	.	PROPN
dti-2573	198	13	high	high	ADJ
dti-2573	198	14	-	-	PUNCT
dti-2573	198	15	density	density	NOUN
dti-2573	198	16	and	and	CCONJ
dti-2573	198	17	verylow	verylow	ADJ
dti-2573	198	18	-	-	PUNCT
dti-2573	198	19	density	density	NOUN
dti-2573	198	20	lipoprotein	lipoprotein	NOUN
dti-2573	198	21	have	have	AUX
dti-2573	198	22	opposing	oppose	VERB
dti-2573	198	23	roles	role	NOUN
dti-2573	198	24	in	in	ADP
dti-2573	198	25	regulating	regulate	VERB
dti-2573	198	26	tumor	tumor	NOUN
dti-2573	198	27	-	-	PUNCT
dti-2573	198	28	initiating	initiate	VERB
dti-2573	198	29	cells	cell	NOUN
dti-2573	198	30	and	and	CCONJ
dti-2573	198	31	sensitivity	sensitivity	NOUN
dti-2573	198	32	to	to	ADP
dti-2573	198	33	radiation	radiation	NOUN
dti-2573	198	34	in	in	ADP
dti-2573	198	35	inflammatory	inflammatory	ADJ
dti-2573	198	36	breast	breast	NOUN
dti-2573	198	37	cancer	cancer	NOUN
dti-2573	198	38	.	.	PUNCT
dti-2573	199	1	int	int	PROPN
dti-2573	199	2	j	j	PROPN
dti-2573	199	3	radiat	radiat	PROPN
dti-2573	199	4	oncol	oncol	ADJ
dti-2573	199	5	biol	biol	PROPN
dti-2573	199	6	phys	phy	NOUN
dti-2573	199	7	.	.	PUNCT
dti-2573	200	1	2015;91(5):10721080	2015;91(5):10721080	NUM
dti-2573	200	2	.	.	PUNCT
dti-2573	201	1	crossref	crossref	PROPN
dti-2573	201	2	pubmed	pubmed	PROPN
dti-2573	201	3	25	25	NUM
dti-2573	201	4	.	.	PUNCT
dti-2573	202	1	lissowska	lissowska	PROPN
dti-2573	202	2	j	j	PROPN
dti-2573	202	3	,	,	PUNCT
dti-2573	202	4	foretova	foretova	NOUN
dti-2573	202	5	l	l	NOUN
dti-2573	202	6	,	,	PUNCT
dti-2573	202	7	dabek	dabek	PROPN
dti-2573	202	8	j	j	PROPN
dti-2573	202	9	,	,	PUNCT
dti-2573	202	10	et	et	PROPN
dti-2573	202	11	al	al	PROPN
dti-2573	202	12	.	.	PUNCT
dti-2573	202	13	family	family	NOUN
dti-2573	202	14	history	history	NOUN
dti-2573	202	15	and	and	CCONJ
dti-2573	202	16	lung	lung	NOUN
dti-2573	202	17	cancer	cancer	NOUN
dti-2573	202	18	risk	risk	NOUN
dti-2573	202	19	:	:	PUNCT
dti-2573	202	20	international	international	ADJ
dti-2573	202	21	multicentre	multicentre	NOUN
dti-2573	202	22	case	case	NOUN
dti-2573	202	23	-	-	PUNCT
dti-2573	202	24	control	control	NOUN
dti-2573	202	25	study	study	NOUN
dti-2573	202	26	in	in	ADP
dti-2573	202	27	eastern	eastern	ADJ
dti-2573	202	28	and	and	CCONJ
dti-2573	202	29	central	central	ADJ
dti-2573	202	30	europe	europe	PROPN
dti-2573	202	31	and	and	CCONJ
dti-2573	202	32	meta	meta	NOUN
dti-2573	202	33	-	-	PUNCT
dti-2573	202	34	analyses	analysis	NOUN
dti-2573	202	35	.	.	PUNCT
dti-2573	203	1	cancer	cancer	NOUN
dti-2573	203	2	causes	cause	VERB
dti-2573	203	3	control	control	NOUN
dti-2573	203	4	.	.	PUNCT
dti-2573	204	1	2010;21(7):1091	2010;21(7):1091	NOUN
dti-2573	204	2	-	-	PUNCT
dti-2573	204	3	1104	1104	NUM
dti-2573	204	4	.	.	PUNCT
dti-2573	205	1	crossref	crossref	PROPN
dti-2573	205	2	pubmed	pubmed	PROPN
dti-2573	205	3	26	26	NUM
dti-2573	205	4	.	.	PUNCT
dti-2573	206	1	yin	yin	PROPN
dti-2573	207	1	x	x	PROPN
dti-2573	207	2	,	,	PUNCT
dti-2573	207	3	chan	chan	PROPN
dti-2573	207	4	cpy	cpy	PROPN
dti-2573	207	5	,	,	PUNCT
dti-2573	207	6	seow	seow	PROPN
dti-2573	207	7	a	a	PROPN
dti-2573	207	8	,	,	PUNCT
dti-2573	207	9	yau	yau	PROPN
dti-2573	207	10	w	w	PROPN
dti-2573	207	11	-	-	PUNCT
dti-2573	207	12	p	p	X
dti-2573	207	13	,	,	PUNCT
dti-2573	207	14	seow	seow	PROPN
dti-2573	207	15	wj	wj	PROPN
dti-2573	207	16	.	.	PUNCT
dti-2573	207	17	association	association	PROPN
dti-2573	207	18	between	between	ADP
dti-2573	207	19	family	family	NOUN
dti-2573	207	20	history	history	NOUN
dti-2573	207	21	and	and	CCONJ
dti-2573	207	22	lung	lung	NOUN
dti-2573	207	23	cancer	cancer	NOUN
dti-2573	207	24	risk	risk	NOUN
dti-2573	207	25	among	among	ADP
dti-2573	207	26	chinese	chinese	ADJ
dti-2573	207	27	women	woman	NOUN
dti-2573	207	28	in	in	ADP
dti-2573	207	29	singapore	singapore	PROPN
dti-2573	207	30	.	.	PUNCT
dti-2573	208	1	sci	sci	PROPN
dti-2573	208	2	rep	rep	PROPN
dti-2573	208	3	.	.	PROPN
dti-2573	208	4	2021;11(1):21862	2021;11(1):21862	NUM
dti-2573	208	5	.	.	PUNCT
dti-2573	209	1	crossref	crossref	PROPN
dti-2573	209	2	pubmed	pubmed	PROPN
dti-2573	209	3	27	27	NUM
dti-2573	209	4	.	.	PUNCT
dti-2573	210	1	kanwal	kanwal	PROPN
dti-2573	210	2	m	m	PROPN
dti-2573	210	3	,	,	PUNCT
dti-2573	210	4	ding	de	VERB
dti-2573	210	5	x	x	PROPN
dti-2573	210	6	-	-	PUNCT
dti-2573	210	7	j	j	PROPN
dti-2573	210	8	,	,	PUNCT
dti-2573	210	9	cao	cao	PROPN
dti-2573	210	10	y.	y.	PROPN
dti-2573	210	11	familial	familial	ADJ
dti-2573	210	12	risk	risk	NOUN
dti-2573	210	13	for	for	ADP
dti-2573	210	14	lung	lung	NOUN
dti-2573	210	15	cancer	cancer	NOUN
dti-2573	210	16	.	.	PUNCT
dti-2573	211	1	oncol	oncol	ADJ
dti-2573	211	2	lett	lett	PROPN
dti-2573	211	3	.	.	PUNCT
dti-2573	212	1	2017;13(2):535	2017;13(2):535	PROPN
dti-2573	212	2	-	-	PUNCT
dti-2573	212	3	542	542	NUM
dti-2573	212	4	.	.	PUNCT
dti-2573	213	1	crossref	crossref	PROPN
dti-2573	213	2	pubmed	pubmed	PROPN
dti-2573	213	3	28	28	PROPN
dti-2573	213	4	.	.	PUNCT
dti-2573	214	1	scragg	scragg	PROPN
dti-2573	214	2	r	r	NOUN
dti-2573	214	3	,	,	PUNCT
dti-2573	214	4	glover	glover	PROPN
dti-2573	214	5	m.	m.	NOUN
dti-2573	214	6	parental	parental	ADJ
dti-2573	214	7	and	and	CCONJ
dti-2573	214	8	adolescent	adolescent	ADJ
dti-2573	214	9	smoking	smoking	NOUN
dti-2573	214	10	:	:	PUNCT
dti-2573	214	11	does	do	AUX
dti-2573	214	12	the	the	DET
dti-2573	214	13	association	association	NOUN
dti-2573	214	14	vary	vary	VERB
dti-2573	214	15	with	with	ADP
dti-2573	214	16	gender	gender	NOUN
dti-2573	214	17	and	and	CCONJ
dti-2573	214	18	ethnicity	ethnicity	NOUN
dti-2573	214	19	?	?	PUNCT
dti-2573	215	1	n	n	CCONJ
dti-2573	215	2	z	z	PROPN
dti-2573	215	3	med	me	VERB
dti-2573	215	4	j.	j.	PROPN
dti-2573	215	5	2007;120(1267):u2862	2007;120(1267):u2862	PROPN
dti-2573	215	6	.	.	PUNCT
dti-2573	216	1	pubmed	pubmed	PROPN
dti-2573	216	2	29	29	NUM
dti-2573	216	3	.	.	PUNCT
dti-2573	217	1	salber	salber	PROPN
dti-2573	217	2	ej	ej	PROPN
dti-2573	217	3	,	,	PUNCT
dti-2573	217	4	macmahon	macmahon	PROPN
dti-2573	217	5	b.	b.	PROPN
dti-2573	217	6	cigarette	cigarette	PROPN
dti-2573	217	7	smoking	smoking	NOUN
dti-2573	217	8	among	among	ADP
dti-2573	217	9	high	high	ADJ
dti-2573	217	10	school	school	NOUN
dti-2573	217	11	students	student	NOUN
dti-2573	217	12	related	relate	VERB
dti-2573	217	13	to	to	ADP
dti-2573	217	14	social	social	ADJ
dti-2573	217	15	class	class	NOUN
dti-2573	217	16	and	and	CCONJ
dti-2573	217	17	parental	parental	ADJ
dti-2573	217	18	smoking	smoking	NOUN
dti-2573	217	19	habits	habit	NOUN
dti-2573	217	20	.	.	PUNCT
dti-2573	218	1	am	be	AUX
dti-2573	218	2	j	j	PROPN
dti-2573	218	3	public	public	ADJ
dti-2573	218	4	health	health	PROPN
dti-2573	218	5	nations	nations	PROPN
dti-2573	218	6	health	health	NOUN
dti-2573	218	7	.	.	PUNCT
dti-2573	219	1	1961;51(12):1780	1961;51(12):1780	NUM
dti-2573	219	2	-	-	SYM
dti-2573	219	3	1789	1789	NUM
dti-2573	219	4	.	.	PUNCT
dti-2573	220	1	crossref	crossref	PROPN
dti-2573	220	2	pubmed	pubmed	PROPN
dti-2573	220	3	30	30	NUM
dti-2573	220	4	.	.	PUNCT
dti-2573	221	1	coté	coté	PROPN
dti-2573	221	2	ml	ml	PROPN
dti-2573	221	3	,	,	PUNCT
dti-2573	221	4	liu	liu	PROPN
dti-2573	221	5	m	m	PROPN
dti-2573	221	6	,	,	PUNCT
dti-2573	221	7	bonassi	bonassi	PROPN
dti-2573	221	8	s	s	PROPN
dti-2573	221	9	,	,	PUNCT
dti-2573	221	10	et	et	PROPN
dti-2573	221	11	al	al	PROPN
dti-2573	221	12	.	.	PROPN
dti-2573	221	13	increased	increase	VERB
dti-2573	221	14	risk	risk	NOUN
dti-2573	221	15	of	of	ADP
dti-2573	221	16	lung	lung	NOUN
dti-2573	221	17	cancer	cancer	NOUN
dti-2573	221	18	in	in	ADP
dti-2573	221	19	individuals	individual	NOUN
dti-2573	221	20	with	with	ADP
dti-2573	221	21	a	a	DET
dti-2573	221	22	family	family	NOUN
dti-2573	221	23	history	history	NOUN
dti-2573	221	24	of	of	ADP
dti-2573	221	25	the	the	DET
dti-2573	221	26	disease	disease	NOUN
dti-2573	221	27	:	:	PUNCT
dti-2573	221	28	a	a	DET
dti-2573	221	29	pooled	pool	VERB
dti-2573	221	30	analysis	analysis	NOUN
dti-2573	221	31	from	from	ADP
dti-2573	221	32	the	the	DET
dti-2573	221	33	international	international	ADJ
dti-2573	221	34	lung	lung	NOUN
dti-2573	221	35	cancer	cancer	NOUN
dti-2573	221	36	consortium	consortium	NOUN
dti-2573	221	37	.	.	PUNCT
dti-2573	222	1	eur	eur	PROPN
dti-2573	222	2	j	j	PROPN
dti-2573	222	3	cancer	cancer	NOUN
dti-2573	222	4	.	.	PUNCT
dti-2573	223	1	2012;48(13):1957	2012;48(13):1957	NUM
dti-2573	223	2	-	-	SYM
dti-2573	223	3	1968	1968	NUM
dti-2573	223	4	.	.	PUNCT
dti-2573	224	1	crossref	crossref	PROPN
dti-2573	224	2	pubmed	pubmed	PROPN
dti-2573	224	3	31	31	NUM
dti-2573	224	4	.	.	PUNCT
dti-2573	225	1	yamamoto	yamamoto	PROPN
dti-2573	225	2	h	h	PROPN
dti-2573	225	3	,	,	PUNCT
dti-2573	225	4	higasa	higasa	PROPN
dti-2573	225	5	k	k	NOUN
dti-2573	225	6	,	,	PUNCT
dti-2573	225	7	sakaguchi	sakaguchi	PROPN
dti-2573	225	8	m	m	PROPN
dti-2573	225	9	,	,	PUNCT
dti-2573	225	10	et	et	PROPN
dti-2573	225	11	al	al	PROPN
dti-2573	225	12	.	.	PROPN
dti-2573	225	13	novel	novel	PROPN
dti-2573	225	14	germline	germline	NOUN
dti-2573	225	15	mutation	mutation	NOUN
dti-2573	225	16	in	in	ADP
dti-2573	225	17	the	the	DET
dti-2573	225	18	transmembrane	transmembrane	ADJ
dti-2573	225	19	domain	domain	NOUN
dti-2573	225	20	of	of	ADP
dti-2573	225	21	her2	her2	PROPN
dti-2573	225	22	in	in	ADP
dti-2573	225	23	familial	familial	ADJ
dti-2573	225	24	lung	lung	NOUN
dti-2573	225	25	adenocarcinomas	adenocarcinoma	NOUN
dti-2573	225	26	.	.	PUNCT
dti-2573	226	1	j	j	PROPN
dti-2573	226	2	natl	natl	PROPN
dti-2573	226	3	cancer	cancer	PROPN
dti-2573	226	4	inst	inst	PROPN
dti-2573	226	5	.	.	PUNCT
dti-2573	227	1	2014;106(1):djt338	2014;106(1):djt338	NUM
dti-2573	227	2	.	.	PUNCT
dti-2573	228	1	crossref	crossref	PROPN
dti-2573	228	2	pubmed	pubmed	PROPN
dti-2573	228	3	32	32	NUM
dti-2573	228	4	.	.	PUNCT
dti-2573	229	1	bell	bell	PROPN
dti-2573	229	2	dw	dw	PROPN
dti-2573	229	3	,	,	PUNCT
dti-2573	229	4	gore	gore	PROPN
dti-2573	229	5	i	i	PROPN
dti-2573	229	6	,	,	PUNCT
dti-2573	229	7	okimoto	okimoto	PROPN
dti-2573	229	8	ra	ra	PROPN
dti-2573	229	9	,	,	PUNCT
dti-2573	229	10	et	et	PROPN
dti-2573	229	11	al	al	PROPN
dti-2573	229	12	.	.	PROPN
dti-2573	229	13	inherited	inherit	VERB
dti-2573	229	14	susceptibility	susceptibility	NOUN
dti-2573	229	15	to	to	ADP
dti-2573	229	16	lung	lung	NOUN
dti-2573	229	17	cancer	cancer	NOUN
dti-2573	229	18	may	may	AUX
dti-2573	229	19	be	be	AUX
dti-2573	229	20	associated	associate	VERB
dti-2573	229	21	with	with	ADP
dti-2573	229	22	the	the	DET
dti-2573	229	23	t790	t790	NUM
dti-2573	229	24	m	m	NOUN
dti-2573	229	25	drug	drug	NOUN
dti-2573	229	26	resistance	resistance	NOUN
dti-2573	229	27	mutation	mutation	NOUN
dti-2573	229	28	in	in	ADP
dti-2573	229	29	egfr	egfr	NOUN
dti-2573	229	30	.	.	PUNCT
dti-2573	230	1	nat	nat	PROPN
dti-2573	230	2	genet	genet	PROPN
dti-2573	230	3	.	.	PUNCT
dti-2573	231	1	2005;37(12):1315	2005;37(12):1315	X
dti-2573	231	2	-	-	SYM
dti-2573	231	3	1316	1316	NUM
dti-2573	231	4	.	.	PUNCT
dti-2573	232	1	crossref	crossref	PROPN
dti-2573	232	2	pubmed	pubmed	PROPN
dti-2573	232	3	33	33	NUM
dti-2573	232	4	.	.	PUNCT
dti-2573	233	1	sawunyavisuth	sawunyavisuth	PROPN
dti-2573	233	2	b	b	NOUN
dti-2573	233	3	,	,	PUNCT
dti-2573	233	4	ngamjarus	ngamjarus	NOUN
dti-2573	233	5	c	c	NOUN
dti-2573	233	6	,	,	PUNCT
dti-2573	233	7	sawanyawisuth	sawanyawisuth	PROPN
dti-2573	233	8	k.	k.	PROPN
dti-2573	234	1	a	a	DET
dti-2573	234	2	metaanalysis	metaanalysis	NOUN
dti-2573	234	3	to	to	PART
dti-2573	234	4	identify	identify	VERB
dti-2573	234	5	factors	factor	NOUN
dti-2573	234	6	associated	associate	VERB
dti-2573	234	7	with	with	ADP
dti-2573	234	8	cpap	cpap	NOUN
dti-2573	234	9	machine	machine	NOUN
dti-2573	234	10	purchasing	purchasing	NOUN
dti-2573	234	11	in	in	ADP
dti-2573	234	12	patients	patient	NOUN
dti-2573	234	13	with	with	ADP
dti-2573	234	14	obstructive	obstructive	ADJ
dti-2573	234	15	sleep	sleep	NOUN
dti-2573	234	16	apnea	apnea	NOUN
dti-2573	234	17	.	.	PUNCT
dti-2573	234	18	biomed	biome	VERB
dti-2573	234	19	rep	rep	PROPN
dti-2573	234	20	.	.	PROPN
dti-2573	234	21	2022;16(6):45	2022;16(6):45	X
dti-2573	234	22	.	.	PUNCT
dti-2573	235	1	crossref	crossref	PROPN
dti-2573	235	2	pubmed	pubmed	PROPN
dti-2573	235	3	34	34	NUM
dti-2573	235	4	.	.	PUNCT
dti-2573	236	1	sanlung	sanlung	PROPN
dti-2573	236	2	t	t	PROPN
dti-2573	236	3	,	,	PUNCT
dti-2573	236	4	sawanyawisuth	sawanyawisuth	NOUN
dti-2573	236	5	k	k	NOUN
dti-2573	236	6	,	,	PUNCT
dti-2573	236	7	silaruks	silaruks	PROPN
dti-2573	236	8	s	s	PROPN
dti-2573	236	9	,	,	PUNCT
dti-2573	236	10	et	et	PROPN
dti-2573	236	11	al	al	PROPN
dti-2573	236	12	.	.	PROPN
dti-2573	237	1	clinical	clinical	ADJ
dti-2573	237	2	characteristics	characteristic	NOUN
dti-2573	237	3	and	and	CCONJ
dti-2573	237	4	complications	complication	NOUN
dti-2573	237	5	of	of	ADP
dti-2573	237	6	obstructive	obstructive	ADJ
dti-2573	237	7	sleep	sleep	NOUN
dti-2573	237	8	apnea	apnea	NOUN
dti-2573	237	9	in	in	ADP
dti-2573	237	10	srinagarind	srinagarind	ADJ
dti-2573	237	11	hospital	hospital	NOUN
dti-2573	237	12	.	.	PUNCT
dti-2573	238	1	j	j	PROPN
dti-2573	238	2	med	med	PROPN
dti-2573	238	3	assoc	assoc	PROPN
dti-2573	238	4	thai	thai	PROPN
dti-2573	238	5	.	.	PUNCT
dti-2573	239	1	2020;103(1):36	2020;103(1):36	NUM
dti-2573	239	2	-	-	SYM
dti-2573	239	3	39	39	NUM
dti-2573	239	4	.	.	PUNCT
dti-2573	240	1	35	35	NUM
dti-2573	240	2	.	.	PUNCT
dti-2573	241	1	khamsai	khamsai	PROPN
dti-2573	241	2	s	s	PROPN
dti-2573	241	3	,	,	PUNCT
dti-2573	241	4	kachenchart	kachenchart	PROPN
dti-2573	241	5	s	s	PROPN
dti-2573	241	6	,	,	PUNCT
dti-2573	241	7	sawunyavisuth	sawunyavisuth	ADJ
dti-2573	241	8	b	b	NOUN
dti-2573	241	9	,	,	PUNCT
dti-2573	241	10	et	et	PROPN
dti-2573	241	11	al	al	PROPN
dti-2573	241	12	.	.	PUNCT
dti-2573	242	1	prevalence	prevalence	NOUN
dti-2573	242	2	and	and	CCONJ
dti-2573	242	3	risk	risk	NOUN
dti-2573	242	4	factors	factor	NOUN
dti-2573	242	5	of	of	ADP
dti-2573	242	6	obstructive	obstructive	ADJ
dti-2573	242	7	sleep	sleep	NOUN
dti-2573	242	8	apnea	apnea	NOUN
dti-2573	242	9	in	in	ADP
dti-2573	242	10	hypertensive	hypertensive	ADJ
dti-2573	242	11	emergency	emergency	NOUN
dti-2573	242	12	.	.	PUNCT
dti-2573	243	1	j	j	PROPN
dti-2573	243	2	emerg	emerg	PROPN
dti-2573	243	3	trauma	trauma	NOUN
dti-2573	243	4	shock	shock	NOUN
dti-2573	243	5	.	.	PUNCT
dti-2573	244	1	2021;14(2):104	2021;14(2):104	X
dti-2573	244	2	-	-	PUNCT
dti-2573	244	3	107	107	PROPN
dti-2573	244	4	.	.	PUNCT
dti-2573	245	1	crossref	crossref	PROPN
dti-2573	245	2	pubmed	pubmed	PROPN
dti-2573	245	3	36	36	NUM
dti-2573	245	4	.	.	PUNCT
dti-2573	246	1	sawunyavisuth	sawunyavisuth	PROPN
dti-2573	246	2	b	b	NOUN
dti-2573	246	3	,	,	PUNCT
dti-2573	246	4	ngamjarus	ngamjarus	NOUN
dti-2573	246	5	c	c	NOUN
dti-2573	246	6	,	,	PUNCT
dti-2573	246	7	sawanyawisuth	sawanyawisuth	PROPN
dti-2573	246	8	k.	k.	PROPN
dti-2573	247	1	any	any	DET
dti-2573	247	2	effective	effective	ADJ
dti-2573	247	3	intervention	intervention	NOUN
dti-2573	247	4	to	to	PART
dti-2573	247	5	improve	improve	VERB
dti-2573	247	6	cpap	cpap	NOUN
dti-2573	247	7	adherence	adherence	NOUN
dti-2573	247	8	in	in	ADP
dti-2573	247	9	children	child	NOUN
dti-2573	247	10	with	with	ADP
dti-2573	247	11	obstructive	obstructive	ADJ
dti-2573	247	12	sleep	sleep	NOUN
dti-2573	247	13	apnea	apnea	NOUN
dti-2573	247	14	:	:	PUNCT
dti-2573	247	15	a	a	DET
dti-2573	247	16	systematic	systematic	ADJ
dti-2573	247	17	review	review	NOUN
dti-2573	247	18	.	.	PUNCT
dti-2573	248	1	glob	glob	NOUN
dti-2573	248	2	pediatr	pediatr	ADJ
dti-2573	248	3	health	health	NOUN
dti-2573	248	4	.	.	PUNCT
dti-2573	249	1	2021;8:1	2021;8:1	NOUN
dti-2573	249	2	-	-	SYM
dti-2573	249	3	8	8	NUM
dti-2573	249	4	.	.	PUNCT
dti-2573	250	1	crossref	crossref	PROPN
dti-2573	250	2	37	37	NUM
dti-2573	250	3	.	.	PUNCT
dti-2573	251	1	sawunyavisuth	sawunyavisuth	PROPN
dti-2573	251	2	b.	b.	PROPN
dti-2573	252	1	what	what	PRON
dti-2573	252	2	personal	personal	ADJ
dti-2573	252	3	experiences	experience	NOUN
dti-2573	252	4	of	of	ADP
dti-2573	252	5	cpap	cpap	NOUN
dti-2573	252	6	use	use	NOUN
dti-2573	252	7	affect	affect	VERB
dti-2573	252	8	cpap	cpap	NOUN
dti-2573	252	9	adherence	adherence	NOUN
dti-2573	252	10	and	and	CCONJ
dti-2573	252	11	duration	duration	NOUN
dti-2573	252	12	of	of	ADP
dti-2573	252	13	cpap	cpap	NOUN
dti-2573	252	14	use	use	NOUN
dti-2573	252	15	in	in	ADP
dti-2573	252	16	osa	osa	PROPN
dti-2573	252	17	patients	patient	NOUN
dti-2573	252	18	?	?	PUNCT
dti-2573	253	1	j	j	PROPN
dti-2573	253	2	med	med	PROPN
dti-2573	253	3	assoc	assoc	PROPN
dti-2573	253	4	thai	thai	PROPN
dti-2573	253	5	.	.	PUNCT
dti-2573	254	1	2018;101(7):s245	2018;101(7):s245	NUM
dti-2573	254	2	-	-	PUNCT
dti-2573	254	3	s249	s249	PROPN
dti-2573	254	4	.	.	PROPN
dti-2573	255	1	38	38	NUM
dti-2573	255	2	.	.	PUNCT
dti-2573	256	1	kaewkes	kaewke	NOUN
dti-2573	256	2	c	c	PROPN
dti-2573	256	3	,	,	PUNCT
dti-2573	256	4	sawanyawisuth	sawanyawisuth	ADJ
dti-2573	256	5	k	k	NOUN
dti-2573	256	6	,	,	PUNCT
dti-2573	256	7	sawunyavisuth	sawunyavisuth	PROPN
dti-2573	256	8	b.	b.	PROPN
dti-2573	256	9	are	be	AUX
dti-2573	256	10	symptoms	symptom	NOUN
dti-2573	256	11	of	of	ADP
dti-2573	256	12	obstructive	obstructive	ADJ
dti-2573	256	13	sleep	sleep	NOUN
dti-2573	256	14	apnoea	apnoea	NOUN
dti-2573	256	15	related	relate	VERB
dti-2573	256	16	to	to	ADP
dti-2573	256	17	good	good	ADJ
dti-2573	256	18	continuous	continuous	ADJ
dti-2573	256	19	positive	positive	ADJ
dti-2573	256	20	airway	airway	NOUN
dti-2573	256	21	pressure	pressure	NOUN
dti-2573	256	22	compliance	compliance	NOUN
dti-2573	256	23	?	?	PUNCT
dti-2573	257	1	erj	erj	PROPN
dti-2573	257	2	open	open	ADJ
dti-2573	257	3	res	re	NOUN
dti-2573	257	4	.	.	PUNCT
dti-2573	258	1	2020;6(3):0016902019	2020;6(3):0016902019	X
dti-2573	258	2	.	.	PUNCT
dti-2573	258	3	crossref	crossref	PROPN
dti-2573	258	4	pubmed	pubmed	PROPN
dti-2573	258	5	https://doi.org/10.1016/j.dsx.2020.09.008	https://doi.org/10.1016/j.dsx.2020.09.008	PROPN
dti-2573	258	6	https://www.ncbi.nlm.nih.gov/pubmed/32992217	https://www.ncbi.nlm.nih.gov/pubmed/32992217	PROPN
dti-2573	258	7	https://doi.org/10.1186/s12872-021-02119-x	https://doi.org/10.1186/s12872-021-02119-x	PROPN
dti-2573	258	8	https://www.ncbi.nlm.nih.gov/pubmed/34162333	https://www.ncbi.nlm.nih.gov/pubmed/34162333	NUM
dti-2573	258	9	https://doi.org/10.1001/jama.2013.284427	https://doi.org/10.1001/jama.2013.284427	PROPN
dti-2573	258	10	https://www.ncbi.nlm.nih.gov/pubmed/24352797	https://www.ncbi.nlm.nih.gov/pubmed/24352797	ADP
dti-2573	258	11	https://doi.org/10.1016/0895-7061(96)00186-0	https://doi.org/10.1016/0895-7061(96)00186-0	ADJ
dti-2573	258	12	https://www.ncbi.nlm.nih.gov/pubmed/8806983	https://www.ncbi.nlm.nih.gov/pubmed/8806983	X
dti-2573	258	13	https://doi.org/10.1371/journal.pone.0050893	https://doi.org/10.1371/journal.pone.0050893	PROPN
dti-2573	258	14	https://www.ncbi.nlm.nih.gov/pubmed/23251399	https://www.ncbi.nlm.nih.gov/pubmed/23251399	NOUN
dti-2573	258	15	https://doi.org/10.1177/1060028018814684	https://doi.org/10.1177/1060028018814684	PRON
dti-2573	258	16	https://www.ncbi.nlm.nih.gov/pubmed/30442036	https://www.ncbi.nlm.nih.gov/pubmed/30442036	X
dti-2573	258	17	https://doi.org/10.1007/s40264-018-0644-4	https://doi.org/10.1007/s40264-018-0644-4	NUM
dti-2573	258	18	https://www.ncbi.nlm.nih.gov/pubmed/29484611	https://www.ncbi.nlm.nih.gov/pubmed/29484611	PROPN
dti-2573	258	19	https://doi.org/10.1097/00004872-199816010-00017	https://doi.org/10.1097/00004872-199816010-00017	ADP
dti-2573	258	20	https://www.ncbi.nlm.nih.gov/pubmed/9533425	https://www.ncbi.nlm.nih.gov/pubmed/9533425	NUM
dti-2573	258	21	https://doi.org/10.1002/(sici)1097-0142(19981101)83:9<2003::aid-cncr17>3.0.co;2-3	https://doi.org/10.1002/(sici)1097-0142(19981101)83:9<2003::aid-cncr17>3.0.co;2-3	NOUN
dti-2573	258	22	https://www.ncbi.nlm.nih.gov/pubmed/9806660	https://www.ncbi.nlm.nih.gov/pubmed/9806660	X
dti-2573	258	23	https://doi.org/10.3389/fphar.2020.610157	https://doi.org/10.3389/fphar.2020.610157	PROPN
dti-2573	258	24	https://www.ncbi.nlm.nih.gov/pubmed/33381045	https://www.ncbi.nlm.nih.gov/pubmed/33381045	PRON
dti-2573	258	25	https://doi.org/10.1016/s0735-1097(99)00447-7	https://doi.org/10.1016/s0735-1097(99)00447-7	NOUN
dti-2573	258	26	https://www.ncbi.nlm.nih.gov/pubmed/10588195	https://www.ncbi.nlm.nih.gov/pubmed/10588195	X
dti-2573	258	27	https://doi.org/10.1016/s0140-6736(97)80084-0	https://doi.org/10.1016/s0140-6736(97)80084-0	PROPN
dti-2573	258	28	https://www.ncbi.nlm.nih.gov/pubmed/9048789	https://www.ncbi.nlm.nih.gov/pubmed/9048789	PRON
dti-2573	258	29	https://doi.org/10.1038/ncomms12961	https://doi.org/10.1038/ncomms12961	PROPN
dti-2573	258	30	https://www.ncbi.nlm.nih.gov/pubmed/27666821	https://www.ncbi.nlm.nih.gov/pubmed/27666821	NUM
dti-2573	258	31	https://doi.org/10.1038/sj.onc.1206134	https://doi.org/10.1038/sj.onc.1206134	X
dti-2573	258	32	https://www.ncbi.nlm.nih.gov/pubmed/12555074	https://www.ncbi.nlm.nih.gov/pubmed/12555074	X
dti-2573	258	33	https://doi.org/10.1186/s12885-021-08971-6	https://doi.org/10.1186/s12885-021-08971-6	NUM
dti-2573	258	34	https://www.ncbi.nlm.nih.gov/pubmed/34763668	https://www.ncbi.nlm.nih.gov/pubmed/34763668	NUM
dti-2573	258	35	https://doi.org/10.1186/s12944-018-0925-z	https://doi.org/10.1186/s12944-018-0925-z	ADV
dti-2573	258	36	https://www.ncbi.nlm.nih.gov/pubmed/30522496	https://www.ncbi.nlm.nih.gov/pubmed/30522496	PUNCT
dti-2573	258	37	https://doi.org/10.1158/1535-7163.mct-11-0905	https://doi.org/10.1158/1535-7163.mct-11-0905	VERB
dti-2573	258	38	https://www.ncbi.nlm.nih.gov/pubmed/22416044	https://www.ncbi.nlm.nih.gov/pubmed/22416044	X
dti-2573	258	39	https://doi.org/10.1016/j.ijrobp.2014.12.039	https://doi.org/10.1016/j.ijrobp.2014.12.039	NOUN
dti-2573	258	40	https://www.ncbi.nlm.nih.gov/pubmed/25832697	https://www.ncbi.nlm.nih.gov/pubmed/25832697	NUM
dti-2573	258	41	https://doi.org/10.1007/s10552-010-9537-2	https://doi.org/10.1007/s10552-010-9537-2	NOUN
dti-2573	258	42	https://www.ncbi.nlm.nih.gov/pubmed/20306329	https://www.ncbi.nlm.nih.gov/pubmed/20306329	PRON
dti-2573	258	43	https://doi.org/10.1038/s41598-021-00929-9	https://doi.org/10.1038/s41598-021-00929-9	NUM
dti-2573	258	44	https://www.ncbi.nlm.nih.gov/pubmed/34750403	https://www.ncbi.nlm.nih.gov/pubmed/34750403	NUM
dti-2573	258	45	https://doi.org/10.3892/ol.2016.5518	https://doi.org/10.3892/ol.2016.5518	NOUN
dti-2573	258	46	https://www.ncbi.nlm.nih.gov/pubmed/28356926	https://www.ncbi.nlm.nih.gov/pubmed/28356926	NUM
dti-2573	258	47	https://www.ncbi.nlm.nih.gov/pubmed/18157188	https://www.ncbi.nlm.nih.gov/pubmed/18157188	PROPN
dti-2573	258	48	https://doi.org/10.2105/ajph.51.12.1780	https://doi.org/10.2105/ajph.51.12.1780	ADJ
dti-2573	258	49	https://www.ncbi.nlm.nih.gov/pubmed/14496305	https://www.ncbi.nlm.nih.gov/pubmed/14496305	NOUN
dti-2573	258	50	https://doi.org/10.1016/j.ejca.2012.01.038	https://doi.org/10.1016/j.ejca.2012.01.038	PROPN
dti-2573	258	51	https://www.ncbi.nlm.nih.gov/pubmed/22436981	https://www.ncbi.nlm.nih.gov/pubmed/22436981	X
dti-2573	258	52	https://doi.org/10.1093/jnci/djt338	https://doi.org/10.1093/jnci/djt338	VERB
dti-2573	258	53	https://www.ncbi.nlm.nih.gov/pubmed/24317180	https://www.ncbi.nlm.nih.gov/pubmed/24317180	NUM
dti-2573	258	54	https://doi.org/10.1038/ng1671	https://doi.org/10.1038/ng1671	X
dti-2573	258	55	https://www.ncbi.nlm.nih.gov/pubmed/16258541	https://www.ncbi.nlm.nih.gov/pubmed/16258541	PRON
dti-2573	258	56	https://doi.org/10.3892/br.2022.1528	https://doi.org/10.3892/br.2022.1528	NOUN
dti-2573	258	57	https://www.ncbi.nlm.nih.gov/pubmed/35620316	https://www.ncbi.nlm.nih.gov/pubmed/35620316	NUM
dti-2573	258	58	https://doi.org/10.4103/jets.jets_47_20	https://doi.org/10.4103/jets.jets_47_20	NOUN
dti-2573	258	59	https://www.ncbi.nlm.nih.gov/pubmed/34321809	https://www.ncbi.nlm.nih.gov/pubmed/34321809	PROPN
dti-2573	258	60	https://doi.org/10.1177/2333794x211019884	https://doi.org/10.1177/2333794x211019884	PROPN
dti-2573	258	61	https://doi.org/10.1183/23120541.00169-2019	https://doi.org/10.1183/23120541.00169-2019	NOUN
dti-2573	258	62	https://www.ncbi.nlm.nih.gov/pubmed/33015148	https://www.ncbi.nlm.nih.gov/pubmed/33015148	NOUN